% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-11}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1696.

\begin{enumerate}[leftmargin=*]
\item Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki (2026). \textit{Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress}. Neuropsychopharmacology Reports. [published; Crossref]. \href{https://doi.org/10.1002/npr2.70152}{doi:10.1002/npr2.70152}.
\item Bruyère Health Research Institute. (2026). \textit{PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07063862}{source link}.
\item Ottawa Hospital Research Institute (2026). \textit{PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04754061}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06341426}{source link}.
\item Yale University (2026). \textit{Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06624137}{source link}.
\item Paslawski W, Doyon D, Ekman CJ, Yngwe H, Mamula D, Zareba-Paslawska J, Beckman M, Xu ZD, Hökfelt T, Tiger M, Lundberg J, Svenningsson P. (2026). \textit{CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-026-02490-3}{doi:10.1038/s41386-026-02490-3}.
\item Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez (2026). \textit{Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review}. Mexican Journal of Medical Research ICSA. [published; OpenAlex]. \href{https://doi.org/10.29057/mjmr.v14i28.16493}{doi:10.29057/mjmr.v14i28.16493}.
\item Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C. (2026). \textit{Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00530}{doi:10.1556/2054.2026.00530}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Seale M. (2026). \textit{Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-10208910/v1}{doi:10.21203/rs.3.rs-10208910/v1}.
\item Hummel Haley M., Obrochta Alexia N., Kerr David C. R., Cservenka Anita (2026). \textit{Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms}. Journal of Drug Issues. [published; Crossref]. \href{https://doi.org/10.1177/00220426261466154}{doi:10.1177/00220426261466154}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y. (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item Centre Hospitalier Universitaire de Nīmes (2026). \textit{Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07638553}{source link}.
\item Pasquini L, Vohryzek J, Escrichs A, Perl YS, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL. (2026). \textit{MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d6cp00943c}{doi:10.1039/d6cp00943c}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Sharp T, Ippolito A (2026). \textit{Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70050}{doi:10.1111/bph.70050}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Arikci D, Borgulya J, Straumann I, Vizeli P, Luethi D, Thomann J, Rudin D, Vukalovic I, Eckert A, Liechti ME, Holze F (2026). \textit{Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02428-9}{doi:10.1038/s41386-026-02428-9}.
\item Ladislavová L, Kútná V, Mazochová K, Šíchová K, Danda H, Lhotková E, Uttl L, Brejtr V, Syrová K, Mazoch V, Horsley R, Páleníček T. (2026). \textit{Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2026.174231}{doi:10.1016/j.pbb.2026.174231}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT. (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Yale University (2026). \textit{The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610369}{source link}.
\item Du Y, Zhao X, Yao Y, Li Y, Wang G, Zhang L. (2026). \textit{Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261453819}{doi:10.1177/02698811261453819}.
\item University of California, San Diego (2026). \textit{Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06814522}{source link}.
\item Dagnino, P. C.; Acero-Pousa, I.; Carhart-Harris, R.; Erritzoe, D.; Nutt, D. J.; Kringelbach, M. L.; Sanz Perl, Y.; Deco, G. (2026). \textit{Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.22.733731}{doi:10.64898/2026.06.22.733731}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06884514}{source link}.
\item Anthony P King (2026). \textit{A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07104916}{source link}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Guidetti C, Fava M, Papakostas GI. (2026). \textit{Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03722-0}{doi:10.1038/s41380-026-03722-0}.
\item Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti (2026). \textit{Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04203-2}{doi:10.1038/s41398-026-04203-2}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06200155}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06801041}{source link}.
\item Yale University (2026). \textit{Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07449351}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07048743}{source link}.
\item Lenka Seillier, Alexandre Seillier, Morgan A. Zvolska, Romana Šlamberová (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R. (2026). \textit{Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9880403/v1}{doi:10.21203/rs.3.rs-9880403/v1}.
\item Carla J. Berg, Darcey M. McCready, Cassidy R. LoParco, Laura C. Schubel, Katelyn F. Romm, Shriya Thakkar, Jessica Williams, Patricia Cavazos-Rehg, Y. Tony Yang (2026). \textit{Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2026.2685527}{doi:10.1080/02791072.2026.2685527}.
\item Astrit Sabani, Adnan Khatak (2026). \textit{Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000005244}{doi:10.1097/ms9.0000000000005244}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G. (2026). \textit{Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.12.731811}{doi:10.64898/2026.06.12.731811}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA}. SAIMSARA Journal. [published; OpenAlex]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano (2026). \textit{Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis}. Psychiatry International. [published; OpenAlex]. \href{https://doi.org/10.3390/psychiatryint7030137}{doi:10.3390/psychiatryint7030137}.
\item Lucas Cruz, Fernando R. Beserra, Julia M.K. Freind, Sandro E. Rodrigues, Daniel C. Mograbi (2026). \textit{Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review}. Journal of Clinical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1002/jclp.70167}{doi:10.1002/jclp.70167}.
\item J. Mingardi, R. Molteni, F. Bifari (2026). \textit{Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression}. Pharmacological Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phrs.2026.108290}{doi:10.1016/j.phrs.2026.108290}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v2}{source link}.
\item Helerin Raikkerus, Andrea Bujour, Mark Kennedy, Jari Tiihonen (2026). \textit{The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2026.10088}{doi:10.1017/neu.2026.10088}.
\item VA Office of Research and Development (2026). \textit{A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07226232}{source link}.
\item Matthew J. Reid, Hannes Kettner, Tessa F. Blanken, Brandon Weiss, Robin Carhart-Harris (2026). \textit{Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action}. Current Psychiatry Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s11920-026-01685-1}{doi:10.1007/s11920-026-01685-1}.
\item Cecelia Kelly, Mathieu Fradet, Catherine M. Bostian, Anna Donnelly, Sara Ellis, Michael Ostacher, Scott Aaronson, Trisha Suppes (2026). \textit{Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.122063}{doi:10.1016/j.jad.2026.122063}.
\item Carter D, Reardon I, Swain J, Vando L. (2026). \textit{Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9839240/v1}{doi:10.21203/rs.3.rs-9839240/v1}.
\item Genís Oña, Cristina Llagostera, Oscar Alvarez, Rosa M. Dueñas, Débora González, Óscar Soto-Angona (2026). \textit{Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy}. Natural Product Research. [published; OpenAlex]. \href{https://doi.org/10.1080/14786419.2026.2683121}{doi:10.1080/14786419.2026.2683121}.
\item Centre for Addiction and Mental Health (2026). \textit{Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512220}{source link}.
\item Usona Institute (2026). \textit{A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06308653}{source link}.
\item Yosr Ziadi, Taehwan Park (2026). \textit{EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION}. Value in Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jval.2026.03.635}{doi:10.1016/j.jval.2026.03.635}.
\item Christopher W. T. Miller, Zofia Kozak (2026). \textit{Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens}. Psychodynamic Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1521/pdps.2026.54.2.308}{doi:10.1521/pdps.2026.54.2.308}.
\item C. Poppe, Liisa Lyck, Laura Bechtold, Dimitris Repantis (2026). \textit{Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71544}{doi:10.1002/brb3.71544}.
\item Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item University of Washington (2026). \textit{A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07336238}{source link}.
\item Valerie A. Canady (2026). \textit{Psilocybin shows rapid relief for depression symptoms}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34890}{doi:10.1002/mhw.34890}.
\item Unknown authors (2026). \textit{Psilocybin shows mixed results for patients with treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31461}{doi:10.1002/pu.31461}.
\item Alex Hood, Gary ELKINS (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Elliot Hampsey, Kirsty Martin, Michail Kalfas, Louis Benson, Sirid Wihlborg, Luke Jelen, Allan H. Young, James Rucker (2026). \textit{A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261453938}{doi:10.1177/02698811261453938}.
\item Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M. (2026). \textit{Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03657-6}{doi:10.1038/s41380-026-03657-6}.
\item Mazen A. Atiq, Eli Weisman, Rodrigo B. Guerra, Luis Luna Martinez, David B. Yaden, Frederick S. Barrett, Sandeep Nayak, Ceyda Sayalı (2026). \textit{Psilocybin-induced neurocardiogenic syncope: a case report}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07079-8}{doi:10.1007/s00213-026-07079-8}.
\item Lea J. Mertens, Felix Betzler, Manuela Brand, Ricarda Evens, Andrea Jungaberle, Henrik Jungaberle, Laura Kärtner, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Henry Harder, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz M. Berger, Michael Koslowski, Gerhard Gründer (2026). \textit{Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial}. Psychotherapy and Psychosomatics. [published; OpenAlex]. \href{https://doi.org/10.1159/000552272}{doi:10.1159/000552272}.
\item Jasbir Singh, Pranathi Mruthyunjaya (2026). \textit{Catatonia Associated With First-Time Psilocybin Exposure: A Case Report}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.c439}{doi:10.7759/cureus.c439}.
\item Emory University (2026). \textit{The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07332143}{source link}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Spanagel R, Vollenweider FX, Preller KH, Meinhardt MW. (2026). \textit{Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03961-3}{doi:10.1038/s41398-026-03961-3}.
\item Laursen DRT, Salazar J, Jürgens G, Hróbjartsson A. (2026). \textit{Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jclinepi.2026.112345}{doi:10.1016/j.jclinepi.2026.112345}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Caleb Lemus (2026). \textit{Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713\&context=dmscjournal}{source link}.
\item Hampus Yngwe, J O Lundberg (2026). \textit{A single dose of psilocybin eased depression symptoms for months, our study found}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/ab.esysa7wnu}{doi:10.64628/ab.esysa7wnu}.
\item University of Colorado, Denver (2026). \textit{Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06230757}{source link}.
\item Washington University School of Medicine (2026). \textit{A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07582120}{source link}.
\item University of California, Los Angeles (2026). \textit{Psilocybin-assisted Cognitive Behavioral Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227612}{source link}.
\item Hampus Yngwe, Pontus Plavén-Sigray, Carl Johan Ekman, Eva Henje, Anders Berglund, Mikael Tiger, Maria Beckman, J O Lundberg (2026). \textit{Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2026.12589}{doi:10.1001/jamanetworkopen.2026.12589}.
\item Alan Davis (2026). \textit{Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07216404}{source link}.
\item University of Calgary (2026). \textit{Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06885996}{source link}.
\item Sean M. Viña (2026). \textit{Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives5020014}{doi:10.3390/psychoactives5020014}.
\item Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; OpenAlex]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm, Scott T. Aaronson (2026). \textit{Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.26m16338}{doi:10.4088/jcp.26m16338}.
\item Khadija Kamene (2026). \textit{Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care}. Premier Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.70389/pjn.100014}{doi:10.70389/pjn.100014}.
\item Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ. (2026). \textit{Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9283280/v1}{doi:10.21203/rs.3.rs-9283280/v1}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item John R. Kelly, Christopher Sheridan, Patricia Iusan, Lisa Coakley, Lisa Burke, C. Brennan, Annie Annie MacDonald, Jo-Hanna Ivers, Dominic Trepel, Garrath Tormey, Martha Finnegan, Gareth W. Young, Andrew Harkin (2026). \textit{Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyag028}{doi:10.1093/ijnp/pyag028}.
\item University Medical Center Groningen (2026). \textit{The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06782724}{source link}.
\item Ioanna Artemis Vamvakopoulou, D. P. Nicholls, David J. Nutt, M. Di Simplicio (2026). \textit{Exploring new avenues: Psychedelic-assisted therapy for young people}. British Journal of Clinical Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1002/bcp.70579}{doi:10.1002/bcp.70579}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05710237}{source link}.
\item Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr (2026). \textit{Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.91.70672}{doi:10.12775/jehs.2026.91.70672}.
\item Bart A. Ellenbroek, Gernot Riedel (2026). \textit{Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000878}{doi:10.1097/fbp.0000000000000878}.
\item Sunstone Medical (2026). \textit{A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05947383}{source link}.
\item University of North Carolina, Chapel Hill (2026). \textit{Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06303739}{source link}.
\item Stanford University (2026). \textit{A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07479550}{source link}.
\item Lyons T, Spriggs M, Kerkelä L, Rosas FE, Roseman L, Mediano PAM, Timmermann C, Oestreich L, Pagni BA, Zeifman RJ, Hampshire A, Trender W, Douglass HM, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall MB, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2026). \textit{Human brain changes after first psilocybin use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-026-71962-3}{doi:10.1038/s41467-026-71962-3}.
\item Usona Institute (2026). \textit{A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04353921}{source link}.
\item University of Washington (2026). \textit{A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565909}{source link}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item University of California, Los Angeles (2026). \textit{Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07566104}{source link}.
\item Ceyda Sayalı, Eli Weisman, Frederick Barrett (2026). \textit{Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.21428/8e6ba8ef.31e358f9}{doi:10.21428/8e6ba8ef.31e358f9}.
\item Lakshmi N Yatham (2026). \textit{Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06943573}{source link}.
\item Joseph Hennessey, John Mantsch, John McCorvy (2026). \textit{Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104291}{doi:10.1016/j.jpet.2026.104291}.
\item Matthew Reid, Eli Weisman, Luis Luna Martinez, William Coon, Frederick Barrett (2026). \textit{1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsag091.1079}{doi:10.1093/sleep/zsag091.1079}.
\item Denise Vidot, Bria-Necole Diggs, Amrit Baral, Michelle Thompson, Girardin Jean-Louis (2026). \textit{0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsag091.0408}{doi:10.1093/sleep/zsag091.0408}.
\item Gyandev Gupta, Ravina Yadav (2026). \textit{Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical}. JOURNAL OF ADVANCE AND FUTURE RESEARCH. [published; OpenAlex]. \href{https://doi.org/10.56975/jaafr.v4i5.509087}{doi:10.56975/jaafr.v4i5.509087}.
\item Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F (2026). \textit{Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389581}{doi:10.1177/02698811251389581}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Otto Simonsson, Taylor Lyons, Joseph Marks, Hannes Kettner, Leor Roseman, Eline Haijen, Mendel Kaelen, Robin Carhart-Harris (2026). \textit{Effects of psychedelic use on authoritarian attitudes revisited}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261443677}{doi:10.1177/02698811261443677}.
\item Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Tatiana Son, Norman Farb, Rotem Petranker (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2026.12000}{doi:10.1192/bjo.2026.12000}.
\item Kristian Beichmann, Polina Catzeflis, Helena D. Aicher, Federico Seragnoli, Abigail Calder, Adam Amrani, Gregor Hasler (2026). \textit{Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261448745}{doi:10.1177/20451253261448745}.
\item University Hospital, Basel, Switzerland (2026). \textit{Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05883540}{source link}.
\item Joshua Woolley, MD, PhD (2026). \textit{A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05351541}{source link}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Joshua Poulin, Nic Viulet, Ashley Liu, Bradley J. MacIntosh, Sean M. Nestor (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Usona Institute (2026). \textit{A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03866174}{source link}.
\item Kyle Greenway (2026). \textit{Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07373535}{source link}.
\item Deivid Antonio Cahuasqui-Mendoza (2026). \textit{Psilocybin as an alternative to conventional treatments: A systematic review}. Gaceta Médica de Caracas. [published; OpenAlex]. \href{https://doi.org/10.47307/gmc.2026.134.s2.32}{doi:10.47307/gmc.2026.134.s2.32}.
\item Kevin H. Yang, Avery Eun, Joseph J. Palamar (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the United States}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20251343}{doi:10.1176/appi.ajp.20251343}.
\item University of Colorado, Denver (2026). \textit{Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06430541}{source link}.
\item Mohsen Khosravi, Domenico De Berardis, Massimo Tusconi (2026). \textit{The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes}. Mental Wellness. [published; OpenAlex]. \href{https://doi.org/10.4081/mw.2026.40}{doi:10.4081/mw.2026.40}.
\item Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari (2026). \textit{Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials}. Open Access Indonesian Journal of Medical Reviews. [published; OpenAlex]. \href{https://doi.org/10.37275/oaijmr.v6i2.883}{doi:10.37275/oaijmr.v6i2.883}.
\item Vipul Janardan, Amit Khanna, Om Prakash, Anadrika Debbarma, SK Mathur (2026). \textit{Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers}. Journal of Mental Health Disorders. [published; OpenAlex]. \href{https://doi.org/10.33696/mentalhealth.6.068}{doi:10.33696/mentalhealth.6.068}.
\item Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine Demirkhanyan (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions}. Current Issues in Molecular Biology. [published; OpenAlex]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Anthony L. Back, Bonnie A. McGregor, Leslie L. Thorn, Kalin Harvey, Dianna Blom, George Callan, John Guy, Sameet Kumar, Rob Hershberg, Melissa Layer, Jackie Levin, Susanna Myers, Juliana Perez, Kathy Salmonson, Peter Thompson, Joseph Whinney (2026). \textit{A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience}. Frontiers in Public Health. [published; OpenAlex]. \href{https://doi.org/10.3389/fpubh.2026.1810904}{doi:10.3389/fpubh.2026.1810904}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2026). \textit{CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06319378}{source link}.
\item J. Morgan Penberthy, Fatma Wise, Nicholas P. Cherup, Evaline Mitchell, Madeline Burns, Oluwafunmilayo Akinlade, David Chung, Harshit Parmar, Jonathan Singer (2026). \textit{Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives5020012}{doi:10.3390/psychoactives5020012}.
\item Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman (2026). \textit{Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.32048850}{doi:10.6084/m9.figshare.32048850}.
\item Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman (2026). \textit{Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression}. BMC Medical Education. [published; OpenAlex]. \href{https://doi.org/10.1186/s12909-026-09124-8}{doi:10.1186/s12909-026-09124-8}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item S. Parker Singleton, Brooke L. Sevchik, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon Vandekar, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite (2026). \textit{A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00630-8}{doi:10.1038/s44220-026-00630-8}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05546658}{source link}.
\item Shakila Meshkat, Manish K. Jha, Venkat Bhat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. FOCUS The Journal of Lifelong Learning in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Kush V. Bhatt, Joseph Friedman, Lindsay Benster, Rekha Narasimhan, Ke Yang, Jyoti Mishra, Cory R. Weissman, Dhakshin Ramanathan (2026). \textit{Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use}. Community Mental Health Journal. [published; OpenAlex]. \href{https://doi.org/10.1007/s10597-026-01620-x}{doi:10.1007/s10597-026-01620-x}.
\item Jordana Kazdan, Karim S. Ladha, M. Ishrat Husain (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Jon E. Grant, Sophia Boutouis, Margaret O’Brien, Laurie Avila, Megha Neelapu, Dustin Ehsan (2026). \textit{An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder}. Clinical Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/wnf.0000000000000683}{doi:10.1097/wnf.0000000000000683}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Sunnybrook Health Sciences Centre (2026). \textit{Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06072898}{source link}.
\item Indiana University (2026). \textit{Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07499583}{source link}.
\item Linda M. Richmond (2026). \textit{MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2026.04.4.3}{doi:10.1176/appi.pn.2026.04.4.3}.
\item Unknown authors (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8s7xk\_v1}{source link}.
\item Katharine Smith, Edward Harcourt, Andrea Cipriani (2026). \textit{Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.2026.10612}{doi:10.1192/bjp.2026.10612}.
\item Sarah Catchlove, Katrin Oliver, Michael Savic, Shalini Arunogiri (2026). \textit{Unlocking ‘stuckness’ and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70403}{doi:10.1111/add.70403}.
\item Federal University of Latin American Integration (2026). \textit{Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06898606}{source link}.
\item Christine Buchanan (2026). \textit{26-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORT}. Journal of the American College of Cardiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jacc.2026.02.3249}{doi:10.1016/j.jacc.2026.02.3249}.
\item Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt MW, Spanagel R, Ladewig J, Köhr G, Koch P. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7554/elife.104006}{doi:10.7554/elife.104006}.
\item Aly Shah Aziz (2026). \textit{Classic psychedelic medicines for adolescent refractory mental health disease}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00452}{doi:10.1556/2054.2026.00452}.
\item Piotr Skalski, Katarzyna Pękacka-Falkowska, Agnieszka Pluto-Prądzyńska, Michał K. Owecki (2026). \textit{Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)}. Brain Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/brainsci16040358}{doi:10.3390/brainsci16040358}.
\item Medical University of Vienna (2026). \textit{Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07490353}{source link}.
\item Shivaputra A. Patil, Holly C. Hunsberger (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Donatella Marazziti, Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Giorgia Sità, Elena Pescini, FRANCESCA RITA DIGIUSEPPE, Federico Mucci (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations}. Expert Opinion on Pharmacotherapy. [published; OpenAlex]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Malkanthi Evans, Andrew Charrette (2026). \textit{Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1816932}{doi:10.3389/fnins.2026.1816932}.
\item Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Robin Carhart-Harris, Megan Croal, David Feifel, David J. Hellerstein, Muhammad I. Husain, John R. Kelly, Namik Kirlić, Rasmus Wentzer Licht, Lindsey Marwood, Ania Nowakowska, Tomáš Páleníček, Dimitris Repantis, Robert A. Schoevers, Hollie Simmons, Jair C. Soares, Metten Somers, Joyce Tsai, Mourad Wahba, Ella Williams, Allan H. Young, Matthew B. Young, Sidney Zisook, Ekaterina Malievskaia (2026). \textit{The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121662}{doi:10.1016/j.jad.2026.121662}.
\item Denis Nößler (2026). \textit{Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12}. EvidenzUpdate. [published; OpenAlex]. \href{https://doi.org/10.69156/quick/2026.03.00011}{doi:10.69156/quick/2026.03.00011}.
\item Taro Kishi, Kenji Sakuma, Masakazu Hatano, Hiroyuki Uchida, Nakao Iwata (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121675}{doi:10.1016/j.jad.2026.121675}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07484906}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731621}{source link}.
\item Portes MAM, Bertoglio LJ. (2026). \textit{Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2026.2644865}{doi:10.1080/02791072.2026.2644865}.
\item Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Àlvar Farré-Colomés, Olga Rublinetska, Óscar Soto-Angona (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Gustavo Vazquez (2026). \textit{Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06818994}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07211438}{source link}.
\item Lea J. Mertens, Michael Koslowski, Felix Betzler, Manuela Brand, Ricarda Evens, Laura Kärtner, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz Berger, Gerhard Gründer (2026). \textit{Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0132}{doi:10.1001/jamapsychiatry.2026.0132}.
\item J. Cramer Hudson, Harrison G. Pope (2026). \textit{Enlightenment in a Pill-Testing the Efficacy of Psilocybin}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0070}{doi:10.1001/jamapsychiatry.2026.0070}.
\item Georgia Chlebek (2026). \textit{Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies}. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). [published; OpenAlex]. \href{https://ir.library.louisville.edu/tce/vol3/iss1/11}{source link}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04123314}{source link}.
\item Akey Sungheetha, R. Rajesh Sharma, Oluwasegun Julius Aroba, Sheila Mahapatra, P. D. Mahendhiran (2026). \textit{Explainable AI framework for psilocybin depression treatment optimization}. Frontiers in Computer Science. [published; OpenAlex]. \href{https://doi.org/10.3389/fcomp.2025.1652190}{doi:10.3389/fcomp.2025.1652190}.
\item Johns Hopkins University (2026). \textit{Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04620759}{source link}.
\item Marc-Antoine Crocq, Philippe Auby (2026). \textit{The renaissance of research on psychedelics in child and adolescent psychopharmacology}. Child and Adolescent Psychiatry and Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1186/s13034-026-01069-6}{doi:10.1186/s13034-026-01069-6}.
\item Michel Sabé, Paul Grof, Nathan Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos, Mickael Eskinazi, Kerem Böge, Stefan Leucht, Federico Seragnoli, Leonice Furtado, Tatiana Aboulafia Brakha, Logos Curtis, Matthias Kirschner, Stefan Kaiser, Louise Penzenstadler, Daniele Zullino, Mikkel Højlund, Jade Gallo, Marco Solmi, Jacopo Sapienza, Marta Bosia, Joseph La Torre (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review}. Schizophrenia Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item Yale University (2026). \textit{Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06442423}{source link}.
\item Shikha Baghel Chauhan, Naziya Akhtar, chirag Jain, Indu Singh (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders}. CNS \& Neurological Disorders - Drug Targets. [published; OpenAlex]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M. (2026). \textit{Age moderates the relationship between psychedelics use and mental health in naturalistic settings}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9022170/v1}{doi:10.21203/rs.3.rs-9022170/v1}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Psyence Australia Pty Ltd (2026). \textit{A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07072728}{source link}.
\item Bo Jarrett Wood, M. Frances Vest, Catharine Carfagno, Kyla Rose Bartley, Papori Sharma, Adam L. Halberstadt, Bruce E. Blough, Kevin S. Murnane (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo (2026). \textit{A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261433836}{doi:10.1177/20451253261433836}.
\item Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian, Olga Kovalchuk, Igor Kovalchuk* (2026). \textit{THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18796594}{doi:10.5281/zenodo.18796594}.
\item Yosr Ziadi, Taehwan Park (2026). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression}. Value in Health Regional Issues. [published; OpenAlex]. \href{https://doi.org/10.1016/j.vhri.2026.101605}{doi:10.1016/j.vhri.2026.101605}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X. (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item C Faria, Diana Dias da Silva, João José Sousa (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7173}{doi:10.26537/prpaeh.v4i3.7173}.
\item Alex Gearin, Jennifer Docherty, Xiaofan Sun, Emmanuel Hei-Lok Cheung, Peter Tanuseputro (2026). \textit{Psychedelic therapy and cultural humility}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-03913-x}{doi:10.1038/s41398-026-03913-x}.
\item Kengo Yonezawa, M. Hirata, Hiroaki Takano, Keisuke Kusudo, Sota Tomiyama, Lisa Harada, Kota Suzuki, DJ Nutt, H. Uchida, Hideaki Tani (2026). \textit{Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations}. Psychiatry and Clinical Neurosciences. [published; OpenAlex]. \href{https://doi.org/10.1111/pcn.70042}{doi:10.1111/pcn.70042}.
\item Albert Garcia-Romeu, Gideon P. Naudé, Alison W. Rebman, Sara So, Abigail Yaffe, Ian Geithner, Erica A. Kozero, Ting Yang, Mark J. Soloski, John N. Aucott (2026). \textit{Pilot study of psilocybin in patients with post-treatment lyme disease}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-026-38091-9}{doi:10.1038/s41598-026-38091-9}.
\item Alan C. Courtes, Blake Myers, Noah Daly, Greg Jones, Jair C. Soares, Carlos A. Zarate, Rodrigo Machado-Vieira (2026). \textit{Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2026.02.011}{doi:10.1016/j.genhosppsych.2026.02.011}.
\item Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A. (2026). \textit{Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8319478/v1}{doi:10.21203/rs.3.rs-8319478/v1}.
\item Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep M. Nayak, David B Yaden (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Gow A, Shih E, Reid R, Qian JJ, Mellor C, McInnes LA, Carhart-Harris R, Davis JN. (2026). \textit{Prospective real-world evidence of mental health outcomes following supervised psilocybin services within the Oregon state-regulated model}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.02.18.26346580}{doi:10.64898/2026.02.18.26346580}.
\item Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba (2026). \textit{Effects of Psilocybin and Select Pharmaceutical Interactions}. MacEwan University Student eJournal. [published; OpenAlex]. \href{https://doi.org/10.31542/bcek6t76}{doi:10.31542/bcek6t76}.
\item Luca Magnani, Luca Ghirotto, Fabio Fesce, Tania Simona Re, Silvia Tanzi, Andrea Amerio, Alessandra Costanza (2026). \textit{Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review}. BMJ Supportive \& Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1136/spcare-2025-005689}{doi:10.1136/spcare-2025-005689}.
\item Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna C. Neill, Verity Wainwright (2026). \textit{Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis}. Qualitative Health Research. [published; OpenAlex]. \href{https://doi.org/10.1177/10497323261419338}{doi:10.1177/10497323261419338}.
\item Yvan Beaussant, MD, MSci (2026). \textit{Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04950608}{source link}.
\item Stéphanie Knatz Peck, Timothy D. Brewerton (2026). \textit{Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-026-01532-x}{doi:10.1186/s40337-026-01532-x}.
\item Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily C. Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10968}{doi:10.1192/bjo.2025.10968}.
\item Marc J. Weintraub, Jessica Jeffrey, Megan Ichinose, R. Lindsey Bergman, Benjamin Shapiro, Gregory Barnett, Hewa Artin, Marc Lynn, Anabel Salimian, Shelby Grody, Rahul Ramesh, Lauren Eales, Charles S. Grob, David J. Miklowitz (2026). \textit{Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121423}{doi:10.1016/j.jad.2026.121423}.
\item MycoMedica Life Sciences PBC (2026). \textit{A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07050368}{source link}.
\item Sean P. Goldy, Nathan D. Sepeda, Samantha Hilbert, Bilal A. Bari, Albert Garcia-Romeu, Natalie Gukasyan, Frederick S. Barrett, David B. Yaden, Sandeep M. Nayak (2026). \textit{Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones}. Psychiatry Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psychres.2026.117010}{doi:10.1016/j.psychres.2026.117010}.
\item Trent Emerick (2026). \textit{Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07406828}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07405606}{source link}.
\item Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey (2026). \textit{Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00485}{doi:10.1556/2054.2026.00485}.
\item Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C. (2026). \textit{Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8733841/v1}{doi:10.21203/rs.3.rs-8733841/v1}.
\item Ziping He, Yijie Wang, Jie Chen, Junzhe Cheng, Yuxin Feng, Shuliang Niu, J. Yan (2026). \textit{Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects}. European Archives of Psychiatry and Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1007/s00406-025-02165-y}{doi:10.1007/s00406-025-02165-y}.
\item Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Shakila Meshkat, Marc G. Blainey, Ryan M. Brudner, Shaun Ali, Kayla M. Teopiz, Roger S. McIntyre, Joshua D. Rosenblat (2026). \textit{Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121385}{doi:10.1016/j.jad.2026.121385}.
\item Unknown authors (2026). \textit{Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/d94hb\_v1}{source link}.
\item Blake Beaton (2026). \textit{Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature}. Deviant Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/01639625.2026.2624690}{doi:10.1080/01639625.2026.2624690}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Hadassah Medical Organization (2026). \textit{Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079930}{source link}.
\item TRYP Therapeutics (2026). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06206265}{source link}.
\item Benjamin R. Lewis, M. Carrington Reid, Andrew M. Novick, Kevin Byrne, Mark J. Niciu, Gregory A. Fonzo, Thomas D. Meyer, David Feifel, Rif S. El-Mallakh, Jair Soares, Trisha Suppes, Frederick S. Barrett (2026). \textit{Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251413490}{doi:10.1177/02698811251413490}.
\item Junhong Liu, Y. Lynn Wang, Ke Xia, Jia-Bin Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2026). \textit{Acute psilocin increased cortical activity in rat}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Thomas Müller (2026). \textit{Psilocybin wirkt bei therapieresistenter Depression}. DNP - Die Neurologie \& Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15202-025-6636-1}{doi:10.1007/s15202-025-6636-1}.
\item Jorge Encantado, Laura C. Carvalho, Pedro Mota, Catarina Cunha, Albert Garcia-Romeu, Matthew W. Johnson, Pedro J. Teixeira (2026). \textit{Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).}. Professional Psychology Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1037/pro0000664}{doi:10.1037/pro0000664}.
\item Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN (2026). \textit{Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251389090}{doi:10.1177/07067437251389090}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Simon Halm (2026). \textit{Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71265}{doi:10.1002/brb3.71265}.
\item Kala K, Bederska-Lojewska D, Lazur J, Gasior K, Maslanka A, Szewczyk A, Sulkowska-Ziaja K, Turek J, Szewczyk B, Pilc A, Muszynska B. (2026). \textit{Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26402/jpp.2026.1.07}{doi:10.26402/jpp.2026.1.07}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Lukasz Siwek, Marta Nowocien, Barbara Balajewicz, Angelika Samborska, Sara Szukalska, Marta Karczewska, Karolina Lichwala, Kamil Wroblewski, Paulina Wróblewska (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya (2026). \textit{Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18425838}{doi:10.5281/zenodo.18425838}.
\item James Downar, Julie Lapenskie, Koby Anderson, Gaelle Parsons, Nadia Polskaia, Genevieve Lalumiere, Peter G. Lawlor (2026). \textit{PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial}. Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/02692163261416269}{doi:10.1177/02692163261416269}.
\item H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra (2026). \textit{Psychedelic research and sexuality: opportunities and pitfalls}. The Journal of Sexual Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/jsxmed/qdag025}{doi:10.1093/jsxmed/qdag025}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Mohsin Raza, Jasleen Kaur (2026). \textit{A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.102421}{doi:10.7759/cureus.102421}.
\item Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska (2026). \textit{Psychedelics in psychiatric treatment: a literature review}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.50.68013}{doi:10.12775/qs.2026.50.68013}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Omer A. Syed, Benjamin Tsang, Sean M. Nestor, Nir Lipsman, Muhammad Ishrat Husain, Fahad Alam, Peter Giacobbe (2026). \textit{Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis}. Neuroscience \& Biobehavioral Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neubiorev.2026.106573}{doi:10.1016/j.neubiorev.2026.106573}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Tripdatabase (2026). \textit{Does psilocybin help with mental health conditions?}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18339283}{doi:10.5281/zenodo.18339283}.
\item Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/94398}{doi:10.48620/94398}.
\item Gianluca Andri Florineth, Isabell Klima, Anna Laura Boeker, Polina Catzeflis, Alexander Wopfner, Niklaus Denier, Tobias Bracht, Kristina Adorjan, Mario Pfammatter, Felix Müller, Leila Maria Soravia (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2025.54843}{doi:10.1001/jamanetworkopen.2025.54843}.
\item Ana Domi, Erika Lucente, Davide Cadeddu, Niklas Bengtsson, Erik Smedler, Louise Adermark (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Laura Mills, Susan L. Rossell, Sean Carruthers (2026). \textit{Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121220}{doi:10.1016/j.jad.2026.121220}.
\item Zoe Doyle, Noah Chisamore, Erica Kaczmarek, Danica E. Johnson, Ryan M. Brudner, Geneva Weiglein, Marc G. Blainey, Jordan Bawks, Jeremy Riva-Cambrin, Rickinder Sethi, Roger S. McIntyre, Joshua D. Rosenblat (2026). \textit{Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2026.01.001}{doi:10.1016/j.genhosppsych.2026.01.001}.
\item Maria Garcia Garcia, Dahbia Belahda, Carine Graux, Chris Serrand, Noe Igounenc, Felix Sergent, Thibault Mura, Amandine Luquiens (2026). \textit{Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121215}{doi:10.1016/j.jad.2026.121215}.
\item Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon (2026). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251413856}{doi:10.1177/28314425251413856}.
\item Damian Świeczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała (2026). \textit{Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2025.112746}{doi:10.1016/j.euroneuro.2025.112746}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v1}{source link}.
\item Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES. (2026). \textit{Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.01.14.699553}{doi:10.64898/2026.01.14.699553}.
\item Unknown authors (2026). \textit{Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/atfum\_v1}{source link}.
\item Celia Faye Jacobsen, Dea Siggaard Stenbæk, Stig Poulsen, Sophia Armand (2026). \textit{The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?}. Psychiatric Research and Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.prcp.20250113}{doi:10.1176/appi.prcp.20250113}.
\item COMPASS Pathways (2026). \textit{A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05711940}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06656702}{source link}.
\item Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id\_orcid 0000-0002-2717-9739 Neill, Verity; id\_orcid 0000-0002-9876-250X Wainwright (2026). \textit{Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis}. Research Explorer (The University of Manchester). [published; OpenAlex]. \href{https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3}{source link}.
\item Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4242829/v3}{doi:10.21203/rs.3.rs-4242829/v3}.
\item Matheus G. Marques, Liliana Patarroyo-Rodríguez, Balwinder Singh (2026). \textit{Psilocybin and Bipolar Depression: Promise and Prudence}. CNS Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40263-025-01255-8}{doi:10.1007/s40263-025-01255-8}.
\item Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser (2026). \textit{An open-label pilot study of psilocybin-assisted therapy for binge eating disorder}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01508-3}{doi:10.1186/s40337-025-01508-3}.
\item Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravaninezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar (2026). \textit{The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis}. BMC Psychology. [published; OpenAlex]. \href{https://doi.org/10.1186/s40359-025-03935-y}{doi:10.1186/s40359-025-03935-y}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Ethan Klukas (2025). \textit{Motivation-based subtypes of psilocybin microdosers}. Open Collections. [published; OpenAlex]. \href{https://doi.org/10.14288/1.0452623}{doi:10.14288/1.0452623}.
\item Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti (2025). \textit{COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER}. Genetics and Molecular Research. [published; OpenAlex]. \href{https://doi.org/10.4238/e91xh631}{doi:10.4238/e91xh631}.
\item Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate (2025). \textit{Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/yu3n9}{doi:10.17605/osf.io/yu3n9}.
\item Yosr Ziadi, Taehwan Park (2025). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/nrt59}{doi:10.17605/osf.io/nrt59}.
\item Mateus Araújo da Luz, Taynah Pereira Galdino, Lucas Matheus da S. Oliveira, H. Guedes, Anauara Silva, Victor I. Afonso, Suédina M. L. Silva, Antônio G. B. Lima, Marcus V. L. Fook, Maria C. M. Torres (2025). \textit{Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract}. Journal of the Brazilian Chemical Society. [published; OpenAlex]. \href{https://doi.org/10.21577/0103-5053.20260049}{doi:10.21577/0103-5053.20260049}.
\item Stefan Jerotić, Olga Čolović, Nađa Marić (2025). \textit{Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"}. Medicinska istrazivanja. [published; OpenAlex]. \href{https://doi.org/10.5937/medi0-62051}{doi:10.5937/medi0-62051}.
\item Belle Buzzi (2025). \textit{Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/etd/8246}{source link}.
\item Unknown authors (2025). \textit{Psilocybin-Therapie vorteilhaft für Stimmungsstörungen von Parkinsonkranken}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2700-8978}{doi:10.1055/a-2700-8978}.
\item Aneta Petrušková (2025). \textit{Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity}. OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg. [published; OpenAlex]. \href{https://doi.org/10.25593/open-fau-2619}{doi:10.25593/open-fau-2619}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2025). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer (2025). \textit{Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105779}{doi:10.1016/j.nsa.2025.105779}.
\item N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin (2025). \textit{An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106821}{doi:10.1016/j.nsa.2025.106821}.
\item L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher (2025). \textit{Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106390}{doi:10.1016/j.nsa.2025.106390}.
\item Jensen, Hailey A (2025). \textit{Psilocybin Treatment for Refractory Depression: A Clinical Review}. Digital Commons - Gardner-Webb University (Gardner-Webb University). [published; OpenAlex]. \href{https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63}{source link}.
\item Viljoen G, Betzler F (2025). \textit{Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_534}{doi:10.1007/7854\_2024\_534}.
\item Connor J. Maltby, Adam K. Klein, Enya Paschen, Jessica Pinto, Dino Dvořák, Joseph R. Hedde, Ashley N. Hanks, Massimiliano Bianchi, Zoe Hughes (2025). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Hediye Moghadam, Parisa Akbari, Elmira Beirami, Samaneh Nabavifard, Akram Ameli, Neda Valian (2025). \textit{The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors}. Journal of Neuroscience Research. [published; OpenAlex]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Brunno Freitas da Costa, Paula Hartmann, Daniel Pagnin (2025). \textit{Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin}. Human Psychopharmacology Clinical and Experimental. [published; OpenAlex]. \href{https://doi.org/10.1002/hup.70032}{doi:10.1002/hup.70032}.
\item Ziran Huang, Xiaoyan Wei, Yihui Wang, Jin Tian, Jihui Dong, Bo Liang, Lin Lu, Wen Zhang (2025). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Spiti A, Caldirola D, Perna G. (2025). \textit{New Antidepressant Development in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA. (2025). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Joshua Mitchell, Logan Neitzke-Spruill, David S. Mathai, Jill O. Robinson, Zuzana Kavan, Lynnette A Averil, Amy L McGuire (2025). \textit{From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care}. Translational Behavioral Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/tbm/ibag027}{doi:10.1093/tbm/ibag027}.
\item Xia K, Gao T. (2025). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2025). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Ashkan Veysi, Daniela Atanasovski, Maryam Ardalan, Nasrin Motamed, Elias Eriksson (2025). \textit{Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2026.10075}{doi:10.1017/neu.2026.10075}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2025). \textit{Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1834094}{doi:10.3389/fpsyt.2026.1834094}.
\item Rotem Petranker (2025). \textit{Microdosing Psychedelics to Improve Mood}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05259943}{source link}.
\item Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Monika Dominiak, Adam Gędek, Szymon Modrzejewski, Agnieszka Permoda-Osip, Anna Zofia Antosik (2025). \textit{Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials}. Journal of Clinical Medicine. [published; OpenAlex]. \href{https://doi.org/10.3390/jcm15010253}{doi:10.3390/jcm15010253}.
\item Rhianna Rich, Kelsey T. Laird, Prabha Siddarth, Brittany Youssef, Grace M. Schwartz, Ashley Ramos, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling (2025). \textit{A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251387655}{doi:10.1177/28314425251387655}.
\item Sahba Afsharnia, Vivian Liang, Yona Lunsky, A Orsini, Ami Tint, Hsiang-yuan Lin (2025). \textit{Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey}. PLOS mental health.. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pmen.0000514}{doi:10.1371/journal.pmen.0000514}.
\item Sheppard Pratt Health System (2025). \textit{The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220410}{source link}.
\item University of Chicago (2025). \textit{An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05399498}{source link}.
\item Anthony L. Back, Bonnie A. McGregor, Lindsay Billingsley, Dianna Blom, George Callan, Susanna Myers, John Guy, Sameet Kumar, Melissa Layer, Jackie Levin, Juliana Pérez, Peter Thompson, Kathy Salmonson, Joseph Whinney, Leslie Lazar Thorn (2025). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251404460}{doi:10.1177/28314425251404460}.
\item Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.18.695064}{doi:10.64898/2025.12.18.695064}.
\item M. Haseeb Ul Rasool, Taha Hannan, Muhammad Imam (2025). \textit{Magic mushrooms and mood: exploring Psilocybin as a depression treatment}. Journal of the Pakistan Medical Association. [published; OpenAlex]. \href{https://doi.org/10.47391/jpma.30858}{doi:10.47391/jpma.30858}.
\item Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli, Leonice Furtado, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study}. Psychology International. [published; OpenAlex]. \href{https://doi.org/10.3390/psycholint8010001}{doi:10.3390/psycholint8010001}.
\item COMPASS Pathways (2025). \textit{A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05624268}{source link}.
\item Gurjot Brar, T. R. JUN. BURKE, Andrew Gribben, Colm Harrington, Guillaume Thuery, John R. Kelly (2025). \textit{Psilocybin reporting in media (PRiMe) for the treatment of depression}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2025.10142}{doi:10.1017/ipm.2025.10142}.
\item Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S. (2025). \textit{Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02692163251383335}{doi:10.1177/02692163251383335}.
\item Megan Dutton, Paul Schwenn, Jules Mitchell, Per Hoffmann, Neil W. Bailey, Paul B. Fitzgerald, Jim Lagopoulos, Adem Can (2025). \textit{Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/00048674251398677}{doi:10.1177/00048674251398677}.
\item Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Tewin Tencomnao, Siriporn Chuchawankul (2025). \textit{Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.120882}{doi:10.1016/j.jad.2025.120882}.
\item Sophie Woodruff, Meghan Hibicke, Charles D. Nichols (2025). \textit{Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251393186}{doi:10.1177/28314425251393186}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Shannon Antoine-Hardy, D’Elia Bonilla (2025). \textit{Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot Study}. Journal of Complementary and Alternative Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jocamr/2025/v26i11723}{doi:10.9734/jocamr/2025/v26i11723}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M. (2025). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Pedro Rodrigues, Weliton Rodrigues dos Santos Júnior, Ivan de Sousa Araújo, Leonardo Maia Leony, Fernanda Adélia Almeida Custódio Pires Gomes, Tairone Matos de Lima Junior, Luís Felipe Freitas Moreira, Rafael Telles Santana, Manoel Carlos Matos Santos, R. Silva (2025). \textit{COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55905/edicon.978-65-83115-47-8\_8}{doi:10.55905/edicon.978-65-83115-47-8\_8}.
\item Unknown authors (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v2}{source link}.
\item Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S. (2025). \textit{Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8079137/v1}{doi:10.21203/rs.3.rs-8079137/v1}.
\item Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger (2025). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M. Goodwin (2025). \textit{The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience}. Journal of Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/jcp.0000000000002119}{doi:10.1097/jcp.0000000000002119}.
\item Sara N. Lappan, Sean D. Davis (2025). \textit{Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251404021}{doi:10.1177/28314425251404021}.
\item Wohlfarth, Gale, Hardy, Susan, Ray, Herman (2025). \textit{Are Magic Mushrooms the Magic to Healing?}. DigitalCommons - Kennesaw State University (Kennesaw State University). [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134}{source link}.
\item Imperial College London (2025). \textit{Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06798636}{source link}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item NYU Langone Health (2025). \textit{A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05398484}{source link}.
\item Samuli Kangaslampi, Max Wolff, Manoj K. Doss, Lilian Kloft, Henry Otgaar (2025). \textit{Questioning the recovery of dissociated traumatic memories under psilocybin: comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01484-8}{doi:10.1186/s40337-025-01484-8}.
\item Spohn, Kyle (2025). \textit{Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://repository.law.miami.edu/umialr/vol57/iss1/7}{source link}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item F. Seragnoli (2025). \textit{Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital model}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100256}{doi:10.1016/j.etdah.2025.100256}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Buchard A, Seragnoli F, Sabe M, Eskinazi M, Aboulafia T, Furtado L, Briefer J, Roediger E, Penzenstadler L, Zullino D, Thorens G. (2025). \textit{Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8214817/v1}{doi:10.21203/rs.3.rs-8214817/v1}.
\item Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L. (2025). \textit{Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.12.01.25341335}{doi:10.1101/2025.12.01.25341335}.
\item Amanda E. Downey, Marlene Tai, Ellen Bradley, Josh Woolley (2025). \textit{Sudden Loss of Consciousness Following Psilocybin Ingestion}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20250037}{doi:10.1176/appi.ajp.20250037}.
\item Nina Kleditzsch, James J Gattuso, Anthony J. Hannan, Thibault Renoir (2025). \textit{Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.70351}{doi:10.1111/ejn.70351}.
\item Nadav Liam Modlin, Victoria Williamson, Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony J. Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlić, James Rucker (2025). \textit{Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2025.103692}{doi:10.1016/j.eclinm.2025.103692}.
\item University of Texas at Austin (2025). \textit{Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06132178}{source link}.
\item Małgorzata Domżalska, Joanna Kwiatkowska, Iwona Cichoń, Ewa Sokołowska (2025). \textit{A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-025-29642-7}{doi:10.1038/s41598-025-29642-7}.
\item Jorge Ferreira (2025). \textit{Psilocybin reduces comorbid chronic pain and depression in mice}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-025-01663-9}{doi:10.1038/s41684-025-01663-9}.
\item Charles S. Grob, M.D. (2025). \textit{Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05403086}{source link}.
\item J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell (2025). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251394012}{doi:10.1177/28314425251394012}.
\item Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi (2025). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Danica E. Johnson, Shakila Meshkat, Erica Kaczmarek, Jennifer S. Rabin, Ryan M. Brudner, Noah Chisamore, Zoe Doyle, Jordan Bawks, Jeremy Riva-Cambrin, Rodrigo B. Mansur, Orly Lipsitz, Roger S McIntyre, Krista L. Lanctôt, Joshua D. Rosenblat (2025). \textit{Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111565}{doi:10.1016/j.pnpbp.2025.111565}.
\item Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafaelle Lancelotta, Alan K. Davis (2025). \textit{Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100006}{doi:10.1016/j.psyche.2025.100006}.
\item Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item Beersheva Mental Health Center (2025). \textit{A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07183748}{source link}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Unknown authors (2025). \textit{Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hmnsw\_v1}{source link}.
\item Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis (2025). \textit{Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100004}{doi:10.1016/j.psyche.2025.100004}.
\item Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer (2025). \textit{Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03693-w}{doi:10.1038/s41398-025-03693-w}.
\item Sian Lewis (2025). \textit{‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain}. Nature reviews. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41583-025-00999-y}{doi:10.1038/s41583-025-00999-y}.
\item Max Wolff, Samuli Kangaslampi (2025). \textit{Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.120637}{doi:10.1016/j.jad.2025.120637}.
\item Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723) (2025). \textit{Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c07092.s001}{doi:10.1021/acsomega.5c07092.s001}.
\item Luisina Castelli Rodríguez, Guillermo Morera, Sandra Lupo, Danilo Davyt, Ignacio Carrera, Gonzalo Hernández Dossi (2025). \textit{Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c07092}{doi:10.1021/acsomega.5c07092}.
\item Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO. (2025). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.06.687023}{doi:10.1101/2025.11.06.687023}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M. (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item AccessScience Editors (2025). \textit{A single dose of psilocybin alleviates chronic pain and associated anxiety and depression in mice}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1036/1097-8542.br2511031}{doi:10.1036/1097-8542.br2511031}.
\item Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-292276}{doi:10.5167/uzh-292276}.
\item Aisling McGuigan (2025). \textit{Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required}. Drugs \& Therapy Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1007/s40267-025-01199-5}{doi:10.1007/s40267-025-01199-5}.
\item Yale University (2025). \textit{Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03554174}{source link}.
\item University of Washington (2025). \textit{A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05847686}{source link}.
\item Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C. (2025). \textit{Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7890051/v1}{doi:10.21203/rs.3.rs-7890051/v1}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Unknown authors (2025). \textit{Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1016/j.addbeh.2026.108652}{doi:10.1016/j.addbeh.2026.108652}.
\item Unknown authors (2025). \textit{Psilocybin bei Alkoholkonsumstörung}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2702-9616}{doi:10.1055/a-2702-9616}.
\item Unknown authors (2025). \textit{Metaanalyse: Wirksamkeit und Sicherheit von Psilocybin bei Major Depressionen}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2576-6069}{doi:10.1055/a-2576-6069}.
\item Thomas Zandonai, Sofia Venturini, Ornella Corazza (2025). \textit{Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?}. Performance Enhancement \& Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.peh.2025.100386}{doi:10.1016/j.peh.2025.100386}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Rahmani S, Crupi R, Riley AL, Davidson T (2025). \textit{The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2025.174087}{doi:10.1016/j.pbb.2025.174087}.
\item Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi (2025). \textit{Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10847}{doi:10.1192/bjo.2025.10847}.
\item Blake Beaton (2025). \textit{“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/00220426251395178}{doi:10.1177/00220426251395178}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G. (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Do A, Cloutier L, Hébert-Tremblay L, Thauvin C. (2025). \textit{Psilocybin use in bipolar disorder: A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120485}{doi:10.1016/j.jad.2025.120485}.
\item Ohio State University (2025). \textit{A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06820723}{source link}.
\item Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster (2025). \textit{Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity}. Biomedicine \& Pharmacotherapy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopha.2025.118720}{doi:10.1016/j.biopha.2025.118720}.
\item Anna Rose Childress, Ph.D. (2025). \textit{A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06786325}{source link}.
\item James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir (2025). \textit{Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025i.0044}{doi:10.61373/pp025i.0044}.
\item Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P. (2025). \textit{Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111541}{doi:10.1016/j.pnpbp.2025.111541}.
\item Pu Jiang, Cong Lin, Xiaohui Wang (2025). \textit{Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025p.0041}{doi:10.61373/pp025p.0041}.
\item special to C EN Mara Johnson-Groh (2025). \textit{Is there more to magic mushrooms than psilocybin?}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10322-feature2}{doi:10.1021/cen-10322-feature2}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák, Shane Raines, Zoë A. Hughes, Eric W. Austin, Adam K. Klein, William Leong, Fas J. Krol, Anne J. van der Graaf, Maria J. Juachon, Marije E. Otto, Laura Borghans, Gabriël E. Jacobs, Andrew C. Kruegel, Jonathan Sporn (2025). \textit{A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251378512}{doi:10.1177/02698811251378512}.
\item Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085), Junjun Liu (674159), Huan Wang (109286), Sheng Wang (339979), Jianjun Cheng (646595) (2025). \textit{Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045.s001}{doi:10.1021/acs.jmedchem.5c02045.s001}.
\item Shadani S, Greaves E, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.14.682467}{doi:10.1101/2025.10.14.682467}.
\item Sha Jin, H.Y. Wang, Xiaohui Wang (2025). \textit{Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025v.0038}{doi:10.61373/pp025v.0038}.
\item Johns Hopkins University (2025). \textit{Psilocybin and Affective Function in Chronic Lower Back Pain Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06355414}{source link}.
\item Rongyan Li, Haohan Yan, Yujin Chen, Yangyang Liu, Lingjie Tang, Jing Yu, Junjun Liu, Huan Wang, Sheng Wang, Jianjun Cheng (2025). \textit{Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045}{doi:10.1021/acs.jmedchem.5c02045}.
\item Rajiv Agrawal, Daniel J. Gillie, Alison E. Mungenast, Milan Chytil, Sharon Engel, Michael C. Wu, Kurt Rasmussen, Eliseo Salinas, David E. Olson (2025). \textit{Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00667}{doi:10.1021/acschemneuro.5c00667}.
\item Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Roxanne Sholevar, Kimberly Roddy, James A. Tulsky, Manish Agrawal (2025). \textit{Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.10.010}{doi:10.1016/j.genhosppsych.2025.10.010}.
\item Renee Ireland (2025). \textit{Psychedelics in Practice: Science, Safety, and the Future of Healing}. The proceedings of sliit international conference on advancements in science and humanities. [published; OpenAlex]. \href{https://doi.org/10.54389/epsd8792}{doi:10.54389/epsd8792}.
\item Unknown authors (2025). \textit{Control group improvement lower in psilocybin trials for depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31371}{doi:10.1002/pu.31371}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E. (2025). \textit{Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120352}{doi:10.1016/j.jad.2025.120352}.
\item Brown KA, Ajibola MI, Medeiros GC, Gould TD. (2025). \textit{Synaptic priming: A framework for pharmacotherapy in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.09.010}{doi:10.1016/j.neuron.2025.09.010}.
\item Centre Hospitalier St Anne (2025). \textit{Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07210112}{source link}.
\item Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E. (2025). \textit{Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7269356/v1}{doi:10.21203/rs.3.rs-7269356/v1}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item University Hospital, Geneva (2025). \textit{Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164287}{source link}.
\item Ahmad Hammo, Stephen Wisser, Joseph Cichon (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain}. Nature Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Michel Sabé, Federico Seragnoli, Louise Penzenstadler, Gabriel Thorens (2025). \textit{[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/41575100}{source link}.
\item Cassandra J. Hatzipantelis, Min Liu, A. H. G. Love, Sadie J. Leventhal, Hero Maera, Srinidhi Viswanathan, Emily Avetisyan, Liana Belinsky, McKenna M. Rangel, Nina J. Jain, Max Kelly, C. Copeland, Yara A. Khatib, Oliver Fiehn, David E. Olson, Danielle S. Stolzenberg (2025). \textit{Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-64371-5}{doi:10.1038/s41467-025-64371-5}.
\item Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti (2025). \textit{Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review}. Clinical Neuropsychopharmacology and Addiction. [published; OpenAlex]. \href{https://doi.org/10.53941/cna.2025.100006}{doi:10.53941/cna.2025.100006}.
\item Healing Advocacy Fund (2025). \textit{Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07189988}{source link}.
\item Matthew Halma, R. Levy, Joseph Varón (2025). \textit{With great power comes great responsibility: Promise and caution in the new psychedelic renaissance}. Brain Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dscb.2025.100286}{doi:10.1016/j.dscb.2025.100286}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V. (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS. (2025). \textit{Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2025.103517}{doi:10.1016/j.eclinm.2025.103517}.
\item Gerhard Gründer, Lea J. Mertens, Andrea Jungaberle, Henrik Jungaberle, Moritz Spangemacher (2025). \textit{Compassionate use of psilocybin for treatment-resistant depression in Germany}. The Lancet Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s2215-0366(25)00277-9}{doi:10.1016/s2215-0366(25)00277-9}.
\item Vítor Bruno, Martha López-Canul, Brandon Richardson, Rosana Camarini, Tânia Marcourakis, Gabriella Gobbi (2025). \textit{High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251368361}{doi:10.1177/02698811251368361}.
\item Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, Steven M. Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett (2025). \textit{Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70187}{doi:10.1111/add.70187}.
\item Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660) (2025). \textit{S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pmed.1004519.s001}{doi:10.1371/journal.pmed.1004519.s001}.
\item Beaglehole B, Manuel J. (2025). \textit{Reappraisal of the hype and hope offered by psilocybin treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26635/6965.7138}{doi:10.26635/6965.7138}.
\item Benjamin R. Lewis, John Hendrick, Kevin Byrne, Madeleine Odette, Chaorong Wu, Eric L. Garland (2025). \textit{Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial}. PLoS Medicine. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pmed.1004519}{doi:10.1371/journal.pmed.1004519}.
\item Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C (2025). \textit{Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses}. ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley). [published; OpenAlex]. \href{https://scholarworks.utrgv.edu/colloquium/2025/talks/1}{source link}.
\item Jake F. Hooper, Jarrod M. Ellingson, Kent E. Hutchison (2025). \textit{Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1648968}{doi:10.3389/fpsyg.2025.1648968}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A. (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS. (2025). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910) (2025). \textit{Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00647.s001}{doi:10.1021/acschemneuro.5c00647.s001}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD. (2025). \textit{Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA. (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Wierzbicka M, Kopczyk R, Gerlach A, Rymaszewska J. (2025). \textit{Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1698185}{doi:10.3389/fpsyt.2025.1698185}.
\item John A. Razidlo, Noelle Cataldo, Cody J. Wenthur (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item King's College London (2025). \textit{Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164755}{source link}.
\item Rachel Yehuda (2025). \textit{Processing Intergenerational Trauma With Psilocybin-Assisted Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899165}{source link}.
\item Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251372449}{doi:10.1177/20451253251372449}.
\item Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett (2025). \textit{Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00461}{doi:10.1556/2054.2025.00461}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Georgios Mikellides, Marios Kyriazis (2025). \textit{Psychedelics and mental health: reimagining care through science, insight, and compassion}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2025.1649929}{doi:10.3389/fphar.2025.1649929}.
\item Kaylee Reid, Daniel Kot, Argel Aguilar-Valles (2025). \textit{Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour}. Carleton undergraduate journal of science.. [published; OpenAlex]. \href{https://doi.org/10.22215/cujs.v5i1.5286}{doi:10.22215/cujs.v5i1.5286}.
\item Gregor Hasler (2025). \textit{Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0032}{doi:10.61373/pp025k.0032}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher (2025). \textit{Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030031}{doi:10.3390/psychoactives4030031}.
\item Khyber Medical University Peshawar (2025). \textit{Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06746441}{source link}.
\item Chris Simms (2025). \textit{We may know why psilocybin helps treat mental health conditions}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(25)01446-0}{doi:10.1016/s0262-4079(25)01446-0}.
\item M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030030}{doi:10.3390/psychoactives4030030}.
\item Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna (2025). \textit{PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.3(47).2025.3650}{doi:10.31435/ijitss.3(47).2025.3650}.
\item David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill (2025). \textit{A lexicon for psychedelic research and treatment}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251380511}{doi:10.1177/20503245251380511}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item Sally Meikle, Olivia Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel Strauss, M.L. Williams, David Castle, Susan L. Rossell (2025). \textit{Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253251377187}{doi:10.1177/20451253251377187}.
\item Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille (2025). \textit{Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03556-4}{doi:10.1038/s41398-025-03556-4}.
\item Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons, Agata Tofil-Kaluza, Shriya Das, Guy M. Goodwin (2025). \textit{Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251362390}{doi:10.1177/02698811251362390}.
\item Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB. (2025). \textit{Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0031}{doi:10.1089/psymed.2024.0031}.
\item Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B. (2025). \textit{Psilocybin: Systematic review of its use in the treatment of depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12436869}{source link}.
\item Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant (2025). \textit{“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251370303}{doi:10.1177/28314425251370303}.
\item Drewko AJ, Habets RLP, Brunt TM. (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R. (2025). \textit{Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7420529/v1}{doi:10.21203/rs.3.rs-7420529/v1}.
\item James J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson, Carolina Gubert, Anthony J. Hannan, Thibault Renoir (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Koenig HG. (2025). \textit{Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00912174251369880}{doi:10.1177/00912174251369880}.
\item COMPASS Pathways (2025). \textit{A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05733546}{source link}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S. (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD. (2025). \textit{Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.13.25333530}{doi:10.1101/2025.08.13.25333530}.
\item Kargbo RB. (2025). \textit{Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00475}{doi:10.1021/acsmedchemlett.5c00475}.
\item Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi (2025). \textit{Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent}. Psychopharmacology Bulletin. [published; OpenAlex]. \href{https://doi.org/10.64719/pb.4525}{doi:10.64719/pb.4525}.
\item Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock, Justin Dwyer (2025). \textit{Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.08.001}{doi:10.1016/j.genhosppsych.2025.08.001}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A. (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Trevor R. Norman (2025). \textit{The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2025.1006105}{doi:10.37349/en.2025.1006105}.
\item Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate, Hannes Kettner, Leor Roseman, David Erritzøe, Robin Carhart-Harris (2025). \textit{Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1594307}{doi:10.3389/fpsyt.2025.1594307}.
\item Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models}. Frontiers in Systems Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Hultgren J, Hafsteinsson MH, Brulin JG. (2025). \textit{A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.07.020}{doi:10.1016/j.genhosppsych.2025.07.020}.
\item Unknown authors (2025). \textit{Response to emotional stimuli weaker in SSRI users compared with psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31349}{doi:10.1002/pu.31349}.
\item Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola (2025). \textit{544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.363}{doi:10.1093/ijnp/pyaf052.363}.
\item Guy M. Goodwin (2025). \textit{670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.159}{doi:10.1093/ijnp/pyaf052.159}.
\item Unknown authors (2025). \textit{631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359594}{source link}.
\item Unknown authors (2025). \textit{229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359778}{source link}.
\item Unknown authors (2025). \textit{597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359505}{source link}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM. (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Unknown authors (2025). \textit{Correction to "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.70003}{doi:10.1002/cncr.70003}.
\item Heidi Allen, B. Stott (2025). \textit{Preparing Social Work for Psychedelic-Assisted Therapy}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swaf031}{doi:10.1093/sw/swaf031}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M. (2025). \textit{Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251363983}{doi:10.1177/28314425251363983}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N. (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul A. Rochefort, Thibault Mura, Felix Sergent (2025). \textit{Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70152}{doi:10.1111/add.70152}.
\item Emory University (2025). \textit{The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05506982}{source link}.
\item Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal (2025). \textit{“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke}. Addiction Science \& Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1186/s13722-025-00563-0}{doi:10.1186/s13722-025-00563-0}.
\item The University of Texas Health Science Center, Houston (2025). \textit{Acceptability \& Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06706232}{source link}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW. (2025). \textit{Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.18.664368}{doi:10.1101/2025.07.18.664368}.
\item Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL. (2025). \textit{The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.06.012}{doi:10.1016/j.neuron.2025.06.012}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI. (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Tobías Fernández-Borkel, Lucas F. Borkel, Jaime Rojas-Hernández, Elisa Hernández-Álvarez, Domingo Jesús Quintana Hernández, Ludovica G. Ponti, Luis Alberto Henríquez-Hernández (2025). \textit{The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00445}{doi:10.1021/acsptsci.5c00445}.
\item Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson (2025). \textit{Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.25.9.2091}{doi:10.1167/jov.25.9.2091}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Zohaib Nadeem, Stephen Parker, Hugh McGovern, Bianca Sebben, Lena Oestreich (2025). \textit{Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/00048674251346679}{doi:10.1177/00048674251346679}.
\item Taynah Pereira Galdino, Lucas Cordeiro de Oliveira, Mateus Araújo da Luz, R.C.A. Barbosa, M. Torres, Kátia Sivieri, Paula A. Fernandes, Márcio Luiz dos Santos, Antônio Gilson Barbosa de Lima, Suédina Maria de Lima Silva, Marcus Vinícius Lia Fook (2025). \textit{Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c02751}{doi:10.1021/acsomega.5c02751}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang (2025). \textit{The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324}{doi:10.1021/acsptsci.5c00324}.
\item Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S. (2025). \textit{Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.healthpol.2025.105392}{doi:10.1016/j.healthpol.2025.105392}.
\item Szigeti B. (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/97cqx\_v1}{doi:10.31234/osf.io/97cqx\_v1}.
\item Unknown authors (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/97cqx\_v1}{source link}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW. (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Yutong Song (2025). \textit{Explore the effect of psilocybin on depression and anxiety}. Arts Culture and Language. [published; OpenAlex]. \href{https://doi.org/10.61173/rcg8me57}{doi:10.61173/rcg8me57}.
\item Khalid Ahmed, Dima Abu Nasrieh, Haneen A. Banihani, Mohammed Fadi Obaidat, Toni Mazzawi, Azzah Khalid Al-Tarawneh, Radwan Bani Mustafa, Zaid Al Kayed (2025). \textit{Exploring Jordanian Physicians’ and Medical Students’ Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2526403}{doi:10.1080/02791072.2025.2526403}.
\item Mark Haden, Sarah A. Paschall, Birgitta Woods (2025). \textit{Beyond prohibition: A public health analysis of naturalistic psychedelic use}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00450}{doi:10.1556/2054.2025.00450}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed, Joseph Peill, Mairead Healy, Cyrus Rohani-Shukla, Hakjun Lee, Robin Carhart-Harris, Trevor W. Robbins, David Nutt, David Erritzøe (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Unknown authors (2025). \textit{Psilocybin bei schwerer behandlungsresistenter Depression}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2524-6277}{doi:10.1055/a-2524-6277}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L. (2025). \textit{Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03066-1}{doi:10.1038/s41380-025-03066-1}.
\item Megan Calnan, Grace Blest-Hopley, Chris Busch, Milly Adams, Simon Ruffell, Theodore Piper, Leor Roseman, Hannes Kettner, Robin Carhart-Harris (2025). \textit{Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.70660}{doi:10.1002/brb3.70660}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J. (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Rodney D. Brown, Niall M. Hamilton, Connor Mallon, James Stevenson, Michael T. Faley, Robert B. Kargbo, Alexander M. Sherwood, Balasubramaniam Upeandran (2025). \textit{Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.1002/jlcr.4155}{doi:10.1002/jlcr.4155}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L. (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Ryan M. Brudner, Erica Kaczmarek, Marc G. Blainey, Christian Schulz, Shakila Meshkat, Zoe Doyle, Orly Lipsitz, Hilary Offman, Rickinder Sethi, Geneva Weiglein, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251346697}{doi:10.1177/02698811251346697}.
\item Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE. (2025). \textit{Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/curroncol32070380}{doi:10.3390/curroncol32070380}.
\item Mathieu Fradet (2025). \textit{Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030021}{doi:10.3390/psychoactives4030021}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item Paul Okugo Imoh, Aderonke Ajiboye, Tahir Kolawole Balogun, Amina Catherine Ijiga, Toyosi Motilola Olola, Emmanuel Oluwasayomi Ahmadu (2025). \textit{Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism}. Magna Scientia Advanced Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.30574/msarr.2025.14.1.0079}{doi:10.30574/msarr.2025.14.1.0079}.
\item Adam Bayes (2025). \textit{Australia’s psychedelic experiment: reflections from a psychiatrist clinical researcher}. Australasian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/10398562251347890}{doi:10.1177/10398562251347890}.
\item Rita De Gasperi, Georgina Pérez Garcia, Miguel A. Gama Sosa, Gissel M. Perez, Rania Abutarboush, Usmah Kawoos, Patrick R. Hof, Carolyn W. Zhu, Stephen T. Ahlers, Gregory A. Elder (2025). \textit{Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure}. Frontiers in Neurology. [published; OpenAlex]. \href{https://doi.org/10.3389/fneur.2025.1594335}{doi:10.3389/fneur.2025.1594335}.
\item Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S. (2025). \textit{The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.86659}{doi:10.7759/cureus.86659}.
\item Vinarcsik L, Smoller C, Grossberg G. (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Martijn H.B. Koolen, Annika Wirsching, Erwin Krediet, Michiel van Elk (2025). \textit{Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2508156}{doi:10.1080/02791072.2025.2508156}.
\item Kyle T. Greenway, Nicolas Garel, Lê-Anh Dinh-Williams, Julien Thibault Lévesque, Mendel Kaelen, Vincent Dagenais-Beaulé, Sara de la Salle, David Erritzøe, Karl Looper, Gustavo Turecki, Soham Rej, Stéphane Richard-Devantoy (2025). \textit{The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.2025.102}{doi:10.1192/bjp.2025.102}.
\item Manish Agrawal, Kim Roddy, Betsy Jenkins, Celia Leeks, Ezekiel Emanuel (2025). \textit{Long-term benefits of single-dose psilocybin in depressed patients with cancer}. Cancer. [published; OpenAlex]. \href{https://doi.org/10.1002/cncr.35889}{doi:10.1002/cncr.35889}.
\item Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item Stephen Ross (2025). \textit{Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0017}{doi:10.61373/pp025k.0017}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item Sara Ellis, Catherine Bostian, Anna J. Donnelly, Wendy Feng, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes (2025). \textit{Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.119655}{doi:10.1016/j.jad.2025.119655}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J. (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item William Roseby, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill, Bruna Giribaldi, David Erritzøe, David Nutt, Robin Carhart-Harris (2025). \textit{Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1580663}{doi:10.3389/fpsyg.2025.1580663}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A. (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Matthew Hicks (2025). \textit{Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06372197}{source link}.
\item National University of Natural Medicine (2025). \textit{Optimizing Microdosing and Meditation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06560658}{source link}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H. (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Abigail M. Blanton, Pooja Parikh, Scott Zhou, Mohamed Mohamed, Rafael Ufret-Vincenty, Ronald Mancini (2025). \textit{Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms}. American Journal of Ophthalmology Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ajoc.2025.102359}{doi:10.1016/j.ajoc.2025.102359}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06654-1}{doi:10.1007/s00213-024-06654-1}.
\item Fonzo GA, Doss MK, Nemeroff CB. (2025). \textit{There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20250247}{doi:10.1176/appi.ajp.20250247}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R. (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Araam Abboud, Clay M. Schiebrel, Ramzi W. Nahhas, Sam Durkin, Kyle Hua, Hannah Redding, Danielle Gainer (2025). \textit{Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2511752}{doi:10.1080/02791072.2025.2511752}.
\item University Hospital, Basel, Switzerland (2025). \textit{Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796361}{source link}.
\item Sara Prostko, Alexander Wu, Samuel Maddams, Veronica Szpak, Naomi Rosenblum, Lori M. Hilt, Joji Suzuki (2025). \textit{Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study}. Journal of Addiction Medicine. [published; OpenAlex]. \href{https://doi.org/10.1097/adm.0000000000001517}{doi:10.1097/adm.0000000000001517}.
\item Palmer C, Ferber AT, Greenwald BD. (2025). \textit{The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15060572}{doi:10.3390/brainsci15060572}.
\item Ines Erkizia-Santamaría, Nerea Martínez-Álvarez, Leyre Salinas-Novoa, J. Javier Meana, Jorge E. Ortega (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Charles Raison (2025). \textit{An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512194}{source link}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v1}{doi:10.31234/osf.io/dczw2\_v1}.
\item Unknown authors (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v1}{source link}.
\item Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2025). \textit{Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116559}{doi:10.1016/j.psychres.2025.116559}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR. (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C. (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6hjkm\_v1}{doi:10.31234/osf.io/6hjkm\_v1}.
\item Unknown authors (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6hjkm\_v1}{source link}.
\item Jake F. Hooper, Emily Gyongyosi, Kent E. Hutchison, Raeghan L. Mueller (2025). \textit{Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1533055}{doi:10.3389/fpsyg.2025.1533055}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Morris R, Keeler J, Treasure J, Himmerich H. (2025). \textit{The pharmacological treatment of anxiety in people with eating disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2025.107782}{doi:10.1016/j.phrs.2025.107782}.
\item Syed OA, Petranker R, Tsang B. (2025). \textit{The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106204}{doi:10.1016/j.neubiorev.2025.106204}.
\item Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD. (2025). \textit{Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116532}{doi:10.1016/j.psychres.2025.116532}.
\item Jennifer Ong (2025). \textit{Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.70462/acim.2025.1.001}{doi:10.70462/acim.2025.1.001}.
\item Wang H, Wang X (2025). \textit{Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00247}{doi:10.1021/acschemneuro.5c00247}.
\item Michael A. Wheeler (2025). \textit{Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0011}{doi:10.61373/pp025k.0011}.
\item Sharmin Ghaznavi (2025). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06247839}{source link}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B. (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Hannes Kettner (2025). \textit{Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/125300}{doi:10.25560/125300}.
\item Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu, Winston De La Haye, Clarence Locklear, Girardin Jean-Louis (2025). \textit{0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsaf090.0391}{doi:10.1093/sleep/zsaf090.0391}.
\item Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther (2025). \textit{Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung}. Nervenheilkunde. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2517-1621}{doi:10.1055/a-2517-1621}.
\item Weintraub MJ, Miklowitz DJ, Jeffrey JK. (2025). \textit{Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000853}{doi:10.1097/pra.0000000000000853}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Saara Susan Sevander, Marja-Liisa Rissanen (2025). \textit{The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.59476/hesdia.v0i1.700}{doi:10.59476/hesdia.v0i1.700}.
\item Unknown authors (2025). \textit{Psilocybin-assisted therapy shows range of benefits in cancer patients}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31316}{doi:10.1002/pu.31316}.
\item Unknown authors (2025). \textit{Trial finds psilocybin improves symptoms in treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31317}{doi:10.1002/pu.31317}.
\item Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt, Robin Carhart-Harris, Leor Roseman (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Centre for Addiction and Mental Health (2025). \textit{Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06518720}{source link}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis}. The International Journal of Psychiatry in Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/00912174251337572}{doi:10.1177/00912174251337572}.
\item Louise Penzenstadler, Sandra Baudois, Alma Lingenberg, Sabina Catalano Chiuvé, Emilie Tomkova, Vanessa Fleury (2025). \textit{[Treatment with psychedelics: potential benefits in Parkinson's disease].}. PubMed. [published; OpenAlex]. \href{https://doi.org/10.53738/revmed.2025.21.915.47180}{doi:10.53738/revmed.2025.21.915.47180}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD. (2025). \textit{5-HT2A receptors: Pharmacology and functional selectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher (2025). \textit{Regulatory Challenges of Integrating Psychedelics into Mental Health Sector}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4020011}{doi:10.3390/psychoactives4020011}.
\item Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD. (2025). \textit{Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152500032x}{doi:10.1017/s147895152500032x}.
\item Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D. (2025). \textit{Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-025-02091-6}{doi:10.1038/s41386-025-02091-6}.
\item Nilubon Thaoboonruang, Ornrat Lohitnavy, Kimheang Ya, Manupat Lohitnavy (2025). \textit{Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-025-98202-w}{doi:10.1038/s41598-025-98202-w}.
\item Mimms C, Sotelo K, Khaliq AS. (2025). \textit{Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.82532}{doi:10.7759/cureus.82532}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH. (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Orly Lipsitz, Joshua D. Rosenblat (2025). \textit{194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.431}{doi:10.1016/j.biopsych.2025.02.431}.
\item Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat (2025). \textit{187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.424}{doi:10.1016/j.biopsych.2025.02.424}.
\item Danica E. Johnson, Erica Kaczmarek, Noah Chisamore, Orly Lipitz, Zoe Doyle, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.423}{doi:10.1016/j.biopsych.2025.02.423}.
\item Xue Zhang, Emily Zhai, Claire Bertrand, Sara Ellis, Isabelle Wydler, Anna J. Donnelly, Trisha Suppes, Leanne M. Williams (2025). \textit{166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.403}{doi:10.1016/j.biopsych.2025.02.403}.
\item University of Otago (2025). \textit{Psilocybin-assisted Interpersonal Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05581797}{source link}.
\item Omidian H, Omidian A. (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Lu OD, White K, Raymond K, Liu C, Klein AS, Green N, Vaillancourt S, Gallagher A, Shindy L, Li A, Wallquist K, Li R, Zou M, Casey AB, Cameron LP, Pomrenze MB, Sohal V, Kheirbek MA, Gomez AM, Lammel S, Heifets BD, Malenka R. (2025). \textit{A multi-institutional investigation of psilocybin’s effects on mouse behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647810}{doi:10.1101/2025.04.08.647810}.
\item Tim Schäfer, Alexander M. Sherwood, Thomas A. Kirkland, Thomas Krüger, Jakob Worbs, Olaf Kniemeyer, Markus Gressler, Dirk Hoffmeister (2025). \textit{In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.202501037}{doi:10.1002/chem.202501037}.
\item Ellen Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, Balázs Szigeti, Connie Ludwig, Jill L. Ostrem, Caroline M. Tanner, Meredith Bock, Katiah Llerena, Patrick R. Finley, Aoife O’Donovan, José Rafael P. Zuzuárregui, Zachary Busby, Amber McKernan, Andrew Penn, Aliss C.C. Wang, Raymond C. Rosen, Joshua Woolley (2025). \textit{Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02097-0}{doi:10.1038/s41386-025-02097-0}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Unknown authors (2025). \textit{The neurons that mediate a psychedelic’s long-term antidepressive effects}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-025-00979-3}{doi:10.1038/d41586-025-00979-3}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.03.002}{doi:10.1016/bs.irn.2025.03.002}.
\item Sean M. Viña (2025). \textit{Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251337357}{doi:10.1177/20503245251337357}.
\item Zhangrao Huang, Yongpeng Yao, Rong Di, Jianchao Zhang, Yuanyuan Pan, Gang Liu (2025). \textit{De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli}. Microbial Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1111/1751-7915.70135}{doi:10.1111/1751-7915.70135}.
\item Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, Margaret Ross, Renee Harvey, Susan L. Rossell, Jerome Sarris, Daniel Perkins, Rachel Ε. Neale, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset, Jörg Strobel, Stephen Parker (2025). \textit{Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement}. BMJ Open. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjopen-2024-095992}{doi:10.1136/bmjopen-2024-095992}.
\item Turkia M. (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/mzkyv\_v1}{doi:10.31234/osf.io/mzkyv\_v1}.
\item Unknown authors (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mzkyv\_v1}{source link}.
\item Bires J. (2025). \textit{Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/07347332.2025.2482917}{doi:10.1080/07347332.2025.2482917}.
\item Noah Chisamore, Erica Kaczmarek, Zoe Doyle, Danica E. Johnson, Geneva Weiglein, Shakila Meshkat, Ryan M. Brudner, Marc G. Blainey, Jeremy Riva-Cambrin, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude}. The Canadian Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/07067437251328316}{doi:10.1177/07067437251328316}.
\item Ghaznavi S, Richter SG. (2025). \textit{Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-025-02172-2}{doi:10.1007/s40265-025-02172-2}.
\item Chunyan Meng, Wenting Guo, Xiao Chuan, Yan Wen, Xudong Zhu, Qingrong Zhang, Yuxuan Liang, Hongwei Li, Sha Xu, Yuntan Qiu, Haitao Chen, Wei-Jye Lin, Baixing Wu (2025). \textit{Structural basis for psilocybin biosynthesis}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-58239-x}{doi:10.1038/s41467-025-58239-x}.
\item Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T. (2025). \textit{The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.03.17.25324123}{doi:10.1101/2025.03.17.25324123}.
\item Portes MAM, Werle I, Bertoglio LJ. (2025). \textit{Is there a place for psychedelics in sports practice?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.13}{doi:10.1017/neu.2025.13}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY. (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Psilocybin in Alcohol Use Disorder With Comorbid Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06235411}{source link}.
\item University of Washington (2025). \textit{A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05163496}{source link}.
\item Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L. (2025). \textit{Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111333}{doi:10.1016/j.pnpbp.2025.111333}.
\item Dino F. (2025). \textit{A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.80707}{doi:10.7759/cureus.80707}.
\item Valentin Yurievich Skryabin (2025). \textit{The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?}. Neurology Bulletin. [published; OpenAlex]. \href{https://doi.org/10.17816/nb639991}{doi:10.17816/nb639991}.
\item Lukas Bobak, Ian Dorney, Alexsandra Kovacevich, Brian S. Barnett (2025). \textit{Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2478097}{doi:10.1080/02791072.2025.2478097}.
\item Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2025). \textit{Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00302744}{source link}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M. (2025). \textit{Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.05.641592}{doi:10.1101/2025.03.05.641592}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A. (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska (2025). \textit{Risks of using psilocybin in treatment of treatment-resistant depression}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2025.79.58319}{doi:10.12775/jehs.2025.79.58319}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05523401}{source link}.
\item Aicher HD, Müller F, Gasser P. (2025). \textit{Further education in psychedelic-assisted therapy - experiences from Switzerland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-025-06871-y}{doi:10.1186/s12909-025-06871-y}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Unknown authors (2025). \textit{Psilocybin therapy might help frontline pandemic workers}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31292}{doi:10.1002/pu.31292}.
\item Barnett BS, Mauney EE, King F. (2025). \textit{Psychedelic-assisted therapy: An overview for the internist.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3949/ccjm.92a.24032}{doi:10.3949/ccjm.92a.24032}.
\item Guy M. Goodwin, Ania Nowakowska, Merve Atli, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Lindsey Marwood, Zainib Shabir, Sunil Mistry, S. C. Stansfield, Emma Teoh, Joyce Tsai, Matthew B. Young, Ekaterina Malievskaia (2025). \textit{Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.24m15449}{doi:10.4088/jcp.24m15449}.
\item Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB. (2025). \textit{Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cam4.70586}{doi:10.1002/cam4.70586}.
\item Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H. (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/26tz7\_v1}{doi:10.31234/osf.io/26tz7\_v1}.
\item Unknown authors (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/26tz7\_v1}{source link}.
\item Aneta Petrušková, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló-Amorós, Renato Frischknecht, Eva-Maria Weiss, Tomáš Páleníček, Anna Fejtová (2025). \textit{Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons}. Journal of Neurochemistry. [published; OpenAlex]. \href{https://doi.org/10.1111/jnc.70020}{doi:10.1111/jnc.70020}.
\item Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P. (2025). \textit{A review of psychedelics trials completed in depression, informed by European regulatory perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105516}{doi:10.1016/j.nsa.2025.105516}.
\item Mauney E, King F, Burton-Murray H, Kuo B. (2025). \textit{Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/mcg.0000000000002149}{doi:10.1097/mcg.0000000000002149}.
\item Unknown authors (2025). \textit{CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.r111}{doi:10.1136/bmj.r111}.
\item Lucido MJ, Dunlop BW. (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard (2025). \textit{Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00375}{doi:10.1556/2054.2025.00375}.
\item Joseph A. Zamaria, Gisele Fernandes-Osterhold, Jonathan Shedler, Rachel Yehuda (2025). \textit{Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1505894}{doi:10.3389/fpsyg.2025.1505894}.
\item de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL. (2025). \textit{Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2025.2460674}{doi:10.1080/17460441.2025.2460674}.
\item Vanessa Fleury, Emilie Tomkova, Sabina Catalano Chiuvé, Louise Penzenstadler (2025). \textit{Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report}. Journal of Parkinson s Disease. [published; OpenAlex]. \href{https://doi.org/10.1177/1877718x241312604}{doi:10.1177/1877718x241312604}.
\item Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Takayoshi Mamiya, Shinji Kitagaki, Masayuki Hiramatsu (2025). \textit{BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyae059.584}{doi:10.1093/ijnp/pyae059.584}.
\item Jérémie Richard, Sandeep M. Nayak, Nathan D. Sepeda, Albert Garcia-Romeu (2025). \textit{Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112184}{doi:10.1016/j.drugalcdep.2024.112184}.
\item Unknown authors (2025). \textit{BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815225}{source link}.
\item Unknown authors (2025). \textit{ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814992}{source link}.
\item Eva Louie, Ellen Towers, Alyssa R. Morse, Joshua Watt, Zachary Bryant, Paul Haber, Kirsten C. Morley (2025). \textit{The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour}. International Journal of Mental Health Nursing. [published; OpenAlex]. \href{https://doi.org/10.1111/inm.70010}{doi:10.1111/inm.70010}.
\item Allen F. Shaughnessy (2025). \textit{Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/39964936}{source link}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS. (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Kinderlehrer DA. (2025). \textit{Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s500337}{doi:10.2147/ndt.s500337}.
\item Kargbo RB. (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Felix Müller, Thomas Sauer, Corina Hänny, Markus Mühlhauser, Undine E. Lang (2025). \textit{Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report}. Psychiatry Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psychres.2025.116381}{doi:10.1016/j.psychres.2025.116381}.
\item Paloma C. Frautschi, Ajay Paul Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John-Paul J. Yu (2025). \textit{Effects of Psilocybin on Mouse Brain Microstructure}. American Journal of Neuroradiology. [published; OpenAlex]. \href{https://doi.org/10.3174/ajnr.a8634}{doi:10.3174/ajnr.a8634}.
\item Central Institute of Mental Health, Mannheim (2025). \textit{A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04670081}{source link}.
\item Liebnau J, Betzler F, Kerber A. (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M. (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A. (2025). \textit{Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-med-050423-095712}{doi:10.1146/annurev-med-050423-095712}.
\item Amin Sharifan (2025). \textit{What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?}. Cochrane Clinical Answers. [published; OpenAlex]. \href{https://doi.org/10.1002/cca.4512}{doi:10.1002/cca.4512}.
\item Valerie A. Canady (2025). \textit{Study finds encouraging results in psilocybin treatment for TRD patients}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34292}{doi:10.1002/mhw.34292}.
\item Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo (2025). \textit{PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS}. Health and Society. [published; OpenAlex]. \href{https://doi.org/10.51249/hs.v5i01.2377}{doi:10.51249/hs.v5i01.2377}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA. (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Mona Irrmischer, Drew Puxty, Barış Onur Yıldırım, J.B. Deijen, Hessel Engelbregt (2025). \textit{Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06733-3}{doi:10.1007/s00213-024-06733-3}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE. (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Sutherland I, Ho MF, Croarkin PE. (2025). \textit{Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/cap.2024.0082}{doi:10.1089/cap.2024.0082}.
\item Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G. (2025). \textit{Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.01.631011}{doi:10.1101/2025.01.01.631011}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Hancock, Mackenzie, Shambhu Prasad Adhikari, Getz, Nicole (2024). \textit{Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/ar2s4}{doi:10.17605/osf.io/ar2s4}.
\item Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro (2024). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Marina D. Kostić, Jana Nedić, Jovana S. Dragojević, Vera M. Divac (2024). \textit{In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.46793/iccbikg25.477k}{doi:10.46793/iccbikg25.477k}.
\item Madison M. H. Simounet, Joy Drinnon (2024). \textit{Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies}. Psi Chi Journal of Psychological Research. [published; OpenAlex]. \href{https://doi.org/10.24839/2325-7342.jn30.4.345}{doi:10.24839/2325-7342.jn30.4.345}.
\item Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris (2024). \textit{Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105421}{doi:10.1016/j.nsa.2025.105421}.
\item Friederike Klein (2024). \textit{Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreich}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-024-4209-z}{doi:10.1007/s15005-024-4209-z}.
\item Mile Jevtić (2024). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Joshua Woolley, MD, PhD (2024). \textit{Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04932434}{source link}.
\item Namik Kirlić, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Nadav Liam Modlin, Stéphanie Knatz Peck, Alice Gaillard, Guy M. Goodwin, Don Koelpin (2024). \textit{Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20230884}{doi:10.1176/appi.ajp.20230884}.
\item Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB. (2024). \textit{Psilocybin: From Psychiatric Pariah to Perceived Panacea.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230682}{doi:10.1176/appi.ajp.20230682}.
\item Ramaekers JG, Reckweg JT, Mason NL. (2024). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Scott T. Aaronson, Andrew van der Vaart, Tammy Miller, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm (2024). \textit{Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20231063}{doi:10.1176/appi.ajp.20231063}.
\item Wolfgang AS, McClair VL, Schnurr PP, Holtzheimer PE, Woolley JD, Stauffer CS, Wolf RC, States LJ, Benedek DM, Capaldi VF, Bradley J, Fuller MA, Smyth MJ, Hermes EDA, Tenhula W, Wiechers IR (2024). \textit{Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20240751}{doi:10.1176/appi.ajp.20240751}.
\item Broc A. Pagni, Richard J. Zeifman, Sarah E. Mennenga, Brennan M. Carrithers, Noam Goldway, Snehal Bhatt, Kelley C. O’Donnell, Stephen Ross, Michael P. Bogenschutz (2024). \textit{Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20230887}{doi:10.1176/appi.ajp.20230887}.
\item Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM. (2024). \textit{Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/wnf.0000000000000617}{doi:10.1097/wnf.0000000000000617}.
\item Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL. (2024). \textit{Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.12.31.24319806}{doi:10.1101/2024.12.31.24319806}.
\item Tap S, Bostoen T, Breeksema J, Schoevers R (2024). \textit{Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.001}{doi:10.1016/bs.irn.2025.03.001}.
\item Zitong Wang, Brett Robbins, Ryan Zhuang, Thaísa Meira Sandini, Rebekah van Bruggen, Xin-Min Li, Yanbo Zhang (2024). \textit{Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2024.111243}{doi:10.1016/j.pnpbp.2024.111243}.
\item Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, Péter Kéri, Jerzy Samochowiec, Livia De Picker, Andrea Fiorillo, Kim P. C. Kuypers, Geert Dom (2024). \textit{Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1806}{doi:10.1192/j.eurpsy.2024.1806}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2024). \textit{Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1508811}{doi:10.3389/fpsyt.2025.1508811}.
\item Marek J, Domek-Gumprecht M, Macionga A, Szafoni S, Więckiewicz G (2024). \textit{PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591658}{doi:10.3389/fpsyt.2025.1591658}.
\item Katherine Cheung, Maxwell Brodie, Sue-Ling Chang, P. Deschamps, Jean-Sébastien Fallu, Houman Farzin, Johanne Hébert, Jean-François Stephan, Michel Dorval, Yann Joly, for the P3A Study Group (2024). \textit{Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns}. The Journal of Law Medicine \& Ethics. [published; OpenAlex]. \href{https://doi.org/10.1017/jme.2025.10109}{doi:10.1017/jme.2025.10109}.
\item Houman Farzin, Benjamin Koren, Helen Ferrier, Justin J. Sanders, Nicolas Garel (2024). \textit{Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report}. Palliative \& Supportive Care. [published; OpenAlex]. \href{https://doi.org/10.1017/s1478951525100941}{doi:10.1017/s1478951525100941}.
\item Elena Koning, Pedro Starzynski Bacchi, Cristiano Chaves, Fabiano A. Gomes, Elisa Brietzke (2024). \textit{Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?}. Trends in Psychiatry and Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.47626/2237-6089-2025-1197}{doi:10.47626/2237-6089-2025-1197}.
\item Papp N, Gonda X. (2024). \textit{[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?]}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/42412648}{source link}.
\item Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly (2024). \textit{Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse}. Saudi Journal of Medicine and Public Health. [published; OpenAlex]. \href{https://doi.org/10.64483/20251153}{doi:10.64483/20251153}.
\item Mohammad Ali, Urbah Viqar (2024). \textit{Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy}. Annals of Punjab Medical College. [published; OpenAlex]. \href{https://doi.org/10.29054/apmc/2024.1658}{doi:10.29054/apmc/2024.1658}.
\item Miguel Farinha-Ferreira, Catarina Miranda-Lourenço, Chloé Galipeau, Zsolt Lenkei, Ana M. Sebastião (2024). \textit{Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2024.110280}{doi:10.1016/j.neuropharm.2024.110280}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2024). \textit{Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116337}{doi:10.1016/j.psychres.2024.116337}.
\item García-Cabrerizo R, Beruete-Fresnillo I, García-Fuster MJ. (2024). \textit{Characterizing psilocybin as an antidepressant for adolescence in male and female rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.20.629571}{doi:10.1101/2024.12.20.629571}.
\item Geller J, Whitney E. (2024). \textit{Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01577-2}{doi:10.1007/s11920-024-01577-2}.
\item Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Robin Carhart-Harris, J. Chai-Rees, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Namik Kirlić, Rasmus Wentzer Licht, Lindsey Marwood, Thomas D. Meyer, Sunil Mistry, Ania Nowakowska, Tomáš Páleníček, Dimitris Repantis, Robert A. Schoevers, Hollie Simmons, Metten Somers, Emma Teoh, Joyce Tsai, Mourad Wahba, Sam Williams, Allan H. Young, Matthew B. Young, Sidney Zisook, Ekaterina Malievskaia (2024). \textit{The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.12.061}{doi:10.1016/j.jad.2024.12.061}.
\item Johannes Jungwirth, Robin von Rotz, Isabel Dziobek, Franz X. Vollenweider, Katrin H. Preller (2024). \textit{Psilocybin increases emotional empathy in patients with major depression}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB. (2024). \textit{The safety of psilocybin-assisted psychotherapy: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241289024}{doi:10.1177/00048674241289024}.
\item Meyer TD, Ibrahim M, Vale LN, Soares JC. (2024). \textit{Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.12.044}{doi:10.1016/j.jad.2024.12.044}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A. (2024). \textit{The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002268}{doi:10.1017/s1092852924002268}.
\item Ethan G. Dutcher, Andrew D. Krystal (2024). \textit{Treatment Expectancies and Psilocybin vs Escitalopram for Depression}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2024.4387}{doi:10.1001/jamapsychiatry.2024.4387}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM. (2024). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Anthony L. Back, Timara K. Freeman-Young, Ladybird Morgan, Tanmeet Sethi, Kelsey K. Baker, Susanna Myers, Bonnie A. McGregor, Kalin Harvey, Marlene Tai, Austin Kollefrath, Brandon J. Thomas, Dennis Sorta, Mendel Kaelen, Benjamin Kelmendi, Ted Gooley (2024). \textit{Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2024.49026}{doi:10.1001/jamanetworkopen.2024.49026}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Terao I, Kodama W. (2024). \textit{Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70042}{doi:10.1002/pcn5.70042}.
\item Humphreys K, Todd Korthuis P, Stjepanović D, Hall W. (2024). \textit{Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-psych-020124-023532}{doi:10.1146/annurev-psych-020124-023532}.
\item Menon V, Ramamurthy P, Venu S, Andrade C. (2024). \textit{Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13778}{doi:10.1111/acps.13778}.
\item Unknown authors (2024). \textit{Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18-26; doi: 10.1089/psymed.2022.0002.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0002.correx}{doi:10.1089/psymed.2022.0002.correx}.
\item Hinkle JT, Graziosi M, Nayak SM, Yaden DB. (2024). \textit{Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.2546}{doi:10.1001/jamapsychiatry.2024.2546}.
\item Collins HM. (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T. (2024). \textit{Psilocybin and hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002487}{doi:10.1017/s1092852924002487}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G. (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item Arman Fard, Allison Cohen (2024). \textit{Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings}. Journal of Student Research. [published; OpenAlex]. \href{https://doi.org/10.47611/jsrhs.v13i4.7602}{doi:10.47611/jsrhs.v13i4.7602}.
\item de Jonge D, van der Meer PB, Kramers C, Schellekens A. (2024). \textit{Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01567-4}{doi:10.1007/s11920-024-01567-4}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2024). \textit{Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.28.625811}{doi:10.1101/2024.11.28.625811}.
\item Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M. (2024). \textit{Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02800-5}{doi:10.1038/s41380-024-02800-5}.
\item TRYP Therapeutics (2024). \textit{A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05035927}{source link}.
\item Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey, Geneva Weiglein, Roger S McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat (2024). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.0032}{doi:10.1089/psymed.2024.0032}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Erin Y. Wang, David S. Mathai, Natalie Gukasyan, Sandeep M. Nayak, Albert Garcia-Romeu (2024). \textit{Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-78736-1}{doi:10.1038/s41598-024-78736-1}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R. (2024). \textit{Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01539-8}{doi:10.1007/s11920-024-01539-8}.
\item University of Utah (2024). \textit{PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05557643}{source link}.
\item Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X. (2024). \textit{Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejmech.2024.117049}{doi:10.1016/j.ejmech.2024.117049}.
\item Kargbo RB. (2024). \textit{Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00519}{doi:10.1021/acsmedchemlett.4c00519}.
\item Kargbo RB. (2024). \textit{Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00521}{doi:10.1021/acsmedchemlett.4c00521}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Andrew Gribben, T. R. JUN. BURKE, Colm Harrington, Amanda Husein, Kevin S. Murnane, Peter S. Hendricks, Katy Tobin, Jo-Hanna Ivers, Guillaume Thuery, Andrew Harkin, John R. Kelly (2024). \textit{Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2024.49}{doi:10.1017/ipm.2024.49}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Barstowe A, Kajonius PJ. (2024). \textit{Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2424272}{doi:10.1080/02791072.2024.2424272}.
\item Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Michael-Paul Schallmo (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.24.12.5}{doi:10.1167/jov.24.12.5}.
\item Jordan J. Negrine, Cheneal Puljević, Jason Ferris, Paul Liknaitzky, Christopher M. Perlman, Timothy Piatkowski (2024). \textit{Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling}. Drug and Alcohol Review. [published; OpenAlex]. \href{https://doi.org/10.1111/dar.13973}{doi:10.1111/dar.13973}.
\item Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2024.768}{doi:10.1192/bjo.2024.768}.
\item Lamia Özgör (2024). \textit{Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen}. InFo Hämatologie + Onkologie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15004-024-0785-9}{doi:10.1007/s15004-024-0785-9}.
\item Slavica Janevska, Sophie Weiser, Ying Huang, Jun Lin, Sandra Hoefgen, Katarina Jojić, Amelia E. Barber, Tim Schäfer, Janis Fricke, Dirk Hoffmeister, Lars Regestein, Vito Valiante, Johann E. Kufs (2024). \textit{Optimized psilocybin production in tryptophan catabolism-repressed fungi}. Microbial Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1111/1751-7915.70039}{doi:10.1111/1751-7915.70039}.
\item Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2024.768}{source link}.
\item Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari, Shahryar Rajai Firouzabadi, Ida Mohammadi, Touran Bahrami Babaheidari, Mahmood Bakhtiyari (2024). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden O’Neill (2024). \textit{Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0309911}{doi:10.1371/journal.pone.0309911}.
\item Kai Rogge, Tobias Wagner, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten (2024). \textit{Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis}. FEBS Letters. [published; OpenAlex]. \href{https://doi.org/10.1002/1873-3468.15042}{doi:10.1002/1873-3468.15042}.
\item Fleury S, Nautiyal KM. (2024). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.18.618582}{doi:10.1101/2024.10.18.618582}.
\item Stefanie Enriquez-Geppert, Jaroslav Krc, Fiachra O'Higgins, Morten Peter Lietz (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study}. Philosophical Transactions of the Royal Society B Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg\_v1}{doi:10.31234/osf.io/u9yeg\_v1}.
\item University Health Network, Toronto (2024). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg}{doi:10.31234/osf.io/u9yeg}.
\item Unknown authors (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u9yeg\_v1}{source link}.
\item Danielle R. Adams, Heidi Allen, Ginger E. Nicol, Leopoldo J. Cabassa (2024). \textit{Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science}. Translational Behavioral Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/tbm/ibae053}{doi:10.1093/tbm/ibae053}.
\item Szpręgiel I, Bysiek A. (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Kargbo RB. (2024). \textit{Expanding the Therapeutic Horizons of Psilocybin in Mental Health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00488}{doi:10.1021/acsmedchemlett.4c00488}.
\item Karthiyayini B, Kalyani NN, Gowdhami B, Muthuselvam M, Dharumadurai D. (2024). \textit{Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12088-024-01396-2}{doi:10.1007/s12088-024-01396-2}.
\item Lindsey Marwood, Megan Croal, Sunil Mistry, Hollie Simmons, Joyce Tsai, Matthew B. Young, Guy M. Goodwin (2024). \textit{The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2024.10.009}{doi:10.1016/j.jpsychires.2024.10.009}.
\item Hannah Douglass (2024). \textit{The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/118978}{doi:10.25560/118978}.
\item Morgan Justin, Kerry Watrin (2024). \textit{Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?}. Evidence-Based Practice. [published; OpenAlex]. \href{https://doi.org/10.1097/ebp.0000000000002281}{doi:10.1097/ebp.0000000000002281}.
\item Li JR, Chiang KT, Kao YC, Yu CL, Yang FC, Liang CS, Hsu TW. (2024). \textit{The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.10.016}{doi:10.1016/j.jad.2024.10.016}.
\item Pincombe J, Williams M, Carruthers S, Rossell S. (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ga9p2}{doi:10.31234/osf.io/ga9p2}.
\item Unknown authors (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ga9p2\_v1}{source link}.
\item Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen, Albert Dahan (2024). \textit{Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-024-00091-w}{doi:10.1038/s44184-024-00091-w}.
\item Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar (2024). \textit{Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3040029}{doi:10.3390/psychoactives3040029}.
\item Junges LH, Müller-Santos M. (2024). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Johan Lundberg, Guusje Haver (2024). \textit{Does psilocybin really provide long-term relief from depression, as new study suggests?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/ab.ywdthqf9c}{doi:10.64628/ab.ywdthqf9c}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7}{doi:10.31234/osf.io/uxhv7}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7\_v1}{doi:10.31234/osf.io/uxhv7\_v1}.
\item Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V. (2024). \textit{Impact of psilocybin on cognitive function: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/pcn.13741}{doi:10.1111/pcn.13741}.
\item Unknown authors (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1002/prp2.70097}{doi:10.1002/prp2.70097}.
\item Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy, Claire J. Foldi (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes (2024). \textit{Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.09.133}{doi:10.1016/j.jad.2024.09.133}.
\item Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A. (2024). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4492873/v1}{doi:10.21203/rs.3.rs-4492873/v1}.
\item University of California, San Francisco (2024). \textit{An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05065294}{source link}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Franklin R. Schneier (2024). \textit{Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024r.0028}{doi:10.61373/pp024r.0028}.
\item Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W. (2024). \textit{Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1416420}{doi:10.3389/fpsyt.2024.1416420}.
\item David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker Jones, David Nutt, Brandon Weiss, Robin Carhart-Harris (2024). \textit{Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2024.102799}{doi:10.1016/j.eclinm.2024.102799}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2024). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.19.24313958}{doi:10.1101/2024.09.19.24313958}.
\item Abigail E. Calder, Benjamin Rausch, Matthias E. Liechti, Friederike Holze, Gregor Hasler (2024). \textit{Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241278873}{doi:10.1177/02698811241278873}.
\item University Hospital, Ghent (2024). \textit{Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06378229}{source link}.
\item Armstrong SB, Davis AK. (2024). \textit{Psychedelic research at a crossroads.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adt1024}{doi:10.1126/science.adt1024}.
\item Danielle B Rodrigues (2024). \textit{Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials}. Journal of Complementary Medicine \& Alternative Healthcare. [published; OpenAlex]. \href{https://doi.org/10.19080/jcmah.2024.13.555852}{doi:10.19080/jcmah.2024.13.555852}.
\item Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S. (2024). \textit{Exploring the regulatory framework of psychedelics in the US \& Europe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104242}{doi:10.1016/j.ajp.2024.104242}.
\item Li G, Facchini PJ. (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Syed F. Rab, Charles L. Raison, Elliot Marseille (2024). \textit{An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024r.0025}{doi:10.61373/pp024r.0025}.
\item Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C. (2024). \textit{Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/14651858.cd015383.pub2}{doi:10.1002/14651858.cd015383.pub2}.
\item Thaoboonruang N, Lohitnavy M, Lohitnavy O. (2024). \textit{Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2399128}{doi:10.1080/02791072.2024.2399128}.
\item Zhen Z, Sun X, Yuan S, Zhang J. (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item Arnim Quante (2024). \textit{Einmalig Psilocybin: antidepressive Effekte}. PSYCH up2date. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2185-5208}{doi:10.1055/a-2185-5208}.
\item Treviranus GRS. (2024). \textit{Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/39378462}{source link}.
\item Federico Seragnoli, Martignoni Geo, Martignoni Entela, Silke Bachmann, Elisa Rabitti, Silvio Cavuto, Dubus Zoë, Penzenstadler Louise, Gabriel Thorens, Joël Billieux, Zullino Daniele (2024). \textit{Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report}. Clinical Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/ccr3.9305}{doi:10.1002/ccr3.9305}.
\item Jungwirth J, Bavato F, Quednow BB. (2024). \textit{[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-024-01727-0}{doi:10.1007/s00115-024-01727-0}.
\item Najib J. (2024). \textit{The role of psilocybin in depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2396536}{doi:10.1080/03007995.2024.2396536}.
\item Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS. (2024). \textit{Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078607}{doi:10.1136/bmj-2023-078607}.
\item Doğancan Sönmez, Aslı Enzel Koç (2024). \textit{Psilocybin in the Treatment of Mental Disorders}. DergiPark (Istanbul University). [published; OpenAlex]. \href{https://doi.org/10.30708/mantar.1535344}{doi:10.30708/mantar.1535344}.
\item Jim Weil (2024). \textit{Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.}. American Anthropologist. [published; OpenAlex]. \href{https://doi.org/10.1111/aman.28009}{doi:10.1111/aman.28009}.
\item Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M. (2024). \textit{Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14080829}{doi:10.3390/brainsci14080829}.
\item Kim A, Halton B, Shah A, Seecof OM, Ross S. (2024). \textit{Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21037/apm-24-35}{doi:10.21037/apm-24-35}.
\item Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS. (2024). \textit{The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1439347}{doi:10.3389/fpsyt.2024.1439347}.
\item Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A. (2024). \textit{Psilocybin for clinical indications: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241269751}{doi:10.1177/02698811241269751}.
\item Rodolfo Myronn de Melo Rodrigues (2024). \textit{Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024c.0022}{doi:10.61373/pp024c.0022}.
\item Michael P. Bogenschutz (2024). \textit{A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16647}{doi:10.1111/add.16647}.
\item Sheppard Pratt Health System (2024). \textit{An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433858}{source link}.
\item Yang X, Kuang W. (2024). \textit{Letter to editor regarding "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116136}{doi:10.1016/j.psychres.2024.116136}.
\item Brugmann University Hospital (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy \& (Neuro)Cognitive Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160232}{source link}.
\item Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach (2024). \textit{Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00298-y}{doi:10.1038/s44220-024-00298-y}.
\item Sarah Jane Palmer (2024). \textit{Insights into the efficacy of psilocybin in treating depression and other disorders}. British Journal of Neuroscience Nursing. [published; OpenAlex]. \href{https://doi.org/10.12968/bjnn.2024.0046}{doi:10.12968/bjnn.2024.0046}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Kaiserman A, Vanderjist L, Kornreich C. (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item V Suresh, Jitendra Lakhani, R Balaraman (2024). \textit{Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients}. Journal of Natural Remedies. [published; OpenAlex]. \href{https://doi.org/10.18311/jnr/2024/35676}{doi:10.18311/jnr/2024/35676}.
\item Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J. Barratt, Adam Winstock, Cheneal Puljević (2024). \textit{From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241265762}{doi:10.1177/02698811241265762}.
\item Washington University School of Medicine (2024). \textit{Psilocybin for the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05675800}{source link}.
\item Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A. (2024). \textit{Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-024-01101-3}{doi:10.1007/s40263-024-01101-3}.
\item Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara G. Gloeckler, David Erritzøe, Robin Carhart-Harris, Kyle T. Greenway (2024). \textit{Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-66817-0}{doi:10.1038/s41598-024-66817-0}.
\item André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent (2024). \textit{Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1394962}{doi:10.3389/fpsyt.2024.1394962}.
\item Zheng S, Ma R, Yang Y, Li G. (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek (2024). \textit{Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence}. Current Psychopharmacologye. [published; OpenAlex]. \href{https://doi.org/10.2174/0122115560288779240628043307}{doi:10.2174/0122115560288779240628043307}.
\item Amir Khajavinia, Déborah Michel, Udoka C. Ezeaka, Randy W. Purves, Robert B. Laprairie, Anas El-Aneed (2024). \textit{Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/j.chroma.2024.465123}{doi:10.1016/j.chroma.2024.465123}.
\item Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, Joanna Solich, Agnieszka Potasiewicz, Marta Dziedzicka-Wasylewska, Ryszard Bugno, Adam S. Hogendorf, Andrzej J. Bojarski, Agata Faron-Górecka (2024). \textit{Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople, Nir Lipsman, Muhammad Ishrat Husain, Joshua D. Rosenblat, Xingshan Cao, Bradley J. MacIntosh, Sean M. Nestor (2024). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression}. Trials. [published; OpenAlex]. \href{https://doi.org/10.1186/s13063-024-08268-6}{doi:10.1186/s13063-024-08268-6}.
\item Lauren Gorfinkel, Julia M. Bujno, Claire Walsh, Dvora Shmulewitz, Deborah S. Hasin (2024). \textit{Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110267}{doi:10.1016/j.drugalcdep.2023.110267}.
\item Amanda Paige Hanstein, Chance Felchlin (2024). \textit{Treating Anxiety and Depression With Psilocybin Therapy.}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/39079732}{source link}.
\item DeBattista C, Schatzberg AF. (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Bader H, Farraj H, Maghnam J, Abu Omar Y. (2024). \textit{Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5306/wjco.v15.i7.908}{doi:10.5306/wjco.v15.i7.908}.
\item Nauman Ashraf (2024). \textit{IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?}. Journal of Pakistan Psychiatric Society. [published; OpenAlex]. \href{https://doi.org/10.63050/jpps.21.02.935}{doi:10.63050/jpps.21.02.935}.
\item Unknown authors (2024). \textit{Review identifies factors associated with response to psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31193}{doi:10.1002/pu.31193}.
\item Brian S. Barnett, Curtis J. Koons, Vincent Van den Eynde, Peter Kenneth Gillman, J. Alexander Bodkin (2024). \textit{Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2368617}{doi:10.1080/02791072.2024.2368617}.
\item Fluyau D, Kailasam VK, Revadigar N. (2024). \textit{Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.06.17.24308787}{doi:10.1101/2024.06.17.24308787}.
\item Appiani FJ, Caroff SN. (2024). \textit{The cyclical revival of psychedelics in psychiatric treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2368725}{doi:10.1080/03007995.2024.2368725}.
\item Guo Q, Guo L, Wang Y, Shang S. (2024). \textit{Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116018}{doi:10.1016/j.psychres.2024.116018}.
\item P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl, David L. Morgan, Ryan Cook, Sarann Bielavitz, Renae Myers, R. Cameron Wolf, Dennis McCarty, Christopher S. Stauffer (2024). \textit{Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241257839}{doi:10.1177/02698811241257839}.
\item Torrado Pacheco A, Moghaddam B. (2024). \textit{Licit use of illicit drugs for treating depression: the pill and the process.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1172/jci180217}{doi:10.1172/jci180217}.
\item Linda M. Richmond (2024). \textit{Psychedelics’ Use as Medicine Hits Significant Roadblock}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.07.7.54}{doi:10.1176/appi.pn.2024.07.7.54}.
\item Joachim Neumann, Kiril Dimov, Karyna Azatsian, Britt Hofmann, Ulrich Gergs (2024). \textit{Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2024.06.006}{doi:10.1016/j.toxlet.2024.06.006}.
\item Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item University of Sydney (2024). \textit{A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06444243}{source link}.
\item Unknown authors (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/adnpg\_v1}{source link}.
\item Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T, Roth B.L, DiBerto J.F, Daniel Wacker, Robertson M.J, Kami Kim, Krumm B.E, Seven A.B (2024). \textit{Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/yb2v-ca64}{doi:10.17615/yb2v-ca64}.
\item Ramos L, Vicente SG. (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Mengyang Xu, Andor J. Kiss, J. Andrew Jones, Matthew S. McMurray, Haifei Shi (2024). \textit{Effect of oral tryptamines on the gut microbiome of rats-a preliminary study}. PeerJ. [published; OpenAlex]. \href{https://doi.org/10.7717/peerj.17517}{doi:10.7717/peerj.17517}.
\item Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM. (2024). \textit{A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1387158}{doi:10.3389/fphar.2024.1387158}.
\item Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T. (2024). \textit{Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4685}{doi:10.1001/jamapsychiatry.2023.4685}.
\item Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11847495}{source link}.
\item Aaronson ST, van der Vaart A, Sackeim HA. (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0423}{doi:10.1001/jamapsychiatry.2024.0423}.
\item Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD. (2024). \textit{Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2024.05.051}{doi:10.1016/j.jpsychires.2024.05.051}.
\item Hoyer D. (2024). \textit{On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171648613.31141136/v1}{doi:10.22541/au.171648613.31141136/v1}.
\item Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB. (2024). \textit{Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2024.2357668}{doi:10.1080/09540261.2024.2357668}.
\item Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X. (2024). \textit{Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115960}{doi:10.1016/j.psychres.2024.115960}.
\item Korkmaz ND, Cikrikcili U, Akan M, Yucesan E. (2024). \textit{Psychedelic therapy in depression and substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.16421}{doi:10.1111/ejn.16421}.
\item S Morris (2024). \textit{A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient}. Clinical Psychopharmacology and Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.9758/cpn.24.1180}{doi:10.9758/cpn.24.1180}.
\item David Nutt, Ilana Crome, Allan H. Young (2024). \textit{Is it now time to prepare psychiatry for a psychedelic future?}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.2024.76}{doi:10.1192/bjp.2024.76}.
\item Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.16.594614}{doi:10.1101/2024.05.16.594614}.
\item Nathan Bryson, Robert Alexander, Aviva Asnis-Alibozek, Michael Ehlers (2024). \textit{RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.4c00058}{doi:10.1021/acschemneuro.4c00058}.
\item Shunichiro Ikeda, Toshihiko Kinoshita (2024). \textit{Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens}. Psychiatry and Clinical Neurosciences Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/pcn5.196}{doi:10.1002/pcn5.196}.
\item Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska (2024). \textit{Psilocybin as a new way for depression treatment}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2024.68.50168}{doi:10.12775/jehs.2024.68.50168}.
\item Terri D’Arrigo (2024). \textit{Calls to Poison Centers Involving Psilocybin Rising in Youth}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.06.6.2}{doi:10.1176/appi.pn.2024.06.6.2}.
\item Jeffrey JK, Weintraub MJ, Grob CS. (2024). \textit{Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaac.2024.03.021}{doi:10.1016/j.jaac.2024.03.021}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D. (2024). \textit{Structural pharmacology and therapeutic potential of 5-methoxytryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41586-024-07403-2}{doi:10.1038/s41586-024-07403-2}.
\item British Medical Journal Publishing Group (2024). \textit{EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.q1025}{doi:10.1136/bmj.q1025}.
\item Hanna Brancaccio (2024). \textit{Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}.
\item Claire Parker, Bethany Wood (2024). \textit{At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Unknown authors (2024). \textit{PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38740403}{source link}.
\item De Giorgi R, Ede R. (2024). \textit{Psilocybin for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.q798}{doi:10.1136/bmj.q798}.
\item Metaxa AM, Clarke M. (2024). \textit{Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078084}{doi:10.1136/bmj-2023-078084}.
\item Val Bellman (2024). \textit{Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon}. Cancers. [published; OpenAlex]. \href{https://doi.org/10.3390/cancers16091702}{doi:10.3390/cancers16091702}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, Karla Frydenvang, Jesper L. Kristensen (2024). \textit{Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.4c00082}{doi:10.1021/acs.jmedchem.4c00082}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2024). \textit{The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04630964}{source link}.
\item Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D’Souza (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden (2024). \textit{Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020014}{doi:10.3390/psychoactives3020014}.
\item Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas, Christopher Timmermann, Robin Carhart-Harris (2024). \textit{Psychedelics and the ‘inner healer’: Myth or mechanism?}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241239206}{doi:10.1177/02698811241239206}.
\item Eiko I. Fried, Ioana A. Cristea, Florian Naudet (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0420}{doi:10.1001/jamapsychiatry.2024.0420}.
\item Erika Dyck (2024). \textit{Who will staff the psychedelic resurgence?}. Open Access Government. [published; OpenAlex]. \href{https://doi.org/10.56367/oag-042-10690}{doi:10.56367/oag-042-10690}.
\item Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. (2024). \textit{[Psychedelic psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38572715}{source link}.
\item J. S. Seo (2024). \textit{Current situation regarding psychedelics and magic mushroom in Korea}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1695}{doi:10.1192/j.eurpsy.2024.1695}.
\item Eva Maria Schindowski, Franz X. Vollenweider (2024). \textit{Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin}. Nervenheilkunde. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2283-0221}{doi:10.1055/a-2283-0221}.
\item Unknown authors (2024). \textit{Depressionen: Remission durch Psilocybin bei laufender SSRI-Therapie}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2254-0360}{doi:10.1055/a-2254-0360}.
\item Kim P. C. Kuypers (2024). \textit{Microdosing psychedelics in the treatment of ADHD and comorbid disorders}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.44}{doi:10.1192/j.eurpsy.2024.44}.
\item Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. (2024). \textit{Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2024.5960}{doi:10.1001/jamanetworkopen.2024.5960}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS. (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Jesse Hudspeth, Kai Rogge, Sebastian Dörner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten (2024). \textit{Methyl transfer in psilocybin biosynthesis}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-024-46997-z}{doi:10.1038/s41467-024-46997-z}.
\item Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y. (2024). \textit{Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115886}{doi:10.1016/j.psychres.2024.115886}.
\item David Nutt (2024). \textit{Psychedelics: reconnecting the brain to heal the mind}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_156}{doi:10.1042/bio\_2023\_156}.
\item Shreyasee Das, Rahul Shil (2024). \textit{Psychedelic Drugs: A Mind-expanding Hallucinogens}. Indian Journal of Behavioural Sciences. [published; OpenAlex]. \href{https://doi.org/10.55229/ijbs.v27i1.13}{doi:10.55229/ijbs.v27i1.13}.
\item David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris (2024). \textit{Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241237870}{doi:10.1177/02698811241237870}.
\item Adrian Preda (2024). \textit{Psychedelic Renaissance: Evidence and Culture}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.04.4.39}{doi:10.1176/appi.pn.2024.04.4.39}.
\item Natalie Ertl, Matthew B. Wall (2024). \textit{Scanning the new frontier of mental health: psychedelic brain imaging}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_171}{doi:10.1042/bio\_2023\_171}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener, Frederick S. Barrett, Roland R. Griffiths, Alan K. Davis (2024). \textit{The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0300501}{doi:10.1371/journal.pone.0300501}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Unknown authors (2024). \textit{Patients with bipolar II disorder benefit from single dose of psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31143}{doi:10.1002/pu.31143}.
\item Velit-Salazar MR, Shiroma PR, Cherian E. (2024). \textit{A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14030248}{doi:10.3390/brainsci14030248}.
\item Henning Hintzsche (2024). \textit{Psilocybin zur Behandlung depressiver Erkrankungen}. BIOspektrum. [published; OpenAlex]. \href{https://doi.org/10.1007/s12268-024-2157-2}{doi:10.1007/s12268-024-2157-2}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview}. American Journal of Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1097/mjt.0000000000001727}{doi:10.1097/mjt.0000000000001727}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin}. American Journal of Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths (2024). \textit{Impact of Psilocybin on Peripheral Cytokine Production}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0039}{doi:10.1089/psymed.2023.0039}.
\item Débora Copa, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi (2024). \textit{Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.02.089}{doi:10.1016/j.jad.2024.02.089}.
\item Hashimoto K. (2024). \textit{Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-024-01770-7}{doi:10.1007/s00406-024-01770-7}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ. (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Fang S, Yang X, Zhang W. (2024). \textit{Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1359088}{doi:10.3389/fpsyt.2024.1359088}.
\item Scott T. Aaronson, Zofia Kozak (2024). \textit{New evidence for flexible psilocybin dosing in patients with treatment-resistant depression}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2024.01.014}{doi:10.1016/j.medj.2024.01.014}.
\item Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, Erica Kaczmarek, Ryan M. Brudner, Kevin Kratiuk, Rodrigo B. Mansur, Christian Schulz, Rickinder Sethi, Amanda Abate, Shaun Ali, Jordan Bawks, Marc G. Blainey, Elisa Brietzke, Victoria Cronin, Jessica Danilewitz, Shalini Dhawan, Anthony Di Fonzo, M. Di Fonzo, Pawel Drzadzewski, William Dunlop, Hajnalka Fiszter, Fabiano A. Gomes, Smrita Grewal, Marisa Leon-Carlyle, Marilyn McCallum, Niki Mofidi, Hilary Offman, Jeremy Riva-Cambrin, Joel E. Schmidt, Mark E. Smolkin, Joan M. Quinn, Andrea Zumrova, Michelle Marlborough, Roger S. McIntyre (2024). \textit{Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2024.01.005}{doi:10.1016/j.medj.2024.01.005}.
\item Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph Peill, Leor Roseman, David Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi (2024). \textit{Psychedelics and sexual functioning: a mixed-methods study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-49817-4}{doi:10.1038/s41598-023-49817-4}.
\item Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, T.L. Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert A. Schoevers (2024). \textit{Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-53188-9}{doi:10.1038/s41598-024-53188-9}.
\item Thomas Müller (2024). \textit{Psilocybin gegen Depressionen}. CME. [published; OpenAlex]. \href{https://doi.org/10.1007/s11298-023-3754-y}{doi:10.1007/s11298-023-3754-y}.
\item Phil Wolfson, Gita Vaid (2024). \textit{Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1209419}{doi:10.3389/fpsyt.2024.1209419}.
\item Borissova A, Rucker JJ. (2024). \textit{The development of psilocybin therapy for treatment-resistant depression: an update.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjb.2023.25}{doi:10.1192/bjb.2023.25}.
\item Holze F, Singh N, Liechti ME, D'Souza DC. (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Massachusetts General Hospital (2024). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05381974}{source link}.
\item Balázs Szigeti, Brandon Weiss, Fernando E. Rosas, David Erritzøe, David Nutt, Robin Carhart-Harris (2024). \textit{Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723003653}{doi:10.1017/s0033291723003653}.
\item Payal Ghosh, Debjeet Sur (2024). \textit{Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/0126660822258502231120074036}{doi:10.2174/0126660822258502231120074036}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V. (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Javier González-Maeso (2024). \textit{Psychedelics for mental health: a biochemical perspective}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_161}{doi:10.1042/bio\_2023\_161}.
\item Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y. (2024). \textit{Older adults in psychedelic-assisted therapy trials: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231215420}{doi:10.1177/02698811231215420}.
\item Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS. (2024). \textit{A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.01.142}{doi:10.1016/j.jad.2024.01.142}.
\item Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas (2024). \textit{Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma}. Cancer Research. [published; OpenAlex]. \href{https://doi.org/10.1158/1538-7445.panca2023-c001}{doi:10.1158/1538-7445.panca2023-c001}.
\item Kaadt E, Søkilde R, Hansen H, Raval N, Lundgaard L, Just J, Knudsen G, Elfving B. (2024). \textit{MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brain}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3787179/v1}{doi:10.21203/rs.3.rs-3787179/v1}.
\item Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5rm62}{doi:10.31234/osf.io/5rm62}.
\item Unknown authors (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5rm62\_v1}{source link}.
\item E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM. (2024). \textit{Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2024.103938}{doi:10.1016/j.nsa.2024.103938}.
\item Mehdi Sekssaoui, Joël Bockaert, Philippe Marin, Carine Bécamel (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3829237/v1}{doi:10.21203/rs.3.rs-3829237/v1}.
\item Barajas, Carlos (2023). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item R.S. Treviranus, Gottfried (2023). \textit{RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?}. University of Zagreb University Computing Centre (SRCE). [published; OpenAlex]. \href{https://doi.org/10.24869/psyd.2024.134}{doi:10.24869/psyd.2024.134}.
\item Bridget Verhaaren (2023). \textit{Panini and Psilocybin}. Dialogue A Journal of Mormon Thought. [published; OpenAlex]. \href{https://doi.org/10.5406/15549399.57.4.08}{doi:10.5406/15549399.57.4.08}.
\item Matthew B. Young, J. Chai-Rees, Anna Nowakowska, Jeng-Yu Tsai, Guy M. Goodwin (2023). \textit{Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104163}{doi:10.1016/j.nsa.2024.104163}.
\item Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris (2023). \textit{Psilocybin vs Escitalopram for depression: 6-month follow-up}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104377}{doi:10.1016/j.nsa.2024.104377}.
\item C. Schmitz, Hana Adolphi, Michael Frank, E. Seeger, Maciej Musiał, Moritz Spangemacher, Michael Koslowski, Lea J. Mertens, Florian Schlagenhauf, Gerhard Gründer (2023). \textit{Neural effects of psilocybin-treatment in patients with treatment-resistant depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105028}{doi:10.1016/j.nsa.2024.105028}.
\item Tessa Watford (2023). \textit{The Therapeutic Potential of Psilocybin for Depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.33548/scientia1082}{doi:10.33548/scientia1082}.
\item Unknown authors (2023). \textit{Psilocybin may be as effective as escitalopram in treating depression, study suggests}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2024.1.327949}{doi:10.1211/pj.2024.1.327949}.
\item Prosenjit Ghosh, Avinash Desousa (2023). \textit{Psychedelics: The New Kid on the Block}. Annals of Indian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/aip.aip\_195\_23}{doi:10.4103/aip.aip\_195\_23}.
\item Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka (2023). \textit{Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104020}{doi:10.1016/j.nsa.2024.104020}.
\item Dominic Sisti (2023). \textit{Introduction to the Special Section on Psychedelics Research and Treatment}. Perspectives in biology and medicine. [published; OpenAlex]. \href{https://doi.org/10.1353/pbm.2024.a919714}{doi:10.1353/pbm.2024.a919714}.
\item N. Hewitt, J. Chai-Rees, Megan Croal, S. Mistry, Jeng-Yu Tsai, Matthew B. Young, Guy M. Goodwin (2023). \textit{Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104391}{doi:10.1016/j.nsa.2024.104391}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D. (2023). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Olivier B, Olivier JDA. (2023). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti (2023). \textit{Safety pharmacology of acute psilocybin administration in healthy participants}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104060}{doi:10.1016/j.nsa.2024.104060}.
\item Baeleigh VanderZwaag, Albert Garcia-Romeu, Mauricio A. García-Barrera (2023). \textit{Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253241264812}{doi:10.1177/20451253241264812}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś (2023). \textit{Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.50.01.005}{doi:10.12775/jehs.2023.50.01.005}.
\item Sophia Armand, Kristian Larsen, M. Madsen, Brice Ozenne, Katrin H. Preller, Gitte M. Knudsen, Dea Siggaard Stenbæk, Patrick M. Fisher (2023). \textit{Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103934}{doi:10.1016/j.nsa.2023.103934}.
\item Tianran Liu (2023). \textit{The Therapeutic Effect and Potential Application of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/3cfwjn09}{doi:10.54097/3cfwjn09}.
\item Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM. (2023). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3474764/v1}{doi:10.21203/rs.3.rs-3474764/v1}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/byms6}{doi:10.31234/osf.io/byms6}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Multidisciplinary Association for Psychedelic Studies (2023). \textit{Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00979693}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/byms6\_v1}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Śladowska K, Kawalec P, Brzostek T, Pilc A. (2023). \textit{Potential use of psilocybin drugs in the treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2023.2264180}{doi:10.1080/14728214.2023.2264180}.
\item Wojtas A, Gołembiowska K. (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Nogueira GN, Vasconcelos MMA, Souza FGM, Bisol LW. (2023). \textit{Is there credible evidence to assert psilocybin-assisted therapy for depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.11.003}{doi:10.1016/j.euroneuro.2023.11.003}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. (2023). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Paul Thambi, James A. Tulsky, Manish Agrawal (2023). \textit{Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis}. Cancer. [published; OpenAlex]. \href{https://doi.org/10.1002/cncr.35024}{doi:10.1002/cncr.35024}.
\item Thrul J, Kozak Z, Carducci MA, Garcia-Romeu A, Yaden DB. (2023). \textit{Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.35127}{doi:10.1002/cncr.35127}.
\item Manish Agrawal, William A. Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian D. Richards, Nick Schor, Heather Honstein, Betsy Jenkins, Mark Bates, Paul Thambi (2023). \textit{Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder}. Cancer. [published; OpenAlex]. \href{https://doi.org/10.1002/cncr.35010}{doi:10.1002/cncr.35010}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Ivana Turek (2023). \textit{Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin}. Medical Writing. [published; OpenAlex]. \href{https://doi.org/10.56012/tsen2260}{doi:10.56012/tsen2260}.
\item Unknown authors (2023). \textit{Drugs for depressionr.}. The Medical letter on drugs and therapeutics. [published; PubMed]. \href{https://doi.org/10.58347/tml.2023.1691a}{doi:10.58347/tml.2023.1691a}.
\item Elliot Marseille, Christopher S. Stauffer, Manish Agrawal, Paul Thambi, Kimberly Roddy, Michael C. Mithoefer, Stefano Bertozzi, James G. Kahn (2023). \textit{Group psychedelic therapy: empirical estimates of cost-savings and improved access}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1293243}{doi:10.3389/fpsyt.2023.1293243}.
\item Kolasa M, Faron-Górecka A (2023). \textit{Preclinical models of treatment-resistant depression: challenges and perspectives.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00542-9}{doi:10.1007/s43440-023-00542-9}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Nicholas Kolbman, Tiecheng Liu, Peter R. Guzzo, Jim Gilligan, George A. Mashour, Giancarlo Vanini, Dinesh Pal (2023). \textit{Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain}. Current Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cub.2023.10.016}{doi:10.1016/j.cub.2023.10.016}.
\item Duan W, Cao D, Wang S, Cheng J. (2023). \textit{Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM. (2023). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item Apex Labs Ltd. (2023). \textit{A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06141876}{source link}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2023). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item George Danias, Jacob M. Appel (2023). \textit{Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis}. JMIR Formative Research. [published; OpenAlex]. \href{https://doi.org/10.2196/43850}{doi:10.2196/43850}.
\item Elizabeth Boudreau, Krissa Orlowski (2023). \textit{Psilocybin therapy to reduce depression following a terminal diagnosis}. JAAPA. [published; OpenAlex]. \href{https://doi.org/10.1097/01.jaa.0000994952.07847.2d}{doi:10.1097/01.jaa.0000994952.07847.2d}.
\item Tahlia R. Harrison (2023). \textit{Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00267}{doi:10.1556/2054.2023.00267}.
\item Danelle Jones (2023). \textit{Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00306}{doi:10.1556/2054.2023.00306}.
\item Hernandez-Leon A, Escamilla-Orozco RI, Tabal-Robles AR, Martínez-Vargas D, Romero-Bautista L, Escamilla-Soto G, González-Romero OS, Torres-Valencia M, González-Trujano ME. (2023). \textit{Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jep.2023.117415}{doi:10.1016/j.jep.2023.117415}.
\item Bahji A, Lunsky I, Gutierrez G, Vazquez G. (2023). \textit{Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2278586}{doi:10.1080/02791072.2023.2278586}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2023). \textit{Aesthetic Chills Mitigate Maladaptive Cognition In Depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3582420/v1}{doi:10.21203/rs.3.rs-3582420/v1}.
\item Raj P, Rauniyar S, Sapkale B. (2023). \textit{Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.48719}{doi:10.7759/cureus.48719}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04739865}{source link}.
\item Heresco-Levy U, Lerer B. (2023). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Elizabeth Sugiarto, Rebecca Leung, Jamie Yuen (2023). \textit{Pharmacists’ perspectives on psilocybin in Canada}. JAPhA Practice Innovations. [published; OpenAlex]. \href{https://doi.org/10.1016/j.japhpi.2023.100003}{doi:10.1016/j.japhpi.2023.100003}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A. (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Van Der Walt J, Parker R. (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. (2023). \textit{Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Unknown authors (2023). \textit{Single dose of psilocybin improves depressive symptoms in Phase 2 study}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31093}{doi:10.1002/pu.31093}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Unknown authors (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Natasha Biscoe, Amanda Bonson, Max Slavin, Walter Busuttil, Deirdre MacManus, Andrew T. Cox, Dominic Murphy (2023). \textit{Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol}. European Journal of Trauma \& Dissociation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejtd.2023.100359}{doi:10.1016/j.ejtd.2023.100359}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00210-023-02778-x}{doi:10.1007/s00210-023-02778-x}.
\item Wsół A. (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Lucia Carbajal, Tessa E. Moore, R. H. Barry Sample, Joseph Nelson (2023). \textit{Is psilocybin effective for treatment of depression?}. Evidence-Based Practice. [published; OpenAlex]. \href{https://doi.org/10.1097/ebp.0000000000002021}{doi:10.1097/ebp.0000000000002021}.
\item Watford T, Masood N. (2023). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Ian B. Hickie, Allan H. Young, F. Markus Leweke (2023). \textit{Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?}. Research Directions Depression. [published; OpenAlex]. \href{https://doi.org/10.1017/dep.2023.21}{doi:10.1017/dep.2023.21}.
\item Payman Baharmand, Amardeep Kambo (2023). \textit{Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin}. BCIT Environmental Public Health Journal. [published; OpenAlex]. \href{https://doi.org/10.47339/ephj.2023.229}{doi:10.47339/ephj.2023.229}.
\item Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115531}{doi:10.1016/j.psychres.2023.115531}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain (2023). \textit{Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.3050}{doi:10.1002/cpt.3050}.
\item C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh, Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha S. Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy (2023). \textit{An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)}. Pilot and Feasibility Studies. [published; OpenAlex]. \href{https://doi.org/10.1186/s40814-023-01399-8}{doi:10.1186/s40814-023-01399-8}.
\item Unknown authors (2023). \textit{Psilocybin shows promising results in subjects continuing to use an antidepressant}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31089}{doi:10.1002/pu.31089}.
\item Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová (2023). \textit{MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.608}{doi:10.1016/j.ibneur.2023.08.608}.
\item Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský (2023). \textit{DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1240}{doi:10.1016/j.ibneur.2023.08.1240}.
\item Kwonmok Ko, Ben Carter, Anthony J. Cleare, James Rucker (2023). \textit{Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis}. Neuropsychiatric Disease and Treatment. [published; OpenAlex]. \href{https://doi.org/10.2147/ndt.s426193}{doi:10.2147/ndt.s426193}.
\item Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. (2023). \textit{Neuroimaging in psychedelic drug development: past, present, and future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02271-0}{doi:10.1038/s41380-023-02271-0}.
\item Thomas Müller (2023). \textit{Psilocybin kann offenbar Depressionen lindern}. MMW - Fortschritte der Medizin. [published; OpenAlex]. \href{https://doi.org/10.1007/s15006-023-3025-6}{doi:10.1007/s15006-023-3025-6}.
\item University of New Mexico (2023). \textit{Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01534494}{source link}.
\item Chiu Y, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer K, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2023). \textit{A suite of engineered mice for interrogating psychedelic drug actions}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.25.559347}{doi:10.1101/2023.09.25.559347}.
\item Sierra Carter, Grace Packard, Callan Coghlan, Jamilah R. George, Ashanti J. Brown, Terence H. W. Ching, Jacob Julian, Jessica L. Maples-Keller (2023). \textit{Perceptions of psychedelic-assisted therapy among Black Americans}. Journal of Mood and Anxiety Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.xjmad.2023.100023}{doi:10.1016/j.xjmad.2023.100023}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202309.1649.v1}{doi:10.20944/preprints202309.1649.v1}.
\item Mitch Earleywine, Maha N. Mian, Joseph A. De Leo (2023). \textit{Expectancies for Subjective and Antidepressant Effects in Psilocybin Users}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678231194798}{doi:10.1177/00221678231194798}.
\item Haniya J. Halim, Bradley G. Burk, Rachel E. Fargason, Badari Birur (2023). \textit{Manic episode following psilocybin use in a man with bipolar II disorder: a case report}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1221131}{doi:10.3389/fpsyt.2023.1221131}.
\item Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe, Hadi Zaki, Trey Brasher, Matthew X. Lowe, Del R. P. Jolly, Frederick S. Barrett, Roland R. Griffiths, Justin C. Strickland, Matthew W. Johnson, Heather Jackson, Albert Garcia-Romeu (2023). \textit{Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1199642}{doi:10.3389/fpsyt.2023.1199642}.
\item Brian S. Barnett, Miranda Arakelian, David S. Beebe, Jared Ontko, Connor Riegal, Willie O. Siu, Jeremy Weleff, Harrison G. Pope (2023). \textit{American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0036}{doi:10.1089/psymed.2023.0036}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Kargbo RB. (2023). \textit{Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00390}{doi:10.1021/acsmedchemlett.3c00390}.
\item NM Mahmudul Alam Bhuiya, Robin J. Jacobs, Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere, Akhila Yerubandi, Joshua Caballero (2023). \textit{Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.45169}{doi:10.7759/cureus.45169}.
\item Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff (2023). \textit{Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2023.190103}{doi:10.1176/appi.ajp-rj.2023.190103}.
\item Wolfgang AS, Hoge CW. (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, Pablo Mallaroni, R. de la Torre Fornell, Johannes T. Reckweg, Desmond H. Y. Tse, Nadia R. P. W. Hutten, Amanda Feilding, Johannes G. Ramaekers (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper, David J. Miklowitz (2023). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0018}{doi:10.1089/psymed.2023.0018}.
\item Unknown authors (2023). \textit{Psilocybin, escitalopram have comparable effects on personality in patients with depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31080}{doi:10.1002/pu.31080}.
\item Szigeti B, Phillips LD, Nutt D (2023). \textit{Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.}. British journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bcp.15841}{doi:10.1111/bcp.15841}.
\item Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA. (2023). \textit{Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000729}{doi:10.1097/pra.0000000000000729}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH. (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S (2023). \textit{Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0030}{doi:10.1089/psymed.2023.0030}.
\item Emmanuelle A. D. Schindler, Peter S. Hendricks (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders}. Expert Review of Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ. (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths (2023). \textit{Single-Dose Psilocybin Treatment for Major Depressive Disorder}. JAMA. [published; OpenAlex]. \href{https://doi.org/10.1001/jama.2023.14530}{doi:10.1001/jama.2023.14530}.
\item Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun (2023). \textit{The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits}. Journal of Applied Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1002/jat.4533}{doi:10.1002/jat.4533}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Antonio F. Pagán, Claudia Lex, Jair C. Soares, Thomas D. Meyer (2023). \textit{Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0022}{doi:10.1089/psymed.2023.0022}.
\item Raúl Escamilla, María Eva González-Trujano, Jesús M. González Mariscal, J. Martı́n Torres-Valencia, Héctor Guzmán-González, José Luis Vega, Anja Loizaga-Velder (2023). \textit{A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2246459}{doi:10.1080/02791072.2023.2246459}.
\item Marie Crowe, Jenni Manuel, Dave Carlyle, Cameron Lacey (2023). \textit{Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?}. International Journal of Mental Health Nursing. [published; OpenAlex]. \href{https://doi.org/10.1111/inm.13214}{doi:10.1111/inm.13214}.
\item Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH (2023). \textit{use of psilocybin in the treatment of psychiatric disorders - review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.43.01.009}{doi:10.12775/jehs.2023.43.01.009}.
\item Nick Zagorski (2023). \textit{Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.09.9.20}{doi:10.1176/appi.pn.2023.09.9.20}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.07.011}{doi:10.1016/j.euroneuro.2023.07.011}.
\item Moritz Spangemacher (2023). \textit{Psilocybin und Funktionalität bei Depression}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-023-3336-2}{doi:10.1007/s15005-023-3336-2}.
\item Jing X, Hoeh NR, Menkes DB. (2023). \textit{Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152300069x}{doi:10.1017/s147895152300069x}.
\item Ibrahim IB, Videbech P, Straszek SPV. (2023). \textit{Psychedelic drugs in the treatment of psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37615227}{source link}.
\item Brain and Cognition Discovery Foundation (2023). \textit{The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05029466}{source link}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A. (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB. (2023). \textit{Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115349}{doi:10.1016/j.psychres.2023.115349}.
\item Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E. (2023). \textit{Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10595939}{source link}.
\item Kuypers K. (2023). \textit{Psychedelics for depression: from neurobiology to treatment}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10417770}{source link}.
\item Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E. (2023). \textit{The therapeutic potential of psilocybin in depression resistant to psychotropic drugs}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10479004}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D. (2023). \textit{Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291723002039}{doi:10.1017/s0033291723002039}.
\item Venugopal Kaden L. (2023). \textit{Psilocybin Therapy for Major Depressive Disorder: A Systematic Review}. Undergraduate Research in Natural and Clinical Science and Technology Journal. [published; Crossref]. \href{https://doi.org/10.26685/urncst.489}{doi:10.26685/urncst.489}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Dan Yaniv, Lois M. Ramondetta, Lorenzo Cohen, Moran Amit (2023). \textit{Psilocybin-assisted psychotherapy for cancer-related anxiety and depression}. International Journal of Gynecological Cancer. [published; OpenAlex]. \href{https://doi.org/10.1136/ijgc-2023-004659}{doi:10.1136/ijgc-2023-004659}.
\item Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stéphanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia (2023). \textit{Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01648-7}{doi:10.1038/s41386-023-01648-7}.
\item Bianca Nogrady (2023). \textit{Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.p1599}{doi:10.1136/bmj.p1599}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3138705/v1}{doi:10.21203/rs.3.rs-3138705/v1}.
\item Tetem J, Fischmann T, Möller TJ. (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztyxh}{doi:10.31234/osf.io/ztyxh}.
\item Cybin Therapeutics Inc. (2023). \textit{Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05594667}{source link}.
\item Unknown authors (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztyxh\_v1}{source link}.
\item Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ. (2023). \textit{Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231180276}{doi:10.1177/02698811231180276}.
\item Kozak Z, Johnson MW, Aaronson ST. (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant (2023). \textit{Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2023.535}{doi:10.1192/bjo.2023.535}.
\item Rich Haridy (2023). \textit{Australia to prescribe MDMA and psilocybin for PTSD and depression in world first}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-023-02093-8}{doi:10.1038/d41586-023-02093-8}.
\item Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza (2023). \textit{Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231179800}{doi:10.1177/02698811231179800}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C. (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Halucenex Life Sciences Inc. (2023). \textit{Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05243329}{source link}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO. (2023). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Terri D’Arrigo (2023). \textit{Experts Offer Tips on Talking With Patients About Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.51}{doi:10.1176/appi.pn.2023.07.7.51}.
\item Katherine Cheung, Kyle Patch, Brian D. Earp, David B. Yaden (2023). \textit{Psychedelics, Meaningfulness, and the “Proper Scope” of Medicine: Continuing the Conversation}. Cambridge Quarterly of Healthcare Ethics. [published; OpenAlex]. \href{https://doi.org/10.1017/s0963180123000270}{doi:10.1017/s0963180123000270}.
\item Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc N. Potenza, Gustavo A. Angarita (2023). \textit{Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1197890}{doi:10.3389/fpsyt.2023.1197890}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L. (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Romain Nardou, Edward J. Sawyer, Young Jun Song, M. F. Wilkinson, Yasmin Padovan-Hernandez, Júnia L. de Deus, Noelle Wright, Carine Lama, Sehr Faltin, Loyal A. Goff, Genevieve Stein-O’Brien, Gül Dölen (2023). \textit{Psychedelics reopen the social reward learning critical period}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-023-06204-3}{doi:10.1038/s41586-023-06204-3}.
\item Kevin Herkenham (2023). \textit{A regulatory framework review of Schedule I psychedelics in the United States}. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. [published; OpenAlex]. \href{https://doi.org/10.1002/jac5.1841}{doi:10.1002/jac5.1841}.
\item Turkia M. (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/qyce5}{doi:10.31234/osf.io/qyce5}.
\item Unknown authors (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pw2tf\_v1}{source link}.
\item Unknown authors (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/qyce5\_v1}{source link}.
\item O'Grady C. (2023). \textit{No trip needed for psychedelics to lift mood?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adj1031}{doi:10.1126/science.adj1031}.
\item Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis Antoine, Sandeep M. Nayak (2023). \textit{Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231179910}{doi:10.1177/02698811231179910}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2023). \textit{Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.29.23290667}{doi:10.1101/2023.05.29.23290667}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne Katrin Schlag, David Nutt, Joanna C. Neill (2023). \textit{Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723001411}{doi:10.1017/s0033291723001411}.
\item Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy, Michelle Baker-Jones, Jonny Martell, David Nutt, Robin Carhart-Harris, David Erritzøe (2023). \textit{Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723001514}{doi:10.1017/s0033291723001514}.
\item Manish Agrawal, Sarah Shnayder, Heather Honstein, Ezekiel Emanuel, Paul Thambi (2023). \textit{Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2023.41.16\_suppl.12021}{doi:10.1200/jco.2023.41.16\_suppl.12021}.
\item Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD (2023). \textit{Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0011}{doi:10.1089/psymed.2022.0011}.
\item Scott Hoener, Aaron Wolfgang, David A. Nissan, Edmund G. Howe (2023). \textit{Ethical considerations for psychedelic-assisted therapy in military clinical settings}. Journal of Medical Ethics. [published; OpenAlex]. \href{https://doi.org/10.1136/jme-2023-108943}{doi:10.1136/jme-2023-108943}.
\item Brown O. (2023). \textit{Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.05.088}{doi:10.1016/j.jad.2023.05.088}.
\item James Rucker (2023). \textit{Evidence versus expectancy: the development of psilocybin therapy}. BJPsych Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1192/bjb.2023.28}{doi:10.1192/bjb.2023.28}.
\item Heal DJ, Smith SL, Belouin SJ, Henningfield JE. (2023). \textit{Psychedelics: Threshold of a Therapeutic Revolution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109610}{doi:10.1016/j.neuropharm.2023.109610}.
\item Combat Stress (2023). \textit{Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05876481}{source link}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN. (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Qasim S, Zaheer Z, Jawad MY, Shad MU. (2023). \textit{Neurobiological Correlates of Psilocybin Response in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/pcc.22r03419}{doi:10.4088/pcc.22r03419}.
\item Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2023). \textit{Acute psilocybin increased cortical activities in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item University of Wisconsin, Madison (2023). \textit{Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04842045}{source link}.
\item Fonseka LN, Woo BK. (2023). \textit{Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5498/wjp.v13.i5.182}{doi:10.5498/wjp.v13.i5.182}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A. (2023). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ. (2023). \textit{Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.16.540994}{doi:10.1101/2023.05.16.540994}.
\item University of Wisconsin, Madison (2023). \textit{A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05467761}{source link}.
\item THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C, ZULLINO D. (2023). \textit{Exposure therapy under psilocybin for general anxiety disorder and claustrophobia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2859973/v1}{doi:10.21203/rs.3.rs-2859973/v1}.
\item Johns Hopkins University (2023). \textit{Effects of Psilocybin in Anorexia Nervosa}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04052568}{source link}.
\item Rossell SL, Meikle SE, Williams ML, Castle DJ. (2023). \textit{Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674231172691}{doi:10.1177/00048674231172691}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Eric N. Kramer, Kalyn Reddy, Bryan Shapiro (2023). \textit{A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history}. Psychiatry Research Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psycr.2023.100118}{doi:10.1016/j.psycr.2023.100118}.
\item Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris (2023). \textit{A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231167848}{doi:10.1177/02698811231167848}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03775200}{source link}.
\item Manish Agrawal, Ezekiel Emanuel, Brian D. Richards, William A. Richards, Kim Roddy, Paul Thambi (2023). \textit{Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder}. JAMA Oncology. [published; OpenAlex]. \href{https://doi.org/10.1001/jamaoncol.2023.0351}{doi:10.1001/jamaoncol.2023.0351}.
\item Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier (2023). \textit{347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.587}{doi:10.1016/j.biopsych.2023.02.587}.
\item Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes (2023). \textit{96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.336}{doi:10.1016/j.biopsych.2023.02.336}.
\item Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A. (2023). \textit{Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109528}{doi:10.1016/j.neuropharm.2023.109528}.
\item Julia Mertens L. (2023). \textit{Psilocybin zeigt Wirkung bei Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-023-2540-9}{doi:10.1007/s15006-023-2540-9}.
\item Dawood Hristova JJ, Pérez-Jover V. (2023). \textit{Psychotherapy with Psilocybin for Depression: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/bs13040297}{doi:10.3390/bs13040297}.
\item Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM. (2023). \textit{The need for establishing best practices and gold standards in psychedelic medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.03.083}{doi:10.1016/j.jad.2023.03.083}.
\item Yingjie Du, Yunfeng Li, Xiangting Zhao, Yishan Yao, Bin Wang, Liming Zhang, Guyan Wang (2023). \textit{Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity}. Chinese Medical Journal. [published; OpenAlex]. \href{https://doi.org/10.1097/cm9.0000000000002647}{doi:10.1097/cm9.0000000000002647}.
\item Ibi D. (2023). \textit{[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Kamal S, Jha MK, Radhakrishnan R. (2023). \textit{Role of Psychedelics in Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psc.2023.02.004}{doi:10.1016/j.psc.2023.02.004}.
\item Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS. (2023). \textit{Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20220835}{doi:10.1176/appi.ajp.20220835}.
\item Optimi Health Corporation (2023). \textit{Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05252598}{source link}.
\item Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza (2023). \textit{Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231154852}{doi:10.1177/02698811231154852}.
\item Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Gregory Ian Robinson, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Mackenzie Cameron, Dongping Li, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2023). \textit{The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules28062624}{doi:10.3390/molecules28062624}.
\item New York State Psychiatric Institute (2023). \textit{Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04656301}{source link}.
\item Wulff AB, Nichols CD, Thompson SM. (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Turkia M. (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/wupvy}{doi:10.31234/osf.io/wupvy}.
\item Turkia M. (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/t6k9b}{doi:10.31234/osf.io/t6k9b}.
\item Unknown authors (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/wupvy\_v1}{source link}.
\item Unknown authors (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/t6k9b\_v1}{source link}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Shi En Kim (2023). \textit{How psychedelics spark neuronal growth}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10108-scicon1}{doi:10.1021/cen-10108-scicon1}.
\item Nathan Emmerich, Bryce Humphries (2023). \textit{Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist’s Training?}. Cambridge Quarterly of Healthcare Ethics. [published; OpenAlex]. \href{https://doi.org/10.1017/s0963180123000099}{doi:10.1017/s0963180123000099}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B. (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Jha MK, Mathew SJ. (2023). \textit{Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230025}{doi:10.1176/appi.ajp.20230025}.
\item Anne Karow (2023). \textit{Psychedelische Therapie mit Psilocybin und Psychotherapie - Wo stehen wir?}. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2010-7640}{doi:10.1055/a-2010-7640}.
\item Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J. (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Ashish Sarangi, Omotola Akinkunmi (2023). \textit{Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease}. American Journal of Geriatric Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jagp.2022.12.201}{doi:10.1016/j.jagp.2022.12.201}.
\item Jacob S. Aday, Zachary Skiles, Noa Eaton, Lisa Fredenburg, Mollie Pleet, Jessica Mantia, Ellen Bradley, Gisele Fernandes-Osterhold, Joshua Woolley (2023). \textit{Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2022.0004}{doi:10.1089/psymed.2022.0004}.
\item Crowe M, Manuel J, Carlyle D, Lacey C. (2023). \textit{Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/inm.13127}{doi:10.1111/inm.13127}.
\item Jeffery Heilman (2023). \textit{The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy}. Journal of Scientific Exploration. [published; OpenAlex]. \href{https://doi.org/10.31275/20222633}{doi:10.31275/20222633}.
\item Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly Lennard-Jones, Rasmus Wentzer Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie Simmons, Jair C. Soares, Metten Somers, S. C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia (2023). \textit{Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2023.01.108}{doi:10.1016/j.jad.2023.01.108}.
\item Rucker JJ. (2023). \textit{Psilocybin therapy for depression. A good trip?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09638237.2023.2183492}{doi:10.1080/09638237.2023.2183492}.
\item Østergaard SD, Hieronymus F. (2023). \textit{Psilocybin for Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmc2215459}{doi:10.1056/nejmc2215459}.
\item Jennings Hernandez (2023). \textit{Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health}. Advances in Research. [published; OpenAlex]. \href{https://doi.org/10.9734/air/2023/v24i1931}{doi:10.9734/air/2023/v24i1931}.
\item Washington University School of Medicine (2023). \textit{SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05601648}{source link}.
\item von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX. (2023). \textit{Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2023.101841}{doi:10.1016/j.eclinm.2023.101841}.
\item Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck (2023). \textit{Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00222}{doi:10.1556/2054.2022.00222}.
\item Dragana Marković, Eleonora Čapelja (2023). \textit{Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder}. AIDASCO Reviews. [published; OpenAlex]. \href{https://doi.org/10.59783/aire.2023.15}{doi:10.59783/aire.2023.15}.
\item White CM, Weisman N, Dalo J. (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Pacheco AT, Olson RJ, Garza G, Moghaddam B. (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.01.09.523291}{doi:10.1101/2023.01.09.523291}.
\item Unknown authors (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f26ce\_v1}{source link}.
\item Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2022). \textit{Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102452}{doi:10.1016/j.nsa.2023.102452}.
\item Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia (2022). \textit{The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102906}{doi:10.1016/j.nsa.2023.102906}.
\item Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc (2022). \textit{Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102939}{doi:10.1016/j.nsa.2023.102939}.
\item Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen (2022). \textit{Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103646}{doi:10.1016/j.nsa.2023.103646}.
\item Adriana D’Arienzo, Giorgio Samorini (2022). \textit{Italian psychedelic therapies of the past century: An historical overview}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231179687}{doi:10.1177/20503245231179687}.
\item O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer (2022). \textit{Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.101067}{doi:10.1016/j.nsa.2023.101067}.
\item Nadiia Omelchenko, Anton Kurapov (2022). \textit{Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change}. Bulletin of Taras Shevchenko National University of Kyiv Psychology. [published; OpenAlex]. \href{https://doi.org/10.17721/bpsy.2023.1(17).8}{doi:10.17721/bpsy.2023.1(17).8}.
\item John R. Rossiter (2022). \textit{Psychedelic Drug Therapy for Mental Disorders?}. Open Journal of Medical Psychology. [published; OpenAlex]. \href{https://doi.org/10.4236/ojmp.2023.123010}{doi:10.4236/ojmp.2023.123010}.
\item Ezeaka UC, Kim HJJ, Laprairie RB. (2022). \textit{Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026623666230705151922}{doi:10.2174/1568026623666230705151922}.
\item Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA (2022). \textit{Functional MRI markers for treatment-resistant depression: Insights and challenges.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.04.001}{doi:10.1016/bs.pbr.2023.04.001}.
\item Ahmed H, Mushahid H, Arshad T. (2022). \textit{UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37992112}{source link}.
\item Gail A. Edelsohn, Dominic Sisti (2022). \textit{Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment}. Perspectives in biology and medicine. [published; OpenAlex]. \href{https://doi.org/10.1353/pbm.2023.0007}{doi:10.1353/pbm.2023.0007}.
\item Natalie Gukasyan (2022). \textit{On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2022.12.003}{doi:10.1016/j.medj.2022.12.003}.
\item Mann JJ. (2022). \textit{Is psilocybin an effective antidepressant and what is its Mechanism of action?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.xcrm.2022.100906}{doi:10.1016/j.xcrm.2022.100906}.
\item IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I. (2022). \textit{The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37387703}{source link}.
\item Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ (2022). \textit{Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2125467}{doi:10.1080/02791072.2022.2125467}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2022). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella (2022). \textit{Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph16010068}{doi:10.3390/ph16010068}.
\item Alistair R. McTaggart, Timothy Y. James, Jason C. Slot, Caine Barlow, Nigel Fechner, Louise S. Shuey, A. Drenth (2022). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway}. Fungal Genetics and Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Vanessa Eveline VLAIC, Andreea ONA (2022). \textit{The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions}. Hop and Medicinal Plants. [published; OpenAlex]. \href{https://doi.org/10.15835/hpm.v30i1-2.14453}{doi:10.15835/hpm.v30i1-2.14453}.
\item Robin von Rotz, Eva Maria Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter J.C.M. Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider (2022). \textit{Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2022.101809}{doi:10.1016/j.eclinm.2022.101809}.
\item Unknown authors (2022). \textit{High dose of psilocybin effective for treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30970}{doi:10.1002/pu.30970}.
\item Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ. (2022). \textit{Canalization and plasticity in psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109398}{doi:10.1016/j.neuropharm.2022.109398}.
\item Nick Zagorski (2022). \textit{Depression Improves Following Single Dose of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.01.1.50}{doi:10.1176/appi.pn.2023.01.1.50}.
\item Meccia J, Lopez J, Bagot RC. (2022). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Joshua C. Gray, Mikela A. Murphy, Sierra Carter, Matthew W. Johnson, Aaron Wolfgang, Michael J. Roy, Jessica L. Maples-Keller (2022). \textit{Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury}. Military Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/milmed/usac400}{doi:10.1093/milmed/usac400}.
\item Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin E. Michalak (2022). \textit{“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0279073}{doi:10.1371/journal.pone.0279073}.
\item Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley (2022). \textit{Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811221131997}{doi:10.1177/02698811221131997}.
\item Unknown authors (2022). \textit{History of epilepsy increases risk of psychedelic-induced seizures}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30967}{doi:10.1002/pu.30967}.
\item Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. (2022). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Daniel Burmester, M. Madsen, Attila Szabó, Sanjay S. Aripaka, Dea Siggaard Stenbæk, Vibe G. Frøkjær, Betina Elfving, Jens D. Mikkelsen, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation}. Comprehensive Psychoneuroendocrinology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cpnec.2022.100163}{doi:10.1016/j.cpnec.2022.100163}.
\item Błażej D. Pędzich, Mireia Medrano, An Buckinx, Ilse Smolders, Dimitri De Bundel (2022). \textit{Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice}. International Journal of Molecular Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/ijms232315284}{doi:10.3390/ijms232315284}.
\item Prokopios Magiatis, Evangelos Dadiotis, Romanos Konstantinos Antonopoulos, K Ioannidis, V Mitsis, E Melliou, Zacharoula Gonou-Zagou (2022). \textit{Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens}. Planta Medica. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0042-1759062}{doi:10.1055/s-0042-1759062}.
\item Gregory Barber, Charles B. Nemeroff, Steven Siegel (2022). \textit{A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.22010073}{doi:10.1176/appi.ajp.22010073}.
\item Alexander J. Bradshaw, Talia Backman, Virginia Ramírez-Cruz, Dale L. Forrister, Jaclyn M. Winter, Laura Guzmán-Dávalos, Giuliana Furci, Paul Stamets, Bryn T. M. Dentinger (2022). \textit{DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites}. Applied and Environmental Microbiology. [published; OpenAlex]. \href{https://doi.org/10.1128/aem.01498-22}{doi:10.1128/aem.01498-22}.
\item Marten Dooper (2022). \textit{Fast and sustained effect of 2 administrations of psilocybin on depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55788/0629715f}{doi:10.55788/0629715f}.
\item Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. (2022). \textit{Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221125354}{doi:10.1177/02698811221125354}.
\item Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. (2022). \textit{Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.31796}{doi:10.7759/cureus.31796}.
\item Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D. (2022). \textit{Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200551}{doi:10.1002/cbic.202200551}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Guss J, Krause R, Sloshower J. (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r96tc}{doi:10.31234/osf.io/r96tc}.
\item Unknown authors (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/r96tc\_v1}{source link}.
\item NYU Langone Health (2022). \textit{A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02061293}{source link}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2022). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.03.515044}{doi:10.1101/2022.11.03.515044}.
\item Iacobucci G. (2022). \textit{Psilocybin reduces symptoms in treatment resistant depression, trial results show.}. BMJ. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.o2623}{doi:10.1136/bmj.o2623}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. (2022). \textit{Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.10.31.22281688}{doi:10.1101/2022.10.31.22281688}.
\item Paganin W, Signorini S, Signorini S, Leccese V, Sciarretta A. (2022). \textit{[Treatment-resistant depression. From classification to new therapies.]}. Rivista di psichiatria. [published; Europe PMC]. \href{https://doi.org/10.1708/3922.39072}{doi:10.1708/3922.39072}.
\item Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. (2022). \textit{Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.}. New England Journal of Medicine. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2206443}{doi:10.1056/nejmoa2206443}.
\item Madras BK. (2022). \textit{Psilocybin in Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejme2210975}{doi:10.1056/nejme2210975}.
\item Jones GM. (2022). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221127304}{doi:10.1177/02698811221127304}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM. (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2zys9}{doi:10.31234/osf.io/2zys9}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.}. Psychedelic Medicine. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0002}{doi:10.1089/psymed.2022.0002}.
\item Unknown authors (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2zys9\_v1}{source link}.
\item Sheppard Pratt Health System (2022). \textit{The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433845}{source link}.
\item Dupuis D, Veissière S. (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Balon R. (2022). \textit{Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001610}{doi:10.1097/jcp.0000000000001610}.
\item Goel DB, Zilate S. (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Ko K, Kopra EI, Cleare AJ, Rucker JJ. (2022). \textit{Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2022.09.168}{doi:10.1016/j.jad.2022.09.168}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI. (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item Natalie Gukasyan (2022). \textit{19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2022.07.664}{doi:10.1016/j.jaac.2022.07.664}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Odland AU, Kristensen JL, Andreasen JT. (2022). \textit{Animal Behavior in Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA. (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kh3cx}{doi:10.31234/osf.io/kh3cx}.
\item Unknown authors (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kh3cx\_v1}{source link}.
\item Michael Eisenstein (2022). \textit{The psychedelic escape from depression}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-022-02872-9}{doi:10.1038/d41586-022-02872-9}.
\item Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M. (2022). \textit{Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms231911450}{doi:10.3390/ijms231911450}.
\item COMPASS Pathways (2022). \textit{Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP001 And COMP003 Trials (P-TRD LTFU)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04519957}{source link}.
\item Barber GS, Aaronson ST. (2022). \textit{The Emerging Field of Psychedelic Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01363-y}{doi:10.1007/s11920-022-01363-y}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Calder AE, Hasler G. (2022). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Kavita Golia (2022). \textit{Psilocybin as a healer}. Consciousness Spirituality \& Transpersonal Psychology. [published; OpenAlex]. \href{https://doi.org/10.53074/cstp.2022.37}{doi:10.53074/cstp.2022.37}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. (2022). \textit{Effective connectivity of emotion and cognition under psilocybin}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.06.22279626}{doi:10.1101/2022.09.06.22279626}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R. (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych Open. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item Lyes M, Yang KH, Castellanos J, Furnish T. (2022). \textit{Microdosing psilocybin for chronic pain: a case series.}. Pain. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pain.0000000000002778}{doi:10.1097/j.pain.0000000000002778}.
\item special to C EN Attabey Rodríguez Benítez (2022). \textit{Psychedelics’ binding depends on receptor mutations}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10031-scicon6}{doi:10.1021/cen-10031-scicon6}.
\item Mitch Earleywine, Zachary Herrmann (2022). \textit{Psychedelics for Psychiatric Disorders: Promise, Not Panacea}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220810-01}{doi:10.3928/00485713-20220810-01}.
\item Girala N. (2022). \textit{Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567945}{source link}.
\item National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. (2022). \textit{Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop}. National Academies Press (US), Washington (DC). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36049038}{source link}.
\item Shah K, Trivedi C, Kamrai D, Akbar M, Tankersley W. (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9563652}{source link}.
\item Johannesdottir A, Sigurdsson E. (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME (2022). \textit{The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.29167}{doi:10.7759/cureus.29167}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Graham Zoe (2022). \textit{‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression}. Journal of High School Science. [published; Crossref]. \href{https://doi.org/10.64336/001c.37945}{doi:10.64336/001c.37945}.
\item Doss MK, Barrett FS, Corlett PR. (2022). \textit{Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.}. ACS Chemical Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.2c00461}{doi:10.1021/acschemneuro.2c00461}.
\item Neşe Devenot, Trey Conner, Richard Doyle (2022). \textit{Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12154}{doi:10.1111/anoc.12154}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert Opinion on Drug Discovery. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B. (2022). \textit{Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.}. Journal of Fungi. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8080870}{doi:10.3390/jof8080870}.
\item Brian Peacock (2022). \textit{A-118 Psychedelic Interventions for Neuropsychological Conditions}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acac060.118}{doi:10.1093/arclin/acac060.118}.
\item Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V. (2022). \textit{The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/07067437221111371}{doi:10.1177/07067437221111371}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J. (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. (2022). \textit{The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06187-5}{doi:10.1007/s00213-022-06187-5}.
\item Unknown authors (2022). \textit{Depression: Psilocybin etwas besser als Escitalopram}. Zeitschrift für Phytotherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1857-9047}{doi:10.1055/a-1857-9047}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y (2022). \textit{Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0036}{doi:10.1089/jpm.2022.0036}.
\item Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D (2022). \textit{Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221101061}{doi:10.1177/02698811221101061}.
\item Golden CT, Chadderton P. (2022). \textit{Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-16325-w}{doi:10.1038/s41598-022-16325-w}.
\item University of California, San Diego (2022). \textit{Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04661514}{source link}.
\item Meyer TD, Meir P, Lex C, Soares JC. (2022). \textit{Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.}. Psychiatry Research. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114727}{doi:10.1016/j.psychres.2022.114727}.
\item Ko K, Knight G, Rucker JJ, Cleare AJ. (2022). \textit{Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.917199}{doi:10.3389/fpsyt.2022.917199}.
\item Berens N, Kim SY. (2022). \textit{Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2022.07.003}{doi:10.1016/j.jagp.2022.07.003}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M. (2022). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Bosch OG, Halm S, Seifritz E. (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. (2022). \textit{Psychedelic drugs for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120332}{doi:10.1016/j.jns.2022.120332}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2022). \textit{Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.29.498015}{doi:10.1101/2022.06.29.498015}.
\item Gokul Raj (2022). \textit{Psychedelic use in India, its pattern and personal significance - findings from an online survey}. Indian Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry\_447\_21}{doi:10.4103/indianjpsychiatry.indianjpsychiatry\_447\_21}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM, Giribaldi B, Erritzoe D, Nutt D, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sb5ur}{doi:10.31234/osf.io/sb5ur}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Lyons A. (2022). \textit{Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/36204170}{source link}.
\item Unknown authors (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/sb5ur\_v1}{source link}.
\item Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P.C. Kuypers, Zach Walsh (2022). \textit{Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls}. VIUspace. [published; OpenAlex]. \href{https://doi.org/10.25316/ir-20556}{doi:10.25316/ir-20556}.
\item Wake Network, Inc. (2022). \textit{Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04989972}{source link}.
\item Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D. (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xwu4j}{doi:10.31234/osf.io/xwu4j}.
\item Unknown authors (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xwu4j\_v1}{source link}.
\item Vorobyeva N, Kozlova AA. (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Inouye A, Wolfgang A. (2022). \textit{3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.26402}{doi:10.7759/cureus.26402}.
\item J Schneider, JP Cooper, S Davies, K Beltran (2022). \textit{MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression}. Value in Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jval.2022.04.1227}{doi:10.1016/j.jval.2022.04.1227}.
\item Knudsen GM. (2022). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Schmidt C, Wolff M, Gründer G, Jungaberle H. (2022). \textit{[Attitudes of Mental Health Experts Towards Psilocybin].}. Fortschritte der Neurologie · Psychiatrie. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1846-1161}{doi:10.1055/a-1846-1161}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K. (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Hibicke M, Nichols CD. (2022). \textit{Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14165-2}{doi:10.1038/s41598-022-14165-2}.
\item Annie M. McCartney, H. T. McGovern, Alexander De Foe (2022). \textit{Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00211}{doi:10.1556/2054.2022.00211}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Manish Agrawal, Paul Thambi, Sarah Shnayder (2022). \textit{The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2022.40.16\_suppl.12097}{doi:10.1200/jco.2022.40.16\_suppl.12097}.
\item Kaushal Shah, C. Trivedi, D. Kamrai, M. Akbar, W. Tankersley (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2022.837}{doi:10.1192/j.eurpsy.2022.837}.
\item van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH (2022). \textit{How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06106-8}{doi:10.1007/s00213-022-06106-8}.
\item Husain MI, Umer M, Mulsant BH (2022). \textit{Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2063274}{doi:10.1080/14740338.2022.2063274}.
\item Smausz R, Neill J, Gigg J. (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Jairaj C, Rucker JJ. (2022). \textit{Postpartum depression: A role for psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221093793}{doi:10.1177/02698811221093793}.
\item Sotille R, Singh H, Weisman A, Vida T. (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item Richard Karel (2022). \textit{Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.06.6.30}{doi:10.1176/appi.pn.2022.06.6.30}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item National Institute of Mental Health, Czech Republic (2022). \textit{Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05383313}{source link}.
\item Lenz C, Dörner S, Trottmann F, Hertweck C, Sherwood A, Hoffmeister D. (2022). \textit{Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200183}{doi:10.1002/cbic.202200183}.
\item Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan (2022). \textit{The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/2666082218666220513142002}{doi:10.2174/2666082218666220513142002}.
\item Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H. (2022). \textit{Magic mushroom extracts in lipid membranes.}. Biochimica et Biophysica Acta (BBA) - Biomembranes. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbamem.2022.183957}{doi:10.1016/j.bbamem.2022.183957}.
\item Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G (2022). \textit{The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.}. Systematic reviews. [published; PubMed]. \href{https://doi.org/10.1186/s13643-022-01930-7}{doi:10.1186/s13643-022-01930-7}.
\item Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M (2022). \textit{The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.}. Journal of midwifery \& women's health. [published; PubMed]. \href{https://doi.org/10.1111/jmwh.13371}{doi:10.1111/jmwh.13371}.
\item Claudia Schwarz-Plaschg (2022). \textit{Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States}. European Journal of Futures Research. [published; OpenAlex]. \href{https://doi.org/10.1186/s40309-022-00199-2}{doi:10.1186/s40309-022-00199-2}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes (2022). \textit{P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.624}{doi:10.1016/j.biopsych.2022.02.624}.
\item Unknown authors (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a25wb\_v1}{source link}.
\item Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. (2022). \textit{Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.}. Expert Opinion on Drug Safety. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2066650}{doi:10.1080/14740338.2022.2066650}.
\item Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR. (2022). \textit{Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2022.108195}{doi:10.1016/j.pharmthera.2022.108195}.
\item Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS. (2022). \textit{The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114577}{doi:10.1016/j.psychres.2022.114577}.
\item Hayes C, Wahba M, Watson S. (2022). \textit{Will psilocybin lose its magic in the clinical setting?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253221090822}{doi:10.1177/20451253221090822}.
\item Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. (2022). \textit{Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules27082520}{doi:10.3390/molecules27082520}.
\item Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2022). \textit{Increased global integration in the brain after psilocybin therapy for depression.}. Nature Medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01744-z}{doi:10.1038/s41591-022-01744-z}.
\item Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana (2022). \textit{Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.271}{doi:10.51126/revsalus.v4isup.271}.
\item Antonia Kuhn, Matthias F. Melzig (2022). \textit{Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf}. Zeitschrift für Phytotherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1540-9907}{doi:10.1055/a-1540-9907}.
\item Unknown authors (2022). \textit{Psilocybin increases brain network integration in patients with depression.}. Nature Medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01769-4}{doi:10.1038/s41591-022-01769-4}.
\item Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R. (2022). \textit{Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.788155}{doi:10.3389/fphar.2021.788155}.
\item Pots W, Chakhssi F. (2022). \textit{Psilocybin-Assisted Compassion Focused Therapy for Depression.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.812930}{doi:10.3389/fpsyg.2022.812930}.
\item Michael Avissar, Adrian Jacques H. Ambrose (2022). \textit{Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.04.4.35}{doi:10.1176/appi.pn.2022.04.4.35}.
\item Earleywine M, Low F, Altman BR, De Leo J. (2022). \textit{How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2047842}{doi:10.1080/02791072.2022.2047842}.
\item McClure-Begley TD, Roth BL. (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Kisely S, Connor M, Somogyi AA, Siskind D. (2022). \textit{A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674221083868}{doi:10.1177/00048674221083868}.
\item Meade E, Hehir S, Rowan N, Garvey M. (2022). \textit{Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8030290}{doi:10.3390/jof8030290}.
\item Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T. (2022). \textit{Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-1321542/v1}{doi:10.21203/rs.3.rs-1321542/v1}.
\item Bethany Halford﻿ (2022). \textit{Rediscovering psychedelics}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10009-cover}{doi:10.1021/cen-10009-cover}.
\item Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF. (2022). \textit{Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11864-022-00954-4}{doi:10.1007/s11864-022-00954-4}.
\item Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G. (2022). \textit{Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.}. Neuroscience Applied. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2022.100104}{doi:10.1016/j.nsa.2022.100104}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item Sekula AD, Downey L, Puspanathan P. (2022). \textit{Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.813746}{doi:10.3389/fpsyg.2022.813746}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. (2022). \textit{Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. (2022). \textit{The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2044096}{doi:10.1080/02791072.2022.2044096}.
\item Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2022). \textit{Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-01846-9}{doi:10.1038/s41398-022-01846-9}.
\item Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL. (2022). \textit{Increased low-frequency brain responses to music after psilocybin therapy for depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.13.480302}{doi:10.1101/2022.02.13.480302}.
\item Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP. (2022). \textit{Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm11040938}{doi:10.3390/jcm11040938}.
\item Bethany Halford﻿ (2022). \textit{Hallucinogen chemistry guides antidepressant drug discovery}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10005-leadcon}{doi:10.1021/cen-10005-leadcon}.
\item Coppola M, Bevione F, Mondola R. (2022). \textit{Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jox12010004}{doi:10.3390/jox12010004}.
\item Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. (2022). \textit{Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).}. ACS Omega. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.1c06708}{doi:10.1021/acsomega.1c06708}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. (2022). \textit{Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211073759}{doi:10.1177/02698811211073759}.
\item Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ. (2022). \textit{[Are psychedelics fast acting antidepressant agents?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01255-1}{doi:10.1007/s00115-021-01255-1}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G. (2022). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S. (2022). \textit{Structure-based discovery of nonhallucinogenic psychedelic analogs.}. Science. [published; Europe PMC]. \href{https://doi.org/10.1126/science.abl8615}{doi:10.1126/science.abl8615}.
\item James Bailey Sanford (2022). \textit{Psychedelics hold promise for primary care research}. Family Practice. [published; OpenAlex]. \href{https://doi.org/10.1093/fampra/cmac009}{doi:10.1093/fampra/cmac009}.
\item Miceli McMillan R, Jordens C. (2022). \textit{Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11019-022-10070-7}{doi:10.1007/s11019-022-10070-7}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Jurriaan F. M. Strous (2022). \textit{Psilocybine vergeleken met escitalopram bij depressie}. Pure Amsterdam UMC. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae}{source link}.
\item Strous JFM. (2022). \textit{[Psilocybin compared with escitalopram for depression].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/35138714}{source link}.
\item Jones GM, Nock MK. (2022). \textit{Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211066714}{doi:10.1177/02698811211066714}.
\item Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH. (2022). \textit{The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211064720}{doi:10.1177/02698811211064720}.
\item Altman BR, Earleywine M, De Leo J. (2022). \textit{Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.2020382}{doi:10.1080/02791072.2021.2020382}.
\item A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska (2021). \textit{Neurochemical properties of psilocybin in comparison to ketamine in vivo}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100408}{doi:10.1016/j.nsa.2022.100408}.
\item Daisuke Ibi (2021). \textit{Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.96.0\_4-b-s43-2}{doi:10.1254/jpssuppl.96.0\_4-b-s43-2}.
\item Jeff Tarrant (2021). \textit{SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?}. Biofeedback. [published; OpenAlex]. \href{https://doi.org/10.5298/1081-5937-50.03.03}{doi:10.5298/1081-5937-50.03.03}.
\item Unknown authors (2021). \textit{Psilocybin may be effective for treatment-resistant depression}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2022.1.164911}{doi:10.1211/pj.2022.1.164911}.
\item Unknown authors (2021). \textit{Psilocybin: a psychedelic alternative to antidepressants?}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2022.1.169269}{doi:10.1211/pj.2022.1.169269}.
\item Daisuke Ibi (2021). \textit{Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.95.0\_3-s35-1}{doi:10.1254/jpssuppl.95.0\_3-s35-1}.
\item G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia (2021). \textit{The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100213}{doi:10.1016/j.nsa.2022.100213}.
\item G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia (2021). \textit{The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100511}{doi:10.1016/j.nsa.2022.100511}.
\item Liechti ME, Holze F. (2021). \textit{Dosing Psychedelics and MDMA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_270}{doi:10.1007/7854\_2021\_270}.
\item Agin-Liebes G, Davis AK. (2021). \textit{Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.}. Current topics in behavioral neurosciences. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_282}{doi:10.1007/7854\_2021\_282}.
\item Sousa TR, Rema J, Machado S, Novais F. (2021). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current Topics in Medicinal Chemistry. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. (2021). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. PubMed. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR (2021). \textit{The Potential of Psychedelics for End of Life and Palliative Care.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_278}{doi:10.1007/7854\_2021\_278}.
\item Khan AJ, Bradley E, O'Donovan A, Woolley J. (2021). \textit{Psilocybin for Trauma-Related Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_366}{doi:10.1007/7854\_2022\_366}.
\item Raison CL, Jain R, Penn AD, Cole SP, Jain S (2021). \textit{Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.831092}{doi:10.3389/fpsyt.2022.831092}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2021). \textit{Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.877390}{doi:10.3389/fpsyt.2022.877390}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. (2021). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Marseille E, Bertozzi S, Kahn JG (2021). \textit{The economics of psychedelic-assisted therapies: A research agenda.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1025726}{doi:10.3389/fpsyt.2022.1025726}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2021). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Köck P, Froelich K, Walter M, Lang U, Dürsteler KM. (2021). \textit{A systematic literature review of clinical trials and therapeutic applications of ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jsat.2021.108717}{doi:10.1016/j.jsat.2021.108717}.
\item University Hospital, Basel, Switzerland (2021). \textit{LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03153579}{source link}.
\item Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M. (2021). \textit{Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211050556}{doi:10.1177/02698811211050556}.
\item Elman I, Pustilnik A, Borsook D. (2021). \textit{Beating pain with psychedelics: Matter over mind?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Pearson C, Siegel J, Gold JA. (2021). \textit{Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2021.120096}{doi:10.1016/j.jns.2021.120096}.
\item Johns Hopkins University (2021). \textit{Effects of Psilocybin in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03181529}{source link}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL. (2021). \textit{1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Whitfield HJ. (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer (2021). \textit{P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.394}{doi:10.1016/j.euroneuro.2021.10.394}.
\item Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris (2021). \textit{P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.741}{doi:10.1016/j.euroneuro.2021.10.741}.
\item Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito (2021). \textit{P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.797}{doi:10.1016/j.euroneuro.2021.10.797}.
\item Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA. (2021). \textit{Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?}. Bioengineered. [published; Europe PMC]. \href{https://doi.org/10.1080/21655979.2021.1987090}{doi:10.1080/21655979.2021.1987090}.
\item Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A. (2021). \textit{Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.}. BMJ Open. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2021-056091}{doi:10.1136/bmjopen-2021-056091}.
\item Slocum ST, DiBerto JF, Roth BL. (2021). \textit{Molecular insights into psychedelic drug action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Linda M. Richmond (2021). \textit{Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.11.29}{doi:10.1176/appi.pn.2021.11.29}.
\item David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman (2021). \textit{Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.12.14}{doi:10.1176/appi.pn.2021.12.14}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. (2021). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME. (2021). \textit{Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.}. Clinical Pharmacology \& Therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.2487}{doi:10.1002/cpt.2487}.
\item Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z. (2021). \textit{Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-021-01811-4}{doi:10.1038/s41598-021-01811-4}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. (2021). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Strickland JC, Johnson MW. (2021). \textit{Human behavioral pharmacology of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2021.10.003}{doi:10.1016/bs.apha.2021.10.003}.
\item Gass P, Vasilescu AN, Inta D. (2021). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Graham F. (2021). \textit{Daily briefing: Largest trial shows psilocybin is effective to treat depression.}. Nature. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-03413-6}{doi:10.1038/d41586-021-03413-6}.
\item Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. (2021). \textit{Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01706-y}{doi:10.1038/s41398-021-01706-y}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M. (2021). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Dee Dee Goldpaugh (2021). \textit{Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction}. Sexual \& Relationship Therapy. [published; OpenAlex]. \href{https://doi.org/10.1080/14681994.2021.1994138}{doi:10.1080/14681994.2021.1994138}.
\item Maryland Oncology Hematology, PA (2021). \textit{The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04593563}{source link}.
\item Ryan Cross﻿ (2021). \textit{Delix to synthesize psychedelic drugs}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09936-buscon3}{doi:10.1021/cen-09936-buscon3}.
\item Gonda X, Dome P, Neill JC, Tarazi FI. (2021). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Zeiss R, Gahr M, Graf H. (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Alison Knopf (2021). \textit{Psilocybin: Next to treat depression, OCD and nicotine addiction}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33204}{doi:10.1002/adaw.33204}.
\item Aleksandrova LR, Phillips AG. (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Li NX, Hu YR, Chen WN, Zhang B. (2021). \textit{Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2021.09.041}{doi:10.1016/j.jad.2021.09.041}.
\item Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir (2021). \textit{The therapeutical role of psychedelic drugs in treatment of mental disorders}. Bulletin of Integrative Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.36219/bpi.2021.3.09}{doi:10.36219/bpi.2021.3.09}.
\item Benjamin R. Lewis, Kevin Byrne (2021). \textit{Is MDD the right target for early-stage psychedelic-assisted therapy trials?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00180}{doi:10.1556/2054.2021.00180}.
\item Leger RF, Unterwald EM. (2021). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Tehseen Noorani, Jonny Martell (2021). \textit{New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2021.727050}{doi:10.3389/fpsyt.2021.727050}.
\item Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia (2021). \textit{Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?}. Revista Portuguesa de Psiquiatria e Saúde Mental. [published; OpenAlex]. \href{https://doi.org/10.51338/rppsm.2021.v7.i3.241}{doi:10.51338/rppsm.2021.v7.i3.241}.
\item Kverno KS, Mangano E. (2021). \textit{Treatment-Resistant Depression: Approaches to Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20210816-01}{doi:10.3928/02793695-20210816-01}.
\item Ryan Cross﻿ (2021). \textit{Beckley raises funds for psychedelic drugs}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09930-buscon17}{doi:10.1021/cen-09930-buscon17}.
\item Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla (2021). \textit{Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v10i10.19297}{doi:10.33448/rsd-v10i10.19297}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Wayne Hall, Michael Farrell (2021). \textit{What can we learn from the history of research on psychedelic drugs in the addictions?}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.15560}{doi:10.1111/add.15560}.
\item Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R. (2021). \textit{Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14080793}{doi:10.3390/ph14080793}.
\item Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.}. Pharmacopsychiatry. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1524-2794}{doi:10.1055/a-1524-2794}.
\item Markus Weih (2021). \textit{Mit Psilocybin gegen Depression}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-021-2012-7}{doi:10.1007/s15005-021-2012-7}.
\item Wiley JF, Bei B. (2021). \textit{Psilocybin for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmc2108082}{doi:10.1056/nejmc2108082}.
\item Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M. (2021). \textit{The Potential Role of Serotonergic Hallucinogens in Depression Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/life11080765}{doi:10.3390/life11080765}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K. (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Nick Zagorski (2021). \textit{Psychedelic Therapy Hits Another Milestone, But Caution Urged}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.7.14}{doi:10.1176/appi.pn.2021.7.14}.
\item King's College London (2021). \textit{A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04959253}{source link}.
\item Unknown authors (2021). \textit{Trial of psilocybin does not show major difference from antidepressant}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30751}{doi:10.1002/pu.30751}.
\item Watts R. (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5x2bu}{doi:10.31234/osf.io/5x2bu}.
\item Unknown authors (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5x2bu\_v1}{source link}.
\item Coppola M, Bevione F, Mondola R. (2021). \textit{Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202106.0682.v1}{doi:10.20944/preprints202106.0682.v1}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9kuhs}{doi:10.31234/osf.io/9kuhs}.
\item Unknown authors (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9kuhs\_v1}{source link}.
\item Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire (2021). \textit{Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa}. OBM Neurobiology. [published; OpenAlex]. \href{https://doi.org/10.21926/obm.neurobiol.2102102}{doi:10.21926/obm.neurobiol.2102102}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR. (2021). \textit{Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.}. Irish Journal of Medical Science (1971 -). [published; Europe PMC]. \href{https://doi.org/10.1007/s11845-021-02668-2}{doi:10.1007/s11845-021-02668-2}.
\item Fradkin D. (2021). \textit{Psilocybin: A brief overview for psychiatric mental health nurse practitioners.}. Perspectives In Psychiatric Care. [published; Europe PMC]. \href{https://doi.org/10.1111/ppc.12888}{doi:10.1111/ppc.12888}.
\item Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT. (2021). \textit{Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.}. Experimental and Clinical Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000490}{doi:10.1037/pha0000490}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL. (2021). \textit{Psychedelics and health behaviour change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item Magaraggia I, Kuiperes Z, Schreiber R. (2021). \textit{Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nlm.2021.107467}{doi:10.1016/j.nlm.2021.107467}.
\item Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2021). \textit{Decreased brain modularity after psilocybin therapy for depression.}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-513323/v1}{doi:10.21203/rs.3.rs-513323/v1}.
\item Unknown authors (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1037/pne0000290}{doi:10.1037/pne0000290}.
\item Lewis-Healey E, Laukkonen RE, van Elk M. (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q3ymd}{doi:10.31234/osf.io/q3ymd}.
\item Wayne Hall (2021). \textit{The need for publicly funded research on therapeutic use of psychedelic drugs}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20847}{doi:10.1002/wps.20847}.
\item Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD. (2021). \textit{Registered clinical studies investigating psychedelic drugs for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2021.05.019}{doi:10.1016/j.jpsychires.2021.05.019}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Unknown authors (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Reynolds CF. (2021). \textit{Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2020.2901}{doi:10.1001/jamapsychiatry.2020.2901}.
\item Davis AK, Griffiths RR. (2021). \textit{Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2020.4638}{doi:10.1001/jamapsychiatry.2020.4638}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Bird CIV, Modlin NL, Rucker JJH. (2021). \textit{Psilocybin and MDMA for the treatment of trauma-related psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2021.1919062}{doi:10.1080/09540261.2021.1919062}.
\item University of Zurich (2021). \textit{Characterization of Altered Waking States of Consciousness in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03853577}{source link}.
\item Katrin H. Preller (2021). \textit{Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.036}{doi:10.1016/j.biopsych.2021.02.036}.
\item Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam (2021). \textit{Effectiveness of Psilocybin on Depression: A Qualitative Study}. Electronic Journal of General Medicine. [published; OpenAlex]. \href{https://doi.org/10.29333/ejgm/10862}{doi:10.29333/ejgm/10862}.
\item Andrew Penn, Janis Phelps, William E. Rosa, Jean Watson (2021). \textit{Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678211011013}{doi:10.1177/00221678211011013}.
\item Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A. (2021). \textit{[Efficacy of psychedelics in psychiatry, a systematic review of the literature].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.12.002}{doi:10.1016/j.encep.2020.12.002}.
\item Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio (2021). \textit{O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n2-395}{doi:10.34119/bjhrv4n2-395}.
\item Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD. (2021). \textit{Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.04.02.21254838}{doi:10.1101/2021.04.02.21254838}.
\item Dworatzyk K, Jansen T, Schmidt TT. (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kxmgq}{doi:10.31234/osf.io/kxmgq}.
\item Unknown authors (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kxmgq\_v1}{source link}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. (2021). \textit{Trial of Psilocybin versus Escitalopram for Depression.}. New England Journal of Medicine. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2032994}{doi:10.1056/nejmoa2032994}.
\item Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. (2021). \textit{Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.}. Proceedings of the National Academy of Sciences. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.2022489118}{doi:10.1073/pnas.2022489118}.
\item Stanley N. Caroff (2021). \textit{The Return of Psychedelics: Still Time to Prevent Tragedy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.4.8}{doi:10.1176/appi.pn.2021.4.8}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR. (2021). \textit{Cannabis-induced oceanic boundlessness.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R. (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8vks6}{doi:10.31234/osf.io/8vks6}.
\item Unknown authors (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8vks6\_v1}{source link}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S. (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE. (2021). \textit{Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.}. ACS Pharmacology \& Translational Science. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.1c00020}{doi:10.1021/acsptsci.1c00020}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Unknown authors (2021). \textit{Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD}. Journal of Clinical \& Experimental Immunology. [published; OpenAlex]. \href{https://doi.org/10.33140/jcei.06.02.01}{doi:10.33140/jcei.06.02.01}.
\item Nick Zagorski (2021). \textit{Session on Psychedelics Sure to Be Enlightening}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.3.14}{doi:10.1176/appi.pn.2021.3.14}.
\item Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM. (2021). \textit{Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.640241}{doi:10.3389/fphar.2021.640241}.
\item Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r726d}{doi:10.31234/osf.io/r726d}.
\item Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. (2021). \textit{Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121991822}{doi:10.1177/0269881121991822}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2021). \textit{Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.16.431276}{doi:10.1101/2021.02.16.431276}.
\item Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E. (2021). \textit{Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.586682}{doi:10.3389/fpsyt.2021.586682}.
\item Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers (2021). \textit{Behandeling met psilocybine}. Data Archiving and Networked Services (DANS). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429}{source link}.
\item Breeksema JJ, Koolen MHB, Somers M, Schoevers RA. (2021). \textit{[Treatment with psilocybin: applications for patients with psychiatric disorders].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/33560605}{source link}.
\item Barnett BS, Greer GR. (2021). \textit{Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaclp.2020.12.011}{doi:10.1016/j.jaclp.2020.12.011}.
\item Mertens LJ, Preller KH. (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2021). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22020835}{doi:10.3390/ijms22020835}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Unknown authors (2021). \textit{Study: Psilocybin enhances therapy in patients with major depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30675}{doi:10.1002/pu.30675}.
\item Joshua Woolley (2021). \textit{Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02950467}{source link}.
\item Unknown authors (2020). \textit{Psilocybin therapy appears as effective as escitalopram, small study finds}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2021.1.91592}{doi:10.1211/pj.2021.1.91592}.
\item Yogesh Kumar Chahar (2020). \textit{Unmet need in depression: Psilocybin, a breakthrough treatment option}. International Journal of Advanced Research in Medicine. [published; OpenAlex]. \href{https://doi.org/10.22271/27069567.2021.v3.i1f.159}{doi:10.22271/27069567.2021.v3.i1f.159}.
\item Robert A. Mikos (2020). \textit{We Need a Cole Memorandum for Magic Mushrooms}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3839551}{source link}.
\item Harmony I. Risca (2020). \textit{Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777\&context=dissertations}{source link}.
\item Tullis P. (2020). \textit{How ecstasy and psilocybin are shaking up psychiatry.}. Nature. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-00187-9}{doi:10.1038/d41586-021-00187-9}.
\item Bouso JC, Ona G, Dos Santos RG, Hallak JEC. (2020). \textit{Psychedelic Medicines in Major Depression: Progress and Future Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-33-6044-0\_26}{doi:10.1007/978-981-33-6044-0\_26}.
\item Sheppard B. (2020). \textit{A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/35026878}{source link}.
\item Castro Santos H, Gama Marques J. (2020). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Gerber K, Flores IG, Ruiz AC, Ali I, Ginsberg NL, Schenberg EE. (2020). \textit{Ethical Concerns about Psilocybin Intellectual Property.}. ACS Pharmacology \& Translational Science. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.0c00171}{doi:10.1021/acsptsci.0c00171}.
\item Eleftheriou ME, Thomas E (2020). \textit{Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.707057}{doi:10.3389/fpsyt.2021.707057}.
\item Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE (2020). \textit{Psychedelics and Other Psychoplastogens for Treating Mental Illness.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727117}{doi:10.3389/fpsyt.2021.727117}.
\item Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J (2020). \textit{Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.737738}{doi:10.3389/fpsyt.2021.737738}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2020). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2020). \textit{Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.780696}{doi:10.3389/fpsyt.2021.780696}.
\item Savalia NK, Shao LX, Kwan AC. (2020). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Sanah Malomile Nkadimeng, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-79328-5}{doi:10.1038/s41598-020-79328-5}.
\item Monnica T. Williams, Alan K. Davis, Yitong Xin, Nathan D. Sepeda, Pamela Colón Grigas, Sinead M. Sinnott, Angela M. Haeny (2020). \textit{People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2020.1854688}{doi:10.1080/09687637.2020.1854688}.
\item Christopher S. Stauffer, B. Anderson, Kile Ortigo, Joshua Woolley (2020). \textit{Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00169}{doi:10.1021/acsptsci.0c00169}.
\item University Hospital, Basel, Switzerland (2020). \textit{Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03912974}{source link}.
\item Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. (2020). \textit{Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13249}{doi:10.1111/acps.13249}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2020). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202011.0742.v1}{doi:10.20944/preprints202011.0742.v1}.
\item De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G. (2020). \textit{Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1659-20.2020}{doi:10.1523/jneurosci.1659-20.2020}.
\item Bottemanne H, Claret A, Fossati P. (2020). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Oskar Hougaard Jefsen, Betina Elfving, Gregers Wegener, Heidi Kaastrup Müller (2020). \textit{Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959614}{doi:10.1177/0269881120959614}.
\item Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, Roland R. Griffiths (2020). \textit{Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2020.3285}{doi:10.1001/jamapsychiatry.2020.3285}.
\item Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/nhbjk}{doi:10.31234/osf.io/nhbjk}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch (2020). \textit{The Role of Psychedelics and Counseling in Mental Health Treatment}. Journal of Mental Health Counseling. [published; OpenAlex]. \href{https://doi.org/10.17744/mehc.42.4.03}{doi:10.17744/mehc.42.4.03}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item B. Anderson, Alicia Danforth, Prof Robert Daroff, Christopher S. Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, James Dilley, Jennifer Mitchell, Joshua Woolley (2020). \textit{Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2020.100538}{doi:10.1016/j.eclinm.2020.100538}.
\item Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML. (2020). \textit{Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2020.1817639}{doi:10.1080/02791072.2020.1817639}.
\item Vitkauskas M, Mathuru AS. (2020). \textit{Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms21186525}{doi:10.3390/ijms21186525}.
\item Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L. (2020). \textit{Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/biomedicines8090331}{doi:10.3390/biomedicines8090331}.
\item Teresa Kay Jones, Steven Lippmann (2020). \textit{Psilocybin Can Diminish Depression}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.19br02580}{doi:10.4088/pcc.19br02580}.
\item Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. (2020). \textit{Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-020-00748-y}{doi:10.1007/s40263-020-00748-y}.
\item Sanah Malomile Nkadimeng, Alice Nabatanzi, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom}. Plants. [published; OpenAlex]. \href{https://doi.org/10.3390/plants9091127}{doi:10.3390/plants9091127}.
\item Kuypers KPC. (2020). \textit{The therapeutic potential of microdosing psychedelics in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320950567}{doi:10.1177/2045125320950567}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Cornelia Stress, Katrin H. Preller, Thomas Koenig, Franz X. Vollenweider (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane (2020). \textit{Psychedelic science in post-COVID-19 psychiatry}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item James D. Tucker (2020). \textit{Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3783484\_code4550530.pdf?abstractid=3783484\&mirid=1}{source link}.
\item Guss J, Krause R, Sloshower J. (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u6v9y}{doi:10.31234/osf.io/u6v9y}.
\item Unknown authors (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u6v9y\_v1}{source link}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item Luoma JB. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sgujx}{doi:10.31234/osf.io/sgujx}.
\item Nick Zagorski (2020). \textit{Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.6a34}{doi:10.1176/appi.pn.2020.6a34}.
\item Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item Nichols DE. (2020). \textit{Psilocybin: from ancient magic to modern medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41429-020-0311-8}{doi:10.1038/s41429-020-0311-8}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020). \textit{Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05477-0}{doi:10.1007/s00213-020-05477-0}.
\item University of Wisconsin, Madison (2020). \textit{Pharmacokinetics of Psilocybin in Normal Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02163707}{source link}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu (2020). \textit{Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin}. Clinical Pharmacology in Drug Development. [published; OpenAlex]. \href{https://doi.org/10.1002/cpdd.796}{doi:10.1002/cpdd.796}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item David Nutt, David Erritzøe, Robin Carhart-Harris (2020). \textit{Psychedelic Psychiatry’s Brave New World}. Cell. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cell.2020.03.020}{doi:10.1016/j.cell.2020.03.020}.
\item Heuschkel K, Kuypers KPC. (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Richard Simoneaux (2020). \textit{Long-Term Analysis of Psilocybin in Cancer Patients With Distress}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000660232.19098.7f}{doi:10.1097/01.cot.0000660232.19098.7f}.
\item Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK. (2020). \textit{Long-term effects of psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.03.017}{doi:10.1016/j.neubiorev.2020.03.017}.
\item Benko J, Vranková S. (2020). \textit{Natural Psychoplastogens As Antidepressant Agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules25051172}{doi:10.3390/molecules25051172}.
\item Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, Zoe K. Talman, Charles D. Nichols (2020). \textit{Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.9b00493}{doi:10.1021/acschemneuro.9b00493}.
\item Robert B. Kargbo (2020). \textit{Psilocybin Therapeutic Research: The Present and Future Paradigm}. ACS Medicinal Chemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1021/acsmedchemlett.0c00048}{doi:10.1021/acsmedchemlett.0c00048}.
\item Janis Fricke, Robert B. Kargbo, Lars Regestein, Claudius Lenz, Gundela Peschel, Miriam A. Rosenbaum, Alexander M. Sherwood, Dirk Hoffmeister (2020). \textit{Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.202000134}{doi:10.1002/chem.202000134}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Diseño interior. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.2019.19010035}{doi:10.1176/appi.ajp.2019.19010035}.
\item Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi (2020). \textit{Self-reported negative outcomes of psilocybin users: A quantitative textual analysis}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0229067}{doi:10.1371/journal.pone.0229067}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ. (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Unknown authors (2020). \textit{LSD und Psilocybin als Selbstmedikation}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1085-0309}{doi:10.1055/a-1085-0309}.
\item Chi T, Gold JA. (2020). \textit{A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2020.116715}{doi:10.1016/j.jns.2020.116715}.
\item Heidi Bush (2020). \textit{Psychedelic therapy: Fresh promise for mental health}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.32207}{doi:10.1002/mhw.32207}.
\item Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris (2020). \textit{Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119895520}{doi:10.1177/0269881119895520}.
\item Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss, Anthony P. Bossis, Jim Grigsby, Stacy M. Fischer, Stephen Ross (2020). \textit{Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119897615}{doi:10.1177/0269881119897615}.
\item Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR. (2020). \textit{The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2020.112749}{doi:10.1016/j.psychres.2020.112749}.
\item Brooke Reichenbach (2019). \textit{Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/531}{source link}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Kiomary Rivera Quintana (2019). \textit{Psychedelics: A Window To Mental Illness; Psilocybin And Depression}. Unknown journal. [published; OpenAlex]. \href{https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000\&context=hpd\_corx\_stuarticles}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Katariina Sarajärvi (2019). \textit{Psilocybin's effects on the brain and implications for depression treatment}. Epubl LTU. [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481}{source link}.
\item Krista Worden (2019). \textit{The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.arcadia.edu/showcase/2020/pa/60/}{source link}.
\item Laura Sanders (2019). \textit{Psilocybin may help cancer patients with depression and anxiety for years}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031}{source link}.
\item Reham Shaba (2019). \textit{Development of an improved psilocybin synthesis}. Uppsala University Publications (Uppsala University). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295}{source link}.
\item Nina Schimmel, Joost J. Breeksema, Jolien K. E. Veraart, W van den Brink, Robert A. Schoevers (2019). \textit{[Psychedelics for existential distress in terminally ill patients].}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/32816294}{source link}.
\item Lea T, Amada N, Jungaberle H (2019). \textit{Psychedelic Microdosing: A Subreddit Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1683260}{doi:10.1080/02791072.2019.1683260}.
\item Dalton Budhram, Preet Dhaliwal (2019). \textit{Psilocybin Therapy for Depression: A Scoping Review Protocol}. Open MIND. [published; OpenAlex]. \href{https://osf.io/4syt6}{source link}.
\item Krishna Kumar Varshney (2019). \textit{Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3528349}{source link}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR. (2019). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On. (2019). \textit{Mapping Psilocybin-Assisted Therapies: A Scoping Review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2019.12.04.19013896}{doi:10.1101/2019.12.04.19013896}.
\item Corne R, Mongeau R. (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Dos Santos RG, Hallak JEC. (2019). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Martin Andersson, Anette Kjellgren (2019). \textit{Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube}. Harm Reduction Journal. [published; OpenAlex]. \href{https://doi.org/10.1186/s12954-019-0333-3}{doi:10.1186/s12954-019-0333-3}.
\item Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas, Greg Murray, M.L. Williams, David Castle (2019). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta (2019). \textit{Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.11.002}{doi:10.1016/j.jcbs.2019.11.002}.
\item Nick Zagorski (2019). \textit{Johns Hopkins Opens Research Center on Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.10a16}{doi:10.1176/appi.pn.2019.10a16}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2019). \textit{Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-019-2288-z}{doi:10.1186/s12888-019-2288-z}.
\item Kernel Networks Inc. (2019). \textit{Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04123314}{doi:10.31525/ct1-nct04123314}.
\item Megha Satyanarayana (2019). \textit{Modified E. coli pump out psilocybin}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09739-scicon9}{doi:10.1021/cen-09739-scicon9}.
\item Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V. (2019). \textit{The psychedelic renaissance: the next trip for psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/ipm.2019.39}{doi:10.1017/ipm.2019.39}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item Begola MJ, Schillerstrom JE. (2019). \textit{Hallucinogens and Their Therapeutic Use: A Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000409}{doi:10.1097/pra.0000000000000409}.
\item Dustin Marlan (2019). \textit{Beyond Cannabis: Psychedelic Decriminalization and Social Justice}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawcommons.lclark.edu/lclr/vol23/iss3/4}{source link}.
\item Muttoni S, Ardissino M, John C. (2019). \textit{Classical psychedelics for the treatment of depression and anxiety: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.07.076}{doi:10.1016/j.jad.2019.07.076}.
\item David Nutt (2019). \textit{Psychedelic drugs-a new era in psychiatry?}. Dialogues in Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.31887/dcns.2019.21.2/dnutt}{doi:10.31887/dcns.2019.21.2/dnutt}.
\item Richard Simoneaux (2019). \textit{The Potential of Psilocybin Administration in Terminal Cancer Patients}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000574916.46844.cf}{doi:10.1097/01.cot.0000574916.46844.cf}.
\item Janis Fricke, Alexander M. Sherwood, Robert B. Kargbo, Andrew Orry, Felix Blei, Andreas Naschberger, Bernhard Rupp, Dirk Hoffmeister (2019). \textit{Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.201900358}{doi:10.1002/cbic.201900358}.
\item Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, Betina Elfving, David Nutt, Gregers Wegener, Heidi Kaastrup Müller (2019). \textit{Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2019.15}{doi:10.1017/neu.2019.15}.
\item B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley (2019). \textit{T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.03.460}{doi:10.1016/j.biopsych.2019.03.460}.
\item Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG. (2019). \textit{Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125319845774}{doi:10.1177/2045125319845774}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL. (2019). \textit{Rapid-acting antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item McKenna Silva (2019). \textit{Attitudes Toward Medical Psychedelics}. Dominican Scholar (Dominican University of California). [published; OpenAlex]. \href{https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83}{source link}.
\item Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols (2019). \textit{Psychedelics Improve the Mental Health of Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2019.33.1\_supplement.666.1}{doi:10.1096/fasebj.2019.33.1\_supplement.666.1}.
\item Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge (2019). \textit{The Past and Future of Psychedelic Science: An Introduction to This Issue}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1606472}{doi:10.1080/02791072.2019.1606472}.
\item Kernel Networks Inc. (2019). \textit{A Study of Psilocybin for Major Depressive Disorder (MDD)}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03866174}{doi:10.31525/ct1-nct03866174}.
\item Nick Zagorski (2019). \textit{Is Psychedelic Medicine on the Horizon?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.1b1}{doi:10.1176/appi.pn.2019.1b1}.
\item Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug, Kim P. C. Kuypers (2019). \textit{Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1580804}{doi:10.1080/02791072.2019.1580804}.
\item Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus (2019). \textit{Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.}. Experimental and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1037/pha0000253}{doi:10.1037/pha0000253}.
\item Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS. (2019). \textit{Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2019.01.002}{doi:10.1016/j.pnpbp.2019.01.002}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS. (2019). \textit{Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5106-2}{doi:10.1007/s00213-018-5106-2}.
\item Isabella Stendahl (2018). \textit{THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749}{source link}.
\item William G. Crane (2018). \textit{Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality}. Furman University Scholar Exchange (Furman University). [published; OpenAlex]. \href{https://scholarexchange.furman.edu/furmanengaged/2019/all/522}{source link}.
\item P. Dürler (2018). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch (2018). \textit{2018: A watershed year for psychedelic science}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519872284}{doi:10.1177/2050324519872284}.
\item Fadiman J, Korb S (2018). \textit{Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1593561}{doi:10.1080/02791072.2019.1593561}.
\item Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC (2018). \textit{Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00672}{doi:10.3389/fpsyt.2019.00672}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. (2018). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D. (2018). \textit{Production Options for Psilocybin: Making of the Magic.}. Chemistry - A European Journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201802758}{doi:10.1002/chem.201802758}.
\item Kvam TM, Stewart LH, Andreassen OA. (2018). \textit{Psychedelic drugs in the treatment of anxiety, depression and addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4045/tidsskr.17.1110}{doi:10.4045/tidsskr.17.1110}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS. (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gk4jd}{doi:10.31234/osf.io/gk4jd}.
\item Unknown authors (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gk4jd\_v1}{source link}.
\item Lyons T, Carhart-Harris RL. (2018). \textit{More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.01721}{doi:10.3389/fpsyg.2018.01721}.
\item Wasko MJ, Witt-Enderby PA, Surratt CK. (2018). \textit{DARK Classics in Chemical Neuroscience: Ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00294}{doi:10.1021/acschemneuro.8b00294}.
\item Robin Carhart-Harris (2018). \textit{Serotonin, psychedelics and psychiatry}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20555}{doi:10.1002/wps.20555}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Flanagan TW, Nichols CD. (2018). \textit{Psychedelics as anti-inflammatory agents.}. International Review of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S. (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Chu Hsien Lim, Brian D. Kangas, Jack Bergman (2018). \textit{The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients}. Biochemistry and Molecular Biology Education. [published; OpenAlex]. \href{https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients}{source link}.
\item Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT. (2018). \textit{Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/374199}{doi:10.1101/374199}.
\item Johns Hopkins University (2018). \textit{Psychopharmacology of Psilocybin in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00465595}{source link}.
\item Geiger HA, Wurst MG, Daniels RN. (2018). \textit{DARK Classics in Chemical Neuroscience: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00186}{doi:10.1021/acschemneuro.8b00186}.
\item Blei F, Baldeweg F, Fricke J, Hoffmeister D. (2018). \textit{Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.}. Chemistry - A European Journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201801047}{doi:10.1002/chem.201801047}.
\item Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL. (2018). \textit{Effects of psilocybin therapy on personality structure.}. Acta Psychiatrica Scandinavica. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.12904}{doi:10.1111/acps.12904}.
\item Whelan A, Johnson MI. (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S. (2018). \textit{Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00256}{doi:10.3389/fphar.2018.00256}.
\item Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL. (2018). \textit{Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.}. Journal of Affective Disorders. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2018.01.006}{doi:10.1016/j.jad.2018.01.006}.
\item Kuypers KPC. (2018). \textit{Out of the box: A psychedelic model to study the creative mind.}. Medical Hypotheses. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2018.03.010}{doi:10.1016/j.mehy.2018.03.010}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Nichols DE. (2018). \textit{Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00043}{doi:10.1021/acschemneuro.8b00043}.
\item Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R. (2018). \textit{The hidden therapist: evidence for a central role of music in psychedelic therapy.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4820-5}{doi:10.1007/s00213-017-4820-5}.
\item Jessica Hamzelou (2018). \textit{Can psychedelic drug help with depression?}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(18)30332-4}{doi:10.1016/s0262-4079(18)30332-4}.
\item Byock I. (2018). \textit{Taking Psychedelics Seriously.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2017.0684}{doi:10.1089/jpm.2017.0684}.
\item Roseman L, Nutt DJ, Carhart-Harris RL. (2018). \textit{Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2017.00974}{doi:10.3389/fphar.2017.00974}.
\item Lyons T, Carhart-Harris RL. (2018). \textit{Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117748902}{doi:10.1177/0269881117748902}.
\item Anisha Lela Larsson (2017). \textit{Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsa}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476}{source link}.
\item Barrett FS, Griffiths RR. (2017). \textit{Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_474}{doi:10.1007/7854\_2017\_474}.
\item Bogenschutz MP, Ross S. (2017). \textit{Therapeutic Applications of Classic Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD. (2017). \textit{The Effects of Hallucinogens on Gene Expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item Sherwood AM, Prisinzano TE (2017). \textit{Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1415755}{doi:10.1080/17512433.2018.1415755}.
\item Canal CE. (2017). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S. (2017). \textit{Rapid-Acting Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL. (2017). \textit{Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.}. Neuropharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.041}{doi:10.1016/j.neuropharm.2017.12.041}.
\item University of Helsinki (2017). \textit{Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03380442}{source link}.
\item Joanna Stefaniuk (2017). \textit{„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku}. CeON Repository (Centre for Evaluation in Education and Science). [published; OpenAlex]. \href{https://depot.ceon.pl/handle/123456789/13483}{source link}.
\item Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR. (2017). \textit{Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.}. Clinical Pharmacokinetics. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-017-0540-6}{doi:10.1007/s40262-017-0540-6}.
\item Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. (2017). \textit{The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2017.00240}{doi:10.3389/fpsyt.2017.00240}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. (2017). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Barbara Geller (2017). \textit{Can Psilocybin Treat Severe Depression}. Journal watch. [published; OpenAlex]. \href{https://doi.org/10.1056/nejm-jw.na45292}{doi:10.1056/nejm-jw.na45292}.
\item Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL. (2017). \textit{Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4754-y}{doi:10.1007/s00213-017-4754-y}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. (2017). \textit{Psychedelic Drugs in Biomedicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. (2017). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Ahmed Al-Imam (2017). \textit{Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User}. Global Journal of Health Science. [published; OpenAlex]. \href{https://doi.org/10.5539/gjhs.v9n11p168}{doi:10.5539/gjhs.v9n11p168}.
\item STEVE RITTER (2017). \textit{‘Magic mushroom’ enzyme mystery solved}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09533-notw1}{doi:10.1021/cen-09533-notw1}.
\item Al-Imam A. (2017). \textit{Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.}. Case Reports in Neurological Medicine. [published; Europe PMC]. \href{https://doi.org/10.1155/2017/2503762}{doi:10.1155/2017/2503762}.
\item Johnson MW, Griffiths RR. (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. (2017). \textit{[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0043-103085}{doi:10.1055/s-0043-103085}.
\item Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris (2017). \textit{Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817709585}{doi:10.1177/0022167817709585}.
\item Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817715966}{doi:10.1177/0022167817715966}.
\item Strauss N. (2017). \textit{Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.}. The Medical Journal of Australia. [published; Europe PMC]. \href{https://doi.org/10.5694/mja17.00081}{doi:10.5694/mja17.00081}.
\item Thomas K, Malcolm B, Lastra D. (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Carhart-Harris RL, Goodwin GM. (2017). \textit{The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2017.84}{doi:10.1038/npp.2017.84}.
\item Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols (2017). \textit{Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.31.1\_supplement.820.4}{doi:10.1096/fasebj.31.1\_supplement.820.4}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. (2017). \textit{The fibrinolytic system: A new target for treatment of depression with psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2017.01.013}{doi:10.1016/j.mehy.2017.01.013}.
\item Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. (2017). \textit{An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116684335}{doi:10.1177/0269881116684335}.
\item Unknown authors (2016). \textit{Magic mushrooms as a treatment for depression}. Clinical pharmacist. [published; OpenAlex]. \href{https://doi.org/10.1211/cp.2017.20204046}{doi:10.1211/cp.2017.20204046}.
\item Natalie Engström (2016). \textit{Lysergsyradietylamid (LSD) och psilocybin vid depression och ångestsjukdom: En litteraturstudie om effekter och biverkningar av LSD- och psilocybin-assisterad psykoterapi}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681}{source link}.
\item Henry A. Nasrallah (2016). \textit{Maddening Therapies: How Hallucinogens Morphed into Novel Treatments}. Current psychiatry. [published; OpenAlex]. \href{https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into}{source link}.
\item Carlyn Delavan (2016). \textit{Narrative therapy-assisted psilocybin use for treatment of depression}. Unknown journal. [published; OpenAlex]. \href{https://digitalcommons.spu.edu/spfc\_research\_conference/spfc\_conf\_2017/spfc\_conf\_2017\_events/43/}{source link}.
\item Nichols DE, Johnson MW, Nichols CD. (2016). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Bobby Lazzara (2016). \textit{Psilocybin to Manage Cancer-Related Depression}. Unknown journal. [published; OpenAlex]. \href{https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression}{source link}.
\item Nutt D. (2016). \textit{Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675754}{doi:10.1177/0269881116675754}.
\item Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. (2016). \textit{Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675512}{doi:10.1177/0269881116675512}.
\item Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. (2016). \textit{Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675513}{doi:10.1177/0269881116675513}.
\item McCorvy JD, Olsen RH, Roth BL. (2016). \textit{Psilocybin for depression and anxiety associated with life-threatening illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675771}{doi:10.1177/0269881116675771}.
\item Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. (2016). \textit{The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116678781}{doi:10.1177/0269881116678781}.
\item Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. (2016). \textit{Psychedelics in the treatment of unipolar mood disorders: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116679368}{doi:10.1177/0269881116679368}.
\item Mahapatra A, Gupta R. (2016). \textit{Role of psilocybin in the treatment of depression.}. Therapeutic Advances in Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316676092}{doi:10.1177/2045125316676092}.
\item Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz (2016). \textit{Psilocybin as an alternative medicine for patients suffering from depression}. Psychiatria i Psychologia Kliniczna. [published; OpenAlex]. \href{https://doi.org/10.15557/pipk.2016.0023}{doi:10.15557/pipk.2016.0023}.
\item Unknown authors (2016). \textit{Psilocybin zur Behandlung der therapieresistenten Depression}. PSYCH up2date. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0042-110896}{doi:10.1055/s-0042-110896}.
\item Hendrie C, Pickles A. (2016). \textit{Psilocybin: panacea or placebo?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30103-1}{doi:10.1016/s2215-0366(16)30103-1}.
\item Dijkstra FM, Jacobs GE, Cohen AF. (2016). \textit{Question-based Drug Development for psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30214-0}{doi:10.1016/s2215-0366(16)30214-0}.
\item Patra S. (2016). \textit{Return of the psychedelics: Psilocybin for treatment resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2016.08.010}{doi:10.1016/j.ajp.2016.08.010}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR. (2016). \textit{Psilocybin for treating substance use disorders?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Tófoli LF, de Araujo DB. (2016). \textit{Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2016.06.005}{doi:10.1016/bs.irn.2016.06.005}.
\item Howland RH. (2016). \textit{Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.}. Journal of Psychosocial Nursing and Mental Health Services. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20160616-09}{doi:10.3928/02793695-20160616-09}.
\item Unknown authors (2016). \textit{Magic mushroom compound is a potential treatment for patients with major depression.}. Nursing standard (Royal College of Nursing (Great Britain): 1987). [published; PubMed]. \href{https://doi.org/10.7748/ns.30.41.15.s18}{doi:10.7748/ns.30.41.15.s18}.
\item Joseph A. Zamaria (2016). \textit{A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2016.14.2.943}{doi:10.14704/nq.2016.14.2.943}.
\item Hawkes N. (2016). \textit{Sixty seconds on... psilocybin.}. BMJ. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.i2775}{doi:10.1136/bmj.i2775}.
\item Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ. (2016). \textit{Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.}. The Lancet Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30065-7}{doi:10.1016/s2215-0366(16)30065-7}.
\item Cowen P. (2016). \textit{Altered states: psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30087-6}{doi:10.1016/s2215-0366(16)30087-6}.
\item Nichols DE. (2016). \textit{Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.115.011478}{doi:10.1124/pr.115.011478}.
\item Kyzar EJ, Kalueff AV. (2016). \textit{Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/zeb.2016.1251}{doi:10.1089/zeb.2016.1251}.
\item Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. (2016). \textit{Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316638008}{doi:10.1177/2045125316638008}.
\item Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis (2016). \textit{The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eurpsy.2016.01.1060}{doi:10.1016/j.eurpsy.2016.01.1060}.
\item Unknown authors (2015). \textit{Psilocybin shows potential as treatment for depression}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2016.20201222}{doi:10.1211/pj.2016.20201222}.
\item Unknown authors (2015). \textit{Psilocybin shows potential as treatment for depression}. Clinical pharmacist. [published; OpenAlex]. \href{https://doi.org/10.1211/cp.2016.20201222}{doi:10.1211/cp.2016.20201222}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(15)30364-3}{doi:10.1016/s0924-977x(15)30364-3}.
\item Johansen PØ, Krebs TS. (2015). \textit{Psychedelics not linked to mental health problems or suicidal behavior: a population study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114568039}{doi:10.1177/0269881114568039}.
\item D.J. Nutt (2015). \textit{5HT2a Receptors - a New Target for Depression?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30027-4}{doi:10.1016/s0924-9338(15)30027-4}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30017-1}{doi:10.1016/s0924-9338(15)30017-1}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2014). \textit{Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2014.04.010}{doi:10.1016/j.biopsych.2014.04.010}.
\item Nichols DE. (2013). \textit{The Heffter Research Institute: past and hopeful future.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2014.873688}{doi:10.1080/02791072.2014.873688}.
\item Krebs TS, Johansen PØ. (2013). \textit{Psychedelics and mental health: a population study.}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0063972}{doi:10.1371/journal.pone.0063972}.
\item Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. (2013). \textit{Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881113494107}{doi:10.1177/0269881113494107}.
\item Young SN. (2013). \textit{Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.}. Фундаментальные исследования (Fundamental Research). [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.120128}{doi:10.1503/jpn.120128}.
\item Kometer, Michael, Schmidt, André, Jäncke, Lutz, Vollenweider, Franz X (2012). \textit{Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations}. Open MIND. [published; OpenAlex]. \href{https://openalex.org/W6929930661}{source link}.
\item Lyvers M, Meester M. (2012). \textit{Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2012.736842}{doi:10.1080/02791072.2012.736842}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Roiser JP, Rees G. (2012). \textit{Neuroimaging: a scanner, colourfully.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2012.02.033}{doi:10.1016/j.cub.2012.02.033}.
\item Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2010). \textit{Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.}. Archives of General Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1001/archgenpsychiatry.2010.116}{doi:10.1001/archgenpsychiatry.2010.116}.
\item Adams JD. (2008). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Briony J. Catlow (2007). \textit{Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis}. Digital Commons - University of South Florida (University of South Florida). [published; OpenAlex]. \href{https://digitalcommons.usf.edu/etd/166}{source link}.
\item Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren (2005). \textit{Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-2005-918695}{doi:10.1055/s-2005-918695}.
\item Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. (2005). \textit{Hallucinogen persisting perception disorder after psilocybin consumption: a case study.}. European Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eurpsy.2005.04.008}{doi:10.1016/j.eurpsy.2005.04.008}.
\item Leon Gussow (2003). \textit{Designer Hallucinogens}. Emergency Medicine News. [published; OpenAlex]. \href{https://doi.org/10.1097/00132981-200312000-00015}{doi:10.1097/00132981-200312000-00015}.
\item Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider (2003). \textit{P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(03)92355-8}{doi:10.1016/s0924-977x(03)92355-8}.
\item Mohan D, Mohandas E, Rajat R. (1981). \textit{Chloroquine psychosis: a chemical psychosis?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7310924}{source link}.
\item Trulson ME, Heym J, Jacobs BL. (1981). \textit{Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(81)90507-2}{doi:10.1016/0006-8993(81)90507-2}.
\item R Fischer, Diana Warshay (1968). \textit{Psilocybin-induced Autonomic, Perceptual, and Behavioral Change}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094227}{doi:10.1055/s-0028-1094227}.
\item REDA GC, VELLA G, CANCRINI L, D AGOSTINO E. (1964). \textit{[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14144273}{source link}.
\item SERCL M, KOVARIK J, JAROS O. (1960). \textit{[Clinical experiences with psilocybin (CY39 Sandoz)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13910754}{source link}.
\end{enumerate}
\end{document}
